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Abstract 
 
Hexacyclinic acid is a polyketide isolated from Streptomyces cellulosae in 2000 and is 
composed of six cycles, a 5/6/5 fused ring system (A, B and C) connected to a bridged 
tricycle (D, E and F). Hexacyclinic has shown some interesting cytotoxic activities but there 
has been no total synthesis reported in the literature at present. 
 
 
In the first chapter of this thesis, published works found in the literature about hexacyclinic 
acid and FR182877 are reported and commented. A quick summary of the previous work 
done in the Prunet group is also described. 
 
In the second and third chapter, a more detailed account of the work undertaken during this 
PhD was given. Firstly, syntheses of two ABC tricycles incorporating tert-butyl and 
(trimethylsilyl)ethyl esters were undertaken. These syntheses include two key steps 
previously developed in the group, a diastereoselective Michael addition and a Snider 
cyclisation. Multiple conditions for the hydrolysis of the esters were attempted but none of 
them gave the desired product. 
 
The main part of this work is focused on the synthesis of a CDEF model and in particular 
about the development of the key step, the formation of a nine-membered ring. Several 
DEF fragments were synthesised in short synthetic sequences and as single isomers. Six 
different synthetic pathways were developed in total and a novel method, a 
Michael/elimination reaction, was found to be a very efficient way to close the desired 
medium-size ring. From the nine-membered ring, regioselective reduction and palladium-
catalysed allylic substitution led to the formation of the CDF tricycle. Final steps of the 
synthesis were fruitless and led only to decomposition. A synthesis of a chiral C-ring was 
also developed during this PhD. 
 
II 
 
Finally, another project was undertaken, not related to hexacyclinic acid. Methodology 
developed in the group for the diastereoselective formation of trisubstituted alkenes 
employing a temporary silicon-tethered ring-closing metathesis was extended to homoallylic 
alcohols. The first steps of the method were similar to the previous methodology but the 
end-game had to be modified in favour of an oxidation/reduction sequence to successfully 
obtain the desired products with the correct geometry. 
 
In the fourth chapter, procedures and analytical data for the synthesised compounds 
previously described are reported. 
  
III 
 
Author’s declaration 
 
This thesis represents the original work of Alexandre Audic unless otherwise explicitly 
stated and referenced in the text. The research was carried out at the University of Glasgow 
in the Raphael Laboratory under the supervision of Dr Joëlle Prunet during 
the period from the 1st of October 2012 to 31st of March 2016. 
 
  
IV 
 
 
 
 
“Failure is the condiment that gives success its flavor.” – Truman Capote 
  
V 
 
Acknowledgments 
 
First of all, I would like to thank my supervisor, Dr Joëlle Prunet, for giving me the opportunity 
to do my PhD in her group, for the help, guidance and trust she kindly gave me during those 
4 years. 
 
I would also like to thank Dr David France, for all the challenging questions and chemistry 
explanations during our group meetings, sometimes about topics I had never even heard of 
before.   
 
Самую главную благодарность я выражаю моей Марушке (бибиза). Ты была со мной 
с самого начала нашего аспирантского путешествия и ты заслуживаешь отдельного 
"спасибо". В плохие и хорошие дни, ты всегда была рядом, всегда была терпелива. 
Я буду всегда признателен тебе за это. Надеюсь, так будет на все года. 
 
First, I would like to thank members of our group and in particular Aurélien “grumpy” Letort, 
for all the professional and personal conversations we had during those years, for your 
professional and personal help in good and especially bad times, for the horse mask, your 
“graffitis” and other shenanigans, for simply being a friend, a huge thank you. Stéphane “the 
beast from the east”, thank you for your kindness, your patience when I started my PhD, 
you were always extremely helpful. And an additional thank you for always writing clear and 
reproducible experimental! Stephen Morrison, for our long conversations about politics, 
English, economy, reddit and sometime a bit of chemistry, for your constant help especially 
when I moved and to convince me to do some sports, Amaia for the joyful conversations, 
Alex “Felix”, for being simply a nice guy to talk and be around, Liam for being the best DJ 
of the Raphael lab. Thank to all the student I supervised during those years, you taught me 
patience.  
 
To the entire Marquez group and especially to: Tom “Tommy Cat”, Yezekhiel, Sean 
“Lepresean”, Alan Sewell, and Colin “super postdoc”. 
 
To Craig and Lewis for the great laughs and investigations while you were still in the lab, 
David P for the calm presence in the France group. 
 
To the Clark group, Michael PP, Aurélien Junior, Filo, Laëtitia for her kind help, Sam, 
Kirsten, Gregor but especially Ludo, with whom I shared  worries about the PhD, the writing-
VI 
 
up, post-doc, life in general. We truly started to know each other toward the end but it was 
great!  
I would like to thank all the members of staff that have been of great help during my PhD, 
especially Ted, Bruce, Karen, Ali, Jim and Harry. 
 
A special thanks to my family and to my mom who supported me from the very beginning, 
believed in me and has always been here when I needed her. 
 
 
 
 
  
VII 
 
Abbreviations 
 
Ac: Acetyl 
Aq: Aqueous 
ACCN: 1,1′-Azobis(cyclohexanecarbonitrile) 
AIBN: Azobisisobutyronitrile 
BAIB: [Bis(acetoxy)iodo]benzene 
BHT: Butylated hydroxytoluene 
Bn: Benzyl 
brsm: Based on recovered of starting material 
Bz: Benzoyl 
Cat: Catalytic 
COD: 1,5-Cyclooctadiene 
CM: Cross-metathesis 
Cp*: 1,2,3,4,5-Pentamethylcyclopentadiene 
CSA: Camphorsulfonic acid 
d: day 
dba: Dibenzylideneacetone 
DBU: 1,8-Diazabicyclo[5.4.0]undec-7-ene 
DIAD: Diisopropyl azodicarboxylate 
DIBAL-H: Diisobutylaluminium hydride 
DIPEA: N,N-Diisopropylethylamine 
DMAP: 4-Dimethylaminopyridine 
DMF: Dimethylformamide 
DMP: Dess-Martin periodinane 
DMSO: Dimethyl sulfoxide 
dppe: 1,2-Bis(diphenylphosphino)ethane 
dppf: 1,1′-Ferrocenediyl-bis(diphenylphosphine) 
dr: Diastereomeric ratio 
EDC: 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
ee: Enantiomeric excess 
ent: Enantiomer 
Et: Ethyl 
Equiv: Equivalent 
FGI: Functional group interconversion 
GI50: Growth inhibition of 50% of cancer cells 
h: hour 
VIII 
 
HMPA: Hexamethylphosphoramide 
HWE: Horner–Wadsworth–Emmons 
Hz: Hertz 
i: iso 
IMDA: Intramolecular Diels-Alder 
IMHDA: Intramolecular hetero-Diels-Alder 
m: Meta 
M: Molar 
MBH: Morita-Baylis-Hillman 
m-CPBA: meta-Chloroperbenzoic acid 
Me: Methyl 
Mes: Mesityl 
Min: Minute 
MS: Molecular sieves 
Ms: Mesyl 
Mw : Molecular weight 
NCS: N-Chlorosuccinimide 
NMO: N-Methylmorpholine N-oxide 
NMP: N-Methyl-2-pyrrolidone 
NMR: Nuclear magnetic resonance 
p: Para 
Ph: Phenyl 
PMB: p-Methoxybenzyl ether 
ppm: Parts per million 
PPTS: Pyridinium p-toluenesulfonate 
Pr: Propyl 
pTSA : p-Toluenesulfonic acid 
Pyr: Pyridine 
R: Generalised group 
RCEYM: Ring-closing ene-yne metathesis 
RCM: Ring-closing metathesis 
RRCM: Relay ring-closing metathesis 
RT: Room temperature  
SM: Starting material 
t: Tert 
TPAP: Tetrapropylammonium perruthenate 
TBAF: Tetra-n-butylammonium fluoride 
TBDPS: tert-Butyldiphenylsilyl 
IX 
 
TBS: tert-Butyldimethylsilyl 
TEAB: Tetraethylammonium bromide 
TEMPO: (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl 
TES: Triethylsilyl 
Tf: Triflyl 
THF: Tetrahydrofuran 
TMANO: Trimethylamine N-oxide 
TMDA: Tetramethylethylenediamine 
TMS: Trimethylsilyl 
TMSE: 2-(Trimethylsilyl)ethyl 
Ts: Tosyl 
TTMSS: Tris(trimethylsilyl)silane 
 
  
X 
 
Table of RCM catalysts 
 
1 
 
Abstract .............................................................................................................................. I 
Author’s declaration .......................................................................................................... III 
Acknowledgments ............................................................................................................. V 
Abbreviations .................................................................................................................. VII 
Table of RCM catalysts ..................................................................................................... X 
Chapter 1: Introduction ...................................................................................................... 3 
1.1 Presentation of hexacyclinic acid and FR182877 ................................................. 3 
1.1.1 Hexacyclinic acid .......................................................................................... 3 
1.1.2 (−)-FR182877 .................................................................................................... 4 
1.2 Total syntheses of FR182877 .............................................................................. 6 
1.2.1 Total synthesis of FR182877 by Sorensen et al. ................................................ 6 
1.2.2 Total synthesis of (–)-FR182877 by Evans et al. .............................................. 12 
1.2.3 Total synthesis of (–)-FR182877 by Nakada et al. ........................................... 17 
1.3 Syntheses of fragments of hexacyclinic acid ...................................................... 21 
1.3.1 ABC tricycle by Kalesse et al. .......................................................................... 21 
1.3.2 ABC tricycle by Landais et al. .......................................................................... 25 
1.3.3 ABC tricycle by Clarke et al. ............................................................................. 29 
1.3.4 DEF tricycle by Clarke et al. ............................................................................. 34 
1.3.4 DEF tricycle by Nakada et al. ........................................................................... 36 
1.4 Previous work in the Prunet group ..................................................................... 39 
1.4.1 ABC tricycle ..................................................................................................... 39 
1.4.2 CDEF tetracycle model .................................................................................... 44 
1.4.3 Thesis project .................................................................................................. 46 
Chapter 2: Hexacyclinic acid ............................................................................................ 48 
2.1 Synthesis of ABC tricycle ....................................................................................... 48 
2.1.1 Synthesis of the A ring ..................................................................................... 48 
2.1.2 Synthesis of the C ring ..................................................................................... 55 
2.1.3 Formation of the ABC tricycle .......................................................................... 57 
2.1.4 Conclusion and future work .............................................................................. 59 
2.2 Synthesis of CDEF model ...................................................................................... 60 
2 
 
2.2.1 Aldol pathway .................................................................................................. 61 
2.2.2 Reformatsky pathway ...................................................................................... 64 
2.2.3 Radical pathway .............................................................................................. 67 
2.2.4 Michael-Isomerisation pathway ........................................................................ 73 
2.2.5 Relay ring-closing metathesis pathway ............................................................ 80 
2.2.6 Michael/Tsuji-Trost pathway ............................................................................ 87 
2.2.7 Conclusion and future work .............................................................................. 96 
2.3 Synthesis of a chiral C-ring model .......................................................................... 98 
Chapter 3: Diastereoselective synthesis of trisubstituted olefins by RCM using an O-Si-C 
tether ............................................................................................................................. 102 
3.1 Previous work in the Prunet group ........................................................................ 102 
3.2 Application of the methodology to homoallylic alcohols ........................................ 106 
3.3 Conclusion and future work .................................................................................. 111 
Chapter 4: Experimental ................................................................................................ 113 
Chapter 5: Refererences ................................................................................................ 208 
Chapter 6: Appendices .................................................................................................. 212 
 
  
3 
 
Chapter 1: Introduction 
1.1  Presentation of hexacyclinic acid and 
FR182877 
1.1.1 Hexacyclinic acid 
Hexacyclinic acid 1.1 is a complex polyketide isolated for the first time by Zeeck et al. in 
2000 from a bacterium, Streptomyces cellulosae (strain S1013).1 The general structure and 
relative configuration were elucidated with the aid of several NMR experiments and X-ray 
analysis; the absolute configuration was successfully determined by Mosher’s ester 
methodology. Hexacyclinic acid 1.1 is composed of six rings, a 5/6/5 fused ring system (A, 
B and C) connected to a bridged tricycle (D, E and F) with a cyclic hemiketal and a δ-lactone 
(Figure 1.1). 
 
Figure 1.1: Structure of hexacyclinic acid 
Hexacyclinic acid 1.1 possesses cytotoxic activities against three cancerous cell lines: 
HM02 (gastric carcinoma), HEPG2 (hepatocellular carcinoma) and MCF7 (breast 
carcinoma) with GI50 values up to 14.0 µmol.L−1. 13C labelling experiments were undertaken 
by feeding growing culture with 13C acetate and 13C propionate. These experiments 
revealed that hexacyclinic acid is built by seven acetate and four propionate units (Figure 
1.2). 
 
Figure 1.2: 13C labelling experiments 
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A biosynthesis was proposed: the AB system could be synthesised by an exo Diels-Alder 
and the C ring by a vinylogous Prins reaction with hemiketal oxygen coming from an external 
source such as water (Scheme 1.1).1,2  
 
Scheme 1.1: Hypothesised biosynthesis 
There has been no total synthesis of hexacyclinic acid 1.1 reported in the literature at 
present. 
 1.1.2 (−)-FR182877 
(−)-FR182877 1.2, a cousin compound, was isolated in 1998 by the research group at the 
Fujisawa Pharmaceutical Co.3 The first attribution of the absolute configuration of 1.2 was 
enantiomeric to the actual structure ((+)-FR182877), however this error was later 
corrected.4 Compounds 1.1 and 1.2 have very similar structures, but there are some key 
differences between them: the stereochemistry of the ABC ring junctions, the hemiketal of 
1.1 is replaced by a conjugated alkene in 1.2, the acetate on the A ring, and the carboxylic 
acid that has been replaced by a methyl group (Figure 1.3). 
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Figure 1.3: Comparison between 1.1 and 1.2 
Compound 1.2 exhibits a greater cytotoxicity than hexacyclinic acid 1.1. For example, the 
IC50 toward P388 cell line (leukemia cells) is 21 ng/mL, which is comparable to the cytotoxic 
effects of Taxol®. It has been suggested that the potent activity of (–)-FR182877 1.2 could 
be due to the strained conjugated alkene, which acts as an excellent Michael acceptor and 
can react with a wide range of nucleophiles (imidazole, thiols and amines).5 Indeed, when 
the alkene was transformed into an epoxide by exposure to dioxygen, compound 1.3 no 
longer exhibited cytotoxicity (Scheme 1.2).6  
 
Scheme 1.2: Reaction between (–)-FR182877 1.2 and dioxygen 
A biosynthesis was hypothesised for FR182877 by Sorensen et al. 5,7 The first step 
described is similar to the biosynthesis of hexacyclinic acid 1.1 as it involves an endo 
intramolecular Diels-Alder (IMDA) to close the AB ring system and installs four new 
stereocenters. The next steps were thought to be a Knoevenagel condensation followed by 
an intramolecular hetero Diels-Alder (IMHDA) and lactonisation to give the final product, 
(– )-FR182877 1.2 (Scheme 1.3). 
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Scheme 1.3: Proposed biosynthesis 
1.2  Total syntheses of FR182877 
1.2.1 Total synthesis of FR182877 by Sorensen et al. 
Sorensen et al. were the first ones to publish the total synthesis of FR182877 in 2002.8 At 
that time, it was still believed that the natural product was (+)-FR182877 1.7 and therefore, 
the total synthesis described by Sorensen et al. first describes this enantiomer. The 
synthetic strategy was to use a biomimetic approach. The final key step was planned to be 
a tandem IMDA/IMHDA to close the ABCDF pentacycle from a nineteen-membered 
macrocycle 1.8. The macrocycle 1.8 could be closed from the linear product 1.9 using a 
Tsuji-Trost cyclisation. Product 1.9 was to be synthesised by a Stille coupling between 
fragment 1.10 and fragment 1.11 (Scheme 1.4). 
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Scheme 1.4: Retrosynthesis of (+)-FR182877 
The synthesis of fragment 1.10 started by a diastereoselective aldol reaction between 
Evans auxiliary 1.12 and aldehyde9 1.13 to furnish an aldol as a single isomer that was 
converted into the corresponding Weinreb amide 1.14. The following steps were TMS 
protection of the secondary alcohol then formation of β-ketophosphonate 1.15. Product 1.15 
reacted with β-iodomethacrolein10 in a Horner–Wadsworth–Emmons reaction (HWE) using 
activated barium(II) oxide to produce the E-olefin.11 Both alcohols were deprotected using 
PPTS to furnish diol 1.17. 1,3-Syn diastereoselective reduction of the β-hydroxy ketone12 
followed by complete TES protection of the triol and Stille coupling with hexamethylditin led 
to the formation of dienylstannane 1.10 in 49% yield over 9 steps (Scheme 1.5). 
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Scheme 1.5: Formation of coupling partner 1.10 
Similar to the previous coupling partner, synthesis of fragment 1.11 started by an Evans 
aldol reaction this time using aldehyde 1.18.13 Weinreb amidation and TMS protection of 
the resulting product generated amide 1.11 in 87% yield over 3 steps (Scheme 1.6). 
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Scheme 1.6: Synthesis of coupling partner 1.8 
Both fragments were then successfully united using a Stille coupling with 
tris(dibenzylideneacetone)dipalladium(0) as a catalyst, lithium chloride and i-Pr2NEt as a 
paramount additive to avoid protodestannylation of fragment 1.10 (Scheme 1.7). 
 
Scheme 1.7: Stille coupling between 1.10 and 1.11  
The next steps were the coupling between 1.20 and the lithium enolate of tert-butyl acetate 
to furnish β-ketoester 1.21, followed by the selective deprotection of the primary TES and 
secondary TMS protected alcohols with TBAF to give diol 1.22 in 70% yield over 2 steps 
Primary alcohol 1.22 was transformed into the corresponding carbonate and the secondary 
alcohol was resilylated to produce Tsuji-Trost precursor 1.9 in excellent yield over 2 steps. 
(Scheme 1.8). 
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Scheme 1.8: Synthesis of precursor 1.9 
The nineteen-membered ring 1.8 was then closed by a Tsuji-Trost cyclisation using a 
catalytic amount of tris(dibenzylideneacetone)dipalladium(0).14,15 Macrocycle 1.8 was 
obtained as a single diastereomer, although the configuration of the stereocenter in the α 
position of the ketoester was not determined (Scheme 1.9). 
 
Scheme 1.9: Formation of macrocycle 1.8 
The next step in the synthesis was the installation of a conjugated diene which could react 
in a tandem IMDA/IMHDA. This diene was produced by α-selenylation of the ketoester 
followed by oxidative deselenylation with m-CPBA to afford an equimolar mixture of E and 
Z alkenes. Due to its reactivity, this diene was not isolated but used directly in the tandem 
IMDA/IMHDA reaction without purification to give pentacycle 1.24 as major product in 40% 
yield. Only the E isomer furnished the desired pentacycle 1.24; the Z isomer of the precursor 
led to the formation of undesired products. The ABCDF ring system and 7 new 
stereocenters were formed during this step. The end game of the synthesis was the 
desilylation of the alcohols, TFA acidolysis of the tert-butyl ester and finally, lactonisation 
11 
 
using EDC as a coupling agent to give (+)-FR182877 1.7 in 2% yield over 22 steps (Scheme 
1.10). 
 
Scheme 1.10: Final steps of the total synthesis 
At the end of the synthesis, Sorensen et al. realised that the general structure and relative 
configuration were a match to the natural product although the absolute configuration was 
incorrect. This discovery was quickly corroborated by an erratum published by Terano et 
al.4 Sorensen et al. decided to use the previously developed strategy with the enantiomers 
of the coupling partners, ent-1.10 and ent-1.11 (Scheme 1.11). 
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.  
Scheme 1.11: Synthesis of (–)-FR182877 
Sorensen et al. successfully developed an enantioselective synthesis of FR182877 and 
were able to produce grams of both enantiomers with comparable yield. However, one of 
the limitations of this strategy was the loss of half of their material during the double 
transannular Diels-Alder reaction due to the Z isomer of the precursor. 
1.2.2 Total synthesis of (–)-FR182877 by Evans et al. 
Concurrently with Sorensen’s efforts, Evans et al. developed a very similar strategy: one 
intramolecular Diels-Alder (IMDA) to close the bicycle AB and an intramolecular hetero 
Diels-Alder (IMDHA) to give the tricycle CDF.16 In their strategy, it was thought that it would 
be possible to complete the synthesis of both hexacyclinic acid 1.1 and (–)-FR182877 1.2 
via the same intermediate, macrocycle 1.25. The endo/exo selectivity during the first 
cycloaddition would be crucial to achieve the synthesis of 1.1 or 1.2; endo would furnish 
(−)-FR182877 1.2, exo would yield hexacyclinic acid 1.1. Evans et al. also planned to 
introduce either the carboxylic acid or the methyl group from the bromine, by palladium 
couplings (Scheme 1.12).  
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Scheme 1.12: Evans retrosynthesis and proposed Diels-Alder transition states 
This macrocycle was to be synthesised using a Suzuki coupling between boronic acid 1.26 
and the dibromoalkene product 1.27 and an alkylation reaction between the β-ketoester 
derived from the Weinreb amide and the allylic iodide derived from the TBDPS ether 
(Scheme 1.13). 
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Scheme 1.13: Retrosynthesis of macrocycle 1.25 
Synthesis of fragment 1.26 started by an aldol reaction between Evans auxiliary ent-1.12 
and aldehyde 1.28 to produce syn aldol adduct 1.29.17 Transformation of 1.29 into the 
Weinreb amide followed by Grignard addition led to the formation of ynone 1.30. Product 
1.30 was submitted to a diastereoselective syn reduction18 to give a diol that was fully 
protected as TBS ethers furnishing compound 1.31. The next steps were alkyne 
hydroboration with catecholborane and saponification to afford boronic acid 1.26 in 62% 
yield over 6 steps (Scheme 1.14). 
 
Scheme 1.14: Synthesis of fragment 1.26  
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Dibromide fragment 1.27 was synthesised starting with a diastereoselective aldol reaction 
with aldehyde 1.32 (55% yield over 4 steps from 3-buten-1-ol) followed by conversion into 
Weinreb amide 1.33 in near quantitative yield. TBS protection of the secondary alcohol and 
selective desilylation of primary alcohol furnished product 1.34 in very good yield. The 
primary alcohol was oxidised and converted into dibromide fragment 1.27 using the Ramirez 
olefination conditions (Scheme 1.15). 
 
Scheme 1.15: Synthesis of coupling partner 1.27 
With both fragments in hand, Evans et al. used a Suzuki coupling to connect them. A wide 
range of bases and countercations were screened but most of them led to a mixture of 
product 1.35, doubly coupled side product and decomposition. Only an unusual base, 
thallium carbonate, afforded a reasonable rate of reaction with neither formation of side 
products nor decomposition.19 Bromodiene 1.35 was formed in 84% yield (Scheme 1.16). 
 
Scheme 1.16: Suzuki coupling  
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The Weinreb amide was reduced to the corresponding aldehyde, which was subjected to a 
Roskamp homologation in the presence of ethyldiazoacetate and tin(II) chloride, followed 
by a selective desilylaton to afford β-ketoester 1.36.20 The primary alcohol was substituted 
by an iodine and the resulting allylic iodide was submitted to macrocyclisation to furnish 
nineteen-membered ring 1.37. Formation of the alkene in the presence of Ph2Se2O3 
followed by heating led to the cycloaddition cascade to form product 1.38 as a single 
diastereomer in good yield (Scheme 1.17).   
 
Scheme 1.17: Formation of pentacycle 1.38 
The final steps of the total synthesis were complete desilylation and Suzuki methylation to 
give product 1.39. Saponification and lactonisation with Mukaiyama’s reagent afforded 
natural product (–)-FR182877 1.2 in 6% yield over 17 steps (Scheme 1.18). 
17 
 
 
 Scheme 1.18: End game of the total synthesis by Evans et al.  
Evans et al. showed that the endo transition state was preferred with (–)-FR182877 1.2 
being formed exclusively. Several attempts were made to obtain the exo transition state, 
however no success has been reported to date. 
1.2.3 Total synthesis of (–)-FR182877 by Nakada et al. 
Another synthesis was published more recently by Nakada et al.21 The synthetic strategy 
was greatly inspired by Sorensen’s and Evans’ previous work.5,16 AB and CD ring systems 
were respectively closed by IMDA and IMHDA from acyclic product 1.41. The major 
difference from previous work was the closure of the F ring by a Heck coupling (Scheme 
1.19). 
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Scheme 1.19: Retrosynthesis of (–)-FR182877 1.2 by Nakada et al. 
Product 1.41 was synthesised in 8 steps over the longest linear sequence.22 From 1.41, the 
secondary alcohol was silylated with chlorotriethylsilane and the acetate was saponified to 
produce the primary alcohol in 75% over 2 steps. The allylic alcohol was then oxidised in 
presence of manganese(II) oxide and the resulting aldehyde spontaneously reacted in a 
tandem IMDA/IMHDA to generate ABCD tetracycle 1.43. It is important to notice the 
inverted stereochemistry of one of the hydroxyl groups; the incorrect configuration was 
proved to be of paramount importance in order to achieve the right diastereoselectivity at 
the ring junctions (Scheme 1.20).  
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Scheme 1.20: Synthesis of tetracycle 1.43 
The next step of the synthesis was selective desilylation of the TES-protected alcohol 
followed by oxidation to give the corresponding ketone. The ketone was reduced to give the 
alcohol with the desired stereochemistry (dr = 24:1), which was protected as a TBS ether 
to furnish compound 1.44. Iodination of the double bond, cleavage of the TBS ether followed 
by oxidation of the resulting alcohol led to the formation of the corresponding aldehyde. 
Addition of vinylzinc bromide produced allylic alcohol 1.40 in a 1:1 mixture of diastereomers. 
The Mizoroki-Heck coupling afforded the 7-exo trig product 1.45 and closed the F ring in 
excellent yield (Scheme 1.21). 
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Scheme 1.21: Formation of pentacycle 1.45 
The allylic alcohol moiety was isomerised to the corresponding α-methyl ketone using 
[IrCl(cod)]2 to yield product 1.46 as a mixture of diastereomers. The undesired stereoisomer 
was epimerised using DBU. The newly formed ketone 1.46 was reduced to the 
corresponding alcohol 1.47 as a single isomer. Final steps of the synthesis included the 
complete desilylation of compound 1.47, saponification of the methyl ester and lactonisation 
using Mukaiyama’s reagent to furnish (–)-FR182877 1.2 in 59% yield over 2 steps (Scheme 
1.22).  
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Scheme 1.22: Completion of the total synthesis by Nakada et al. 
Nakada’s synthesis, despite being successful, did not bring a lot of novelty from Sorensen’s 
and Evans’ works. It was also a longer synthesis with a lower yield for the key cyclisation 
step. 
1.3  Syntheses of fragments of hexacyclinic acid 
1.3.1 ABC tricycle by Kalesse et al. 
The first synthesis of the ABC tricycle was published by Kalesse et al. in 2004.2 The 
proposed retrosynthesis started from the ABC ring system 1.48 installed by a tandem 
intramolecular Michael-aldol reaction. Compound 1.49 was to be obtained by conjugate 
addition from 1.50 and cross-metathesis with methyl acrylate. Product 1.50 could be 
produced by an intramolecular Diels-Alder reaction starting from product 1.51, which would 
be synthesised by an asymmetric aldol reaction from aldehyde 1.52 (Scheme 1.23).  
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Scheme 1.23: Synthetic strategy for ABC tricycle 1.48 
The synthesis began with racemic alcohol 1.53 that was protected as a TBS ether, before 
undergoing cleavage of the trisubstituted alkene by ozonolysis to afford aldehyde 1.54. 
Olefination of 1.54 using HWE conditions was followed by a DIBAL-H reduction of the ester 
and oxidation of the resulting allylic alcohol to give the conjugated aldehyde 1.52 in 64% 
yield over 5 steps (Scheme 1.24). 
 
Scheme 1.24: Synthesis of aldehyde 1.52 
The Evans reaction gave the required aldol in excellent yield and as a single isomer, which 
was converted into corresponding Weinreb amide 1.55. Silylation of the secondary alcohol 
and transformation of Weinreb amide generated aldehyde 1.56. Addition of 
ethynylmagnesium bromide furnished a propargylic alcohol, which was oxidised using 
Dess-Martin periodinane to produce Diels-Alder precursor 1.51 (Scheme 1.25).  
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Scheme 1.25: Formation of Diels-Alder precursor 1.51 
Diels-Alder reaction led to the elaboration of bicycle 1.50, with the correct configuration at 
the newly formed stereocenters. The cyclisation supposedly proceeds via a chair-like 
transition state, with the OTBS and methyl groups remaining in a pseudo equatorial position 
(Scheme 1.26). 
 
Scheme 1.26: Diels-Alder reaction and favoured transition state 
Formation of the vinyl cuprate followed by conjugate addition to enone 1.50 from the convex 
face gave product 1.57 without formation of the undesired isomer. In order to obtain the 
desired stereochemistry during the ketone reduction, the hydride source had to come from 
the most hindered side, (i.e the concave face). First attempts using different reducing agents 
24 
 
and, especially bulky reagents such as L-selectride, led to the formation of the undesired 
isomer, which could not be inverted using Mitsunobu reaction. Pleasingly, lithium aluminium 
hydride at very low temperature furnished the desired isomer 1.58 with a very good 
selectivity (Scheme 1.27). 
 
Scheme 1.27: Diastereoselective cuprate addition and reduction 
The following steps were cross methathesis between 1.58 and methyl acrylate with 
Hoveyda-Grubbs’ II catalyst to give a mixture of E and Z conjugated esters. The secondary 
alcohol was protected as a TBDPS ether, TBS ether was selectively cleaved and the 
resulting alcohol oxidised using Ley-Griffith conditions to produce compound 1.49. The next 
step was a tandem intramolecular Michael-aldol reaction, with formation of the TMS enol 
ether under thermodynamic control to give the cyclobutane product 1.59. Finally, 
cyclobutane 1.59 was opened to establish the ABC ring system 1.48 (and the undesired 
diastereomer 1.48’) in 11% overall yield over 20 steps (Scheme 1.28). 
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Scheme 1.28: Synthesis of ABC tricycle 1.48  
The Kalesse et al. synthesis present an interesting approach of constructing the ABC 
tricycle with the correct absolute configuration, however there is no mention yet of how to 
install the allylic carboxylic acid presents in the natural product of hexacyclinic acid. 
1.3.2 ABC tricycle by Landais et al. 
In 2004 and 2005, Landais et al. published their work regarding the 5-exo-trig cyclisations 
of 1,6-heptadienes.23,24 Their strategy was based on the radical cascade involving the 
addition of tosyl radical, 5-exo-trig cyclisation and β-fragmentation to furnish polysubstituted 
five-membered rings. They also explored the induction of 1,2 and 1,5-stereocontrol using 
bulky allylic substituents (Scheme 1.29).  
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Scheme 1.29: 5-exo-trig cyclisation of chiral 1,6-heptadienes 
In order to test their theory, several cyclisation precursors were synthesised. Allylic tert-
butyl diene 1.60 led to the formation of the corresponding cyclopentane 1.61 as a single 
diastereomer with the trans-cis stereochemistry. When a smaller methyl group was used 
instead, a mixture of 4 diastereomers was obtained (Scheme 1.30). 
 
Scheme 1.30: Diastereoselectivity depending on allylic substitution 
The reaction was shown to also proceed in the presence of a silyl group and protected 
alcohols with excellent diastereoselectivity. In the case of a protected allylic alcohol, the 
selectivity was inverted to give the cis-cis product 1.68 (Scheme 1.31). 
 
Scheme 1.31: Stereochemistry depending on allylic substitution 
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The stereochemistry was rationalised using the Beckwith-Houk model; the major isomer 
arising from a chair-like transition state with the bulky substituents in pseudo equatorial 
position (Scheme 1.32). 
 
Scheme 1.32: Transition station leading to the formation of the major product 
This novel methodology was extended to the racemic synthesis of an ABC ring system of 
hexacyclinic acid 1.72 where the BC bicycle could be formed by a Pauson-Khand reaction 
from cyclopentane 1.73. Cyclopentane 1.73 could be closed from hepta-1,6-diene 1.74 
using the new method developed, and diene 1.74 could be synthesised by an aldol reaction 
between aldehyde 1.75 and ester 1.76 (Scheme 1.33). 
 
Scheme 1.33: Retrosynthesis of the ABC tricycle by Landais et al.  
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Aldehyde 1.75 was prepared in 3 steps from butyn-1,4-diol and reacted with ester 1.76 in 
an aldol reaction to furnish products 1.77/1.77’ in a 65:35 mixture of 2 diastereomers 
(Scheme 1.34). 
 
 
Scheme 1.34: Aldol reaction to furnish 1.77/1.77’ 
Acetate 1.77 was converted into the corresponding sulfone 1.74 using a palladium-
catalysed sulfonylation.25 Sulfone 1.74 was then closed by a radical cyclisation to give the 
cyclopentane 1.78 with complete stereocontrol (Scheme 1.35). 
 
Scheme 1.35: Formation of cyclopentane 1.78 
Complete reduction of the ester with DIBAL-H gave the corresponding primary alcohol; 
MOM protection of the diol furnished product 1.79 in 60% over 2 steps. Deprotonation of 
compound 1.79 using Schlosser’s base gave the corresponding sulfonyl carbanion which 
was alkylated to produce enyne 1.73. The final step was a Pauson-Khand reaction 
promoted by trimethylamine N-oxide (TMANO) to give final product 1.72 (Scheme 1.36).  
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Scheme 1.36: Final steps of the synthesis 
The synthesis by Landais et al. proved to be an efficient way to construct the ABC tricycle 
1.72 in 7 steps from β-silylester 1.76, and to install the correct relative stereochemistry at 
the AB ring junction. However, the synthesis is racemic and several functional groups are 
missing, such as the double bond in the B ring and the carboxylic acid. The correct 
stereochemistry of the BC ring junction also needs to be installed.  
1.3.3 ABC tricycle by Clarke et al. 
The general strategy developed for the racemic synthesis of the ABC ring system by Clarke 
et al.26,27 was inspired by the previous work of Kalesse et al. The C ring was envisaged to 
be closed by a ring-closing ene-yne methathesis (RCEYM) from an intermediate which 
could be produced by oxidation and alkynylation from bicycle 1.81. A radical cyclisation 
promoted by samarium(II) iodide would close the A ring from cyclohexene 1.82. The 
cyclohexene ring 1.82 could be afforded from lactone 1.83. The bicycle system 1.83 would 
be formed by an intramolecular Diels-Alder reaction from diene 1.84, which could be easily 
prepared by an esterification reaction between alcohol 1.85 and propiolic acid (Scheme 
1.37). 
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Scheme 1.37: Retrosynthesis proposed by Clarke et al. 
The synthesis started by a Mitsunobu reaction between propiolic acid  and readily available 
alcohol 1.8528 to give ester 1.84. Ester 1.84 underwent an intramolecular Diels-Alder 
reaction to furnish bicycle 1.86 in 80% yield and as a single diastereomer. The next step 
was a diastereoselective addition of vinyl cuprate to furnish product 1.83 with two new 
stereocenters installed. The diastereoselectivity is explained to be the result of the cuprate 
addition and reprotonation of the resulting enolate from the less hindedred face. Lactone 
1.83 was reduced to the corresponding lactol 1.87 that was transformed into dithiolane 1.88 
(Scheme 1.38). 
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Scheme 1.38: First steps of the synthesis 
Alcohol 1.88 was oxidised and the corresponding aldehyde was transformed into allylic 
alcohol 1.89 by addition of vinyl magnesium bromide in a very good yield and excellent 
diastereoselectivity. Allylic alcohol 1.89 was protected as a TBS ether and the dithiolane 
was converted into the unstable aldehyde 1.82 by addition of methyl iodide and silver 
carbonate (Scheme 1.39).  
 
Scheme 1.39: Synthesis of radical cyclisation precursor 1.82 
The reductive cyclisation was promoted by samarium(II) iodide in the presence of HMPA 
and water to give the desired five-membered ring, with only traces of both the undesired 
diastereomer and of the dimer product. The newly formed alcohol was silylated with TBSOTf 
to give product 1.81. Debenzylation occurred in the presence of boron trichloride to furnish 
primary alcohol 1.90 (Scheme 1.40).  
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Scheme 1.40: 5-exo- trig radical cyclisation and benzyl deprotection 
In the next step, the alcohol was oxidised using Dess-Martin periodinane to generate an 
unstable aldehyde which was immediately alkynylated by propynylmagnesium bromide to 
furnish propargylic alcohol 1.91 as a 4:1 mixture of diastereomers. The alcohol was finally 
protected as a TMS ether to give RCEYM precursor 1.92 in quantitative yield (Scheme 
1.41). 
 
Scheme 1.41: Formation of RCEYM precursor 
For the RCEYM, different pathways are possible depending on which unsaturated bond the 
catalyst attacks first. If the catalyst reacts first with the alkene, a mechanism known as ene-
then-yne will occur, with the resulting product being cyclopentene 1.94. In the case of an 
yne-then-ene mechanism, two results are possible depending on the regioselectivity during 
the formation of the ruthenium carbene: the regioisomer B with the metallocarbene further 
away from the methyl would furnish cyclopentene 1.94, while the one close to the methyl 
group C would give the corresponding cyclohexene 1.95 (Scheme 1.42). 
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Scheme 1.42: Three possible pathways for the RCEYM 
When Clarke et al. attempted the RCEYM on substrate 1.92, disappointingly only the 
undesired cyclohexene 1.96 was recovered with no traces of the desired cyclopentene 1.80 
(Scheme 1.43). 
 
Scheme 1.43: Formation of undesired RCEYM product 
The synthetic route to close the C-ring was modified, the previously synthesised alcohol 
1.90 was oxidised and the resulting aldehyde reacted with vinylmagnesium bromide to 
furnish allylic alcohol 1.97. Diene 1.97 was submitted to RCM conditions to furnish ABC 
tricycle 1.98 as a mixture of 2 diastereomers (Scheme 1.44). 
 
Scheme 1.44: Synthesis of final product 1.98 by RCM 
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Clarke et al. synthesised ABC tricycle in 6% yield over 15 steps and as a racemic mixture. 
Relative stereochemistry of the AB and BC junctions were efficiently installed and despite 
the unsuccessful RCEYM, the C-ring was closed by diene RCM.  
 
1.3.4 DEF tricycle by Clarke et al. 
Clarke et al. were the first to publish a synthesis of a DEF tricycle model of hexacyclinic 
acid in 2003.29 The envisaged retrosynthesis of DEF ring system 1.99 began with the 
closure of the E-ring by lactonisation and some functionalisation from bicycle 1.100. 
Hemiketal 1.100 could be formed by addition of acetate to oxacarbenium 1.101. The 
oxacarbenium intermediate could be synthesised by iodoetherification of the nine-
membered ring 1.102. Nine-membered ring 1.102 would be formed from linear chain 1.103 
by a Tsuji-Trost cyclisation (Scheme 1.45). 
 
Scheme 1.45: Retrosynthesis of DEF tricycle 1.99 
The synthesis started from nerol 1.104 by acetylation of the primary alcohol, selective 
epoxidation of one of the trisubstituted alkene and oxidative cleavage of the resulting 
epoxide to furnish aldehyde 1.105. Mukaiyama aldol reaction gave β-ketoester and the 
newly formed alcohol was silylated in the presence of TBSOTf to produce compound 1.103 
(Scheme 1.46). 
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Scheme 1.46: Synthesis of β-ketoester 1.103 
The formation of the nine-membered ring was obtained by a palladium catalysed Tsuji-Trost 
reaction. Clarke et al. discovered that 1,2-bis(diphenylphosphino)ethane (dppe) was crucial 
to obtain an adequate ratio (2:1) of the desired product 1.102 and the elimination by-product 
1.106, with only traces of the seven-membered ring (Scheme 1.47). 
 
Scheme 1.47: Formation of nine-membered ring 1.102 
After successful synthesis of 1.102, the next step was the cyclisation of the DF rings. This 
reaction proceeded by formation of the iodonium ion in the presence of iodine(I) acetate. 
The iodonium bridge was then attacked by the carbonyl via a boat-boat conformation to 
give oxacarbenium 1.101, which was trapped by an acetate to finally produce DF bicycle 
1.100. Final steps included desilylation of the secondary alcohol and hydrolysis of the 
acetate to furnish hemiketal 1.107. TFA acidolysis of tert-butyl ester followed by acid-
catalysed lactonisation gave the final product, DEF tricycle 1.99 in 9% overall yield over 
nine steps (Scheme 1.48). 
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Scheme 1.48: Iodination/cyclisation of product 1.102 and end game of the synthesis 
Clarke et al. were first to publish the synthesis of a model of DEF tricycle. They synthesised 
a desmethyl DEF tricycle with the correct relative stereochemistry in a short synthetic 
sequence and with a very good overall yield. Unfortunately, when they tried the same 
strategy with the product incorporating a methyl group, the iodoetherification step was 
unsuccessful. There is also no mention of a general strategy to unite the two models and 
synthesise an ABCDEF hexacycle. 
1.3.4 DEF tricycle by Nakada et al. 
The most recent work published about hexacyclinic acid and its derivatives was from 
Nakada et al in 2012.30 After the total synthesis of (–)-FR182877, they decided to use a 
similar strategy to their previous work in order to synthesise the DEF tricycle of (–)-
FR182877 and hexacyclinic acid and subsequently evaluate their biological activity. Their 
envisaged retrosynthesis started from DEF tricycle 1.108, which could be formed by 
addition of water and lactonisation from carboxylic acid 1.109. Bicycle 1.109 could be 
cyclised by an IMHDA reaction from conjugated ketoester 1.110. Diels-Alder precursor 
1.110 was to be synthesised from aldehyde 1.111 by an alkylation reaction and oxidation. 
Finally, aldehyde 1.111 could be obtained by an Evans aldol reaction and subsequent 
auxiliary cleavage from aldehyde 1.112 (Scheme 1.49). 
37 
 
 
Scheme 1.49: Retrosynthesis for the formation of DEF tricycle 1.108 by Nakada et al. 
The synthesis started by an Evans aldol reaction using aldehyde 1.112 to give aldol 1.114 
in 85% yield as a single isomer. Conversion of aldol 1.114 into the corresponding Weinreb 
amide, followed by TES protection of the secondary alcohol led to the formation of product 
1.115. Weinreb amide 1.115 was reduced to give the corresponding aldehyde, which was 
reacted with a vinylaluminium reagent generated in situ from methyl propiolate and 
DIBAL- H to furnish allylic alcohol 1.116 as a 1:1 mixture of diastereomers (Scheme 1.50).31 
 
Scheme 1.50: Synthesis of allylic alcohol 1.116 
Due to some problems later in the synthesis for the conversion of the methyl ester into a 
carboxylic acid, ester 1.116 was transformed into the PMB ester using Otera’s catalyst.32 
The allylic alcohol was then oxidised to the corresponding enone to produce Diels-Alder 
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precursor 1.117. Intramolecular hetero Diels-Alder reaction proceeded slowly over 4 days 
to furnish the DF bicycle 1.118 as a single diastereomer (Scheme 1.51). 
 
Scheme 1.51: Transesterification and IMHDA cyclisation 
Product 1.118 was converted into hydroxy carboxylic acid 1.109 under acidic conditions. 
Lactonisation using Mukaiyama’s reagent furnished (−)-FR182877 DEF tricycle 1.119, 
which was not isolated due to its reactivity. Tricycle 1.119 reacted with water during the 
work-up to give final product 1.108 as a single diastereomer in 14% overall yield over 10 
steps (Scheme 1.52). 
 
Scheme 1.52: Final steps of the Nakada’s synthesis 
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Nakada et al. synthesised DEF tricycle 1.108 in a concise stereoselective synthesis and 
with very good overall yield. They also modified the DEF tricycle with the formation of the 
corresponding acetate 1.120 and benzoate 1.121. The biological activities of DEF tricycle 
1.108 and its derivatives were tested and only very low to moderate effects toward cell cycle 
arrest were found. This result is an additional proof of the crucial role of the double bond in 
(–)-FR182877 for the cytotoxicity (Figure 1.4). 
 
Figure 1.4: DEF tricycle 1.108 and its derivatives 
1.4  Previous work in the Prunet group 
This work is focused on the synthesis of the ABC tricycle and a CDEF tetracycle model of 
hexacyclinic acid. This project is based on the previous work done by Julie Toueg, Raphaël 
Oriez (Ecole Polytechnique, France) and Michael Mathieson (University of Glasgow) during 
their PhD theses under the supervision of Dr Joëlle Prunet.33–35 
1.4.1 ABC tricycle 
The strategy envisaged in the Prunet group to complete the total synthesis of hexacyclinic 
acid 1.1 started with some functionalisations from pentacycle 1.122. Pentacycle 1.122 could 
be formed by an oxa-Michael reaction to close the D-ring from tetracycle 1.123. Product 
1.123 could be produced using an aldol reaction to cyclise the nine-membered ring from 
compound 1.124. Product 1.124 was to be synthesised by a Michael reaction between ABC 
tricycle 1.125 and DEF fragment 1.126 and by a Wacker oxidation (Scheme 1.53). 
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Scheme 1.53: Proposed retrosynthesis  
ABC tricycle 1.125 could be synthesised by a Wharton rearrangement, decarboxylation of 
the ester at the AB ring junction, isomerisation of the exocyclic double bond and a Corey-
Winter reaction to give the corresponding enone from intermediate 1.127. The ketone would 
be diastereoselectively reduced and the B-ring would be closed by a Snider cyclisation from 
bicycle 1.128. Product 1.128 was to be synthesised by a diastereoselective Michael reaction 
between conjugated ketoester 1.129 and silyl enol ether 1.130 (Scheme 1.54). 
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Scheme 1.54: Proposed retrosynthesis of ABC tricycle 1.125 
Optimisation of the diastereoselective Michael reaction between 1.129 and 1.130 identified 
the Lewis acid zinc(II) chloride and n-butyllithium as the best conditions for the reaction; 
however variation of the solvent led to some interesting effects. It appeared that the polarity 
of the solvent was crucial for the diastereoselectivity. With a low polarity solvent like Et2O, 
the major diastereoisomer, with a ratio of 7:1, was the undesired stereoisomer. Surprisingly, 
the selectivity was completely inverted using a more polar solvent system such as DMF/THF 
for the reaction (Table 1.1).36 
 
Solvent Yield (%) Ratio 1.128/1.128’ 
Et2O 60 1:7 
1:4 THF/Toluene 50 1:2.5 
4:1 THF/Toluene 46 2.5:1 
4:1 DMF/THF 60 7:1 
Table 1.1: Effects of the solvent polarity on the yield/diastereoselectivity 
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These effects could be explained by two possible transition states. In the case of a non-
polar solvent, zinc would be complexed preferentially by the oxygens from both reagents, 
forming an eight-membered transition state and attack of the enolate would occur trans to 
the methyl group of the A-ring. On the other hand, when using a polar solvent, this 
complexation would be disrupted and the reaction would proceed via an open transition 
state with the enolate trans to the OTBS group (Figure 1.5). 
 
Figure 1.5: Two proposed transition states 
The steric hindrance of the ester was also crucial for the diastereoselectivity of this reaction. 
By increasing the size of the R group, the diastereomeric ratio increased in favor of the 
desired diastereomer (Table 1.2).34,35 
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R Yield (%) Ratio Desired/Undesired 
Me 50 3:1 
Et 60 5:1 to 7:1 
t-Bu 55 1:0 
Table 1.2: Effects of the ester size on the yield/diastereoselectivity 
Product 1.128 was then submitted to a Snider cyclisation in the presence of manganese(III) 
acetate and copper(II) acetate. After optimisation, the best solvent system was found to be 
a 10:1 mixture of trifluoroethanol/acetic acid. Interestingly, only the desired diastereomer 
1.128 underwent cyclisation while the undesired diastereomer solely led to degradation. 
Tricycle 1.131 was obtained after cyclisation in 50% yield as a single stereoisomer. The 
following step was the reduction of the ketone moieties; it was hoped that using Luche 
conditions, cerium(III) chloride would complex the oxygens from the convex face, forcing 
the hydride source to attack the most hindered concave face to generate the desired 
diastereomer. Surprisingly, Luche reduction of tricycle 1.131 produced compound 1.132, 
converting the ketone of the C-ring into a hemiketal while diastereoselectively reducing the 
ketone of the A-ring. Decarboxylation of product 1.132, despite numerous attempts, proved 
to be unsuccessful (Scheme 1.55). 
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Scheme 1.55: Snider cyclisation and following steps 
1.4.2 CDEF tetracycle model 
In order to complete the total synthesis of hexacyclinic acid 1.1, it was decided to develop 
a synthetic strategy for the formation of the DEF tricycle on a model. The synthesis of a 
CDEF model would furnish a more accessible synthetic pathway instead of using the more 
valuable ABC tricycle 1.125. The CDEF tetracycle models 1.134 and 1.135 could be 
elaborated by lactonisation and several functional group interconversions from tricycles 
1.136 and 1.137. The hemiketal could be formed by an oxa-Michael reaction from the 5,9 
ring systems. Nine-membered rings 1.138 and 1.139 would be closed by an aldol reaction 
from the corresponding linear compounds 1.140 and 1.141, which could be synthesised by 
a Wacker oxidation and a Michael addition between DEF fragment 1.126 and different 
models of the C ring (Scheme 1.56). 
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Scheme 1.56: Envisaged retrosynthesis of CDEF models 
The DEF fragment 1.126 was synthesised in 56% yield in 4 steps as a single diastereomer 
from 4-penten-1-al.35 The β-ketoester 1.126 reacted with two different C-ring models 
(cyclopentenone and 1.142) to give the corresponding addiction products (1.143 and 
1.144). Wacker oxidation of the alkene and formation of TES silyl enol ether gave two 
different cyclisation precursors (1.145 and 1.146). Unfortunately, attempts to obtain nine-
membered rings led only to the formation of an unknown product, which could not be 
identified at the time as it was produced in only small quantities (Scheme 1.57). 
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Scheme 1.57: Formation of an unidentified product 
1.4.3 Thesis project 
The first objective of this project is to synthesise the ABC tricycles with different esters using 
the synthesis previously developed in the group.33–35 Decarboxylation conditions will be 
explored and the synthesis toward the final ABC tricycle 1.125 will be developed (Scheme 
1.58). 
  
Scheme 1.58: Synthesis of ABC tricycle 1.125 
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The second objective is to continue the synthesis of different CDEF models. The conditions 
for the cyclisation of the desired nine-membered rings will be developed; the closure of the 
DF ring system will be studied leading to the synthesis of CDEF models (Scheme 1.59). 
 
Scheme 1.59: Planned synthesis of CDEF models 
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Chapter 2: Hexacyclinic acid 
 
2.1 Synthesis of ABC tricycle 
One of the aims of the project was to synthesise tricycles with different esters, then 
subsequently explore decarboxylation methods in order to complete the ABC tricycle 1.125 
synthesis. It is known that β-ketoacids tend to lose carbon dioxide rapidly in presence of 
acid. Our goal was to transform the ester into the corresponding carboxylic acid 2.1 and find 
suitable conditions for the decarboxylation step (Scheme 2.1). 
 
 
Scheme 2.1: Plan for the synthesis of ABC tricycle 
2.1.1 Synthesis of the A ring 
In order to produce the ABC tricycle 1.125, it was crucial to prepare both A and C rings in 
multigram scale. The retrosynthesis previously developed in the group started by the 
formation of A rings with different R groups (1.147 and 1.148), which could be closed by a 
ring-closing metathesis from corresponding conjugated ketoesters 1.153 and 1.154. The 
conjugated ketoesters could be produced by a Roskamp homologation with different 
diazoacetates to generate ester moieties, followed by Knoevenagel condensation with 
formaldehyde to install the trisubstituted alkenes from aldehyde 2.3. Aldehyde 2.3 would be 
synthesised by a Crimmins aldol reaction between Crimmins auxiliary 2.4 and acrolein, 
followed by formation of the TBS ether from the resulting β-hydroxyketone and cleavage of 
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the auxiliary. Finally, acylated Crimmins auxiliary 2.4 would be obtained in 3 steps from D-
Phenylalanine (Scheme 2.2). 
 
Scheme 2.2: Retrosynthesis of the A ring 
The forward synthesis started by the reduction D-Phenylalanine into D-Phenylalaninol  using 
a convenient method for the reduction of carboxylic acids.37 Sodium borohydride reacted 
with iodine to generate in situ two equivalents of borane, allowing the reduction of the 
carboxylic acid into the corresponding alcohol to take place The crude aminoalcohol was 
then transformed into thiazolidinethione 2.5 in the presence of carbon disulfide and an 
aqueous solution of potassium hydroxide.38 Unfortunately, a mixture of thiazolidinethione 
2.5 and oxazolidinethione 2.6 was produced (Scheme 2.3).  
 
Scheme 2.3: Formation of thiazolidinethione 2.5 
It was hypothesised that the oxazolidinethione resulted from reaction conditions being too 
mild. More drastic conditions were used (stronger alkaline solution, higher temperature) and 
the desired heterocycle 2.5 was obtained as the only product. Thiazolidinethione 2.5 was 
acylated with propionyl chloride, triethylamine and DMAP to give acylated Crimmins 
auxiliary 2.4 in 82% over 3 steps (Scheme 2.4). 
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Scheme 2.4: Formation of acylated Crimmins auxiliary 2.4 
Diastereoselective aldol reactions are very useful tools in organic synthesis to generate 
asymmetric C-C bonds. A widely used method is the Evans aldol reaction.39 Evans’ method 
uses a temporary chiral auxiliary to produce chiral boron enolates of N-acyl oxazolidinones, 
and create aldols with high diastereomeric ratios. Titanium enolates of N-acyl 
oxazolidinones were explored but the diastereoselectivity was lower than with boron. The 
reaction proceeded as described below: in the presence of dibutylboron triflate and an 
amine, a Z-boron enolate was generated. The diastereoselectivty can be rationalised by the 
formation of a Zimmerman-Traxler transition state where the R group of the aldehyde 
adopts a pseudo equatorial position and the dipoles are minimised to furnish the Evans syn 
adduct as a major product (Scheme 2.5). 
 
Scheme 2.5: Transition state for Evans aldol reaction 
More recently, other chiral auxiliaries were developed. Crimmins et al. decided to 
investigate the use of N-acyl thiazolidinethiones and oxazolidinethiones to generate chiral 
titanium enolates.40,41 Due to the high affinity of sulfur for titanium, it was shown that, by 
replacing the oxygen on the auxiliary with a sulfur atom, it was possible to access both 
Evans syn and non-Evans syn products with high diastereomeric ratios. Different amine 
bases were tested and the best results were found when (−)-sparteine was used. Due to 
(−)-sparteine being quite an expensive reagent, other bidendate bases were explored and 
TMEDA was discovered to be a potential replacement despite a slight decrease in yield. 
The diastereoselectivity could be modified by altering the number of equivalents of both 
reagents. Crimmins aldol reaction using one equivalent of titanium and two equivalents of 
diamine proceeds in a similar transition state to that of the Evans reaction and furnishes the 
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Evans syn product. When only one equivalent of diamine is used, the sulfur of the auxiliary 
can coordinate to the metal to produce this time the non-Evans syn product (Scheme 2.6).  
 
Scheme 2.6: Possible transition states for Crimmins aldol reaction 
Another difference between Evans’ and Crimmins’ auxiliaries is the cleavage step. 
Transformation of the Evans auxiliary into the corresponding aldehyde is usually a two-step 
process, whereas to convert Crimmins auxiliary into an aldehyde, only one step is required, 
allowing a higher overall yield and fewer synthetic steps (Scheme 2.7). 
  
Scheme 2.7: Cleavage of Evans’ and Crimmins’ auxiliaries 
It was decided for our synthesis to use a modified version of the Crimmins aldol reaction 
with DIPEA and NMP as amine bases.42 This method is known to give comparable 
diastereomic ratios and yields as other methods (e.g. (−)-sparteine) but for a lesser cost. 
The previously synthesised acylated Crimmins auxiliary 2.4 reacted with a slight excess of 
acrolein in the presence of DIPEA and NMP to give aldol 2.7 in good yield and excellent 
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diastereomeric ratio. Silylation of aldol 2.7 proved to be a slow process; the best conditions 
found were TBSCl, with 2,6-lutidine as a base and DMAP in DMF at high concentration 
concentration over three days to furnish TBS protected aldol 2.8. When imidazole was used 
instead of 2,6-lutidine, some epimerisation product was obtained. The Crimmins auxiliary 
was cleaved by DIBAL-H to give aldehyde 2.3 in very good yield and thiazolidinethione 2.5 
was recovered (Scheme 2.8). 
  
Scheme 2.8: Formation of aldehyde 2.3 
The next step of the synthesis was the conversion of aldehyde 2.3 into β-ketoester 2.9 by 
a Roskamp homologation. It was decided to use methyl diazoacetate as a partner in the 
Roskamp homologation; several grams of methyl diazoacetate  were already available in 
the lab and a methyl ester would allow the production of a wide range of esters by 
transesterification later on.34,35 The reaction proceeded well and β-ketoester 2.9 was 
obtained in 81% yield. Methyl ester 2.9 was then submitted to transesterification conditions 
using a catalytic amount of ZnO and 2-trimethylsilyl ethanol in refluxing toluene to 
successfully deliver ester 2.10  (Scheme 2.9).43 
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Scheme 2.9: Roskamp and transesterification steps 
In order to install the trisubstituted alkene, a Knoevenagel condensation with acetaldehyde 
was performed. In the presence of titanium(IV) chloride, pyridine and acetaldehyde, β-
ketoester 2.10 was transformed into RCM precursor 2.11 as a 1:1 mixture of diastereomers 
in excellent yield. Trisubstituted alkene 2.11 underwent RCM, promoted by Grubbs’ second 
generation catalyst, to furnish the A-ring model 1.147 in 61% yield. RCM precursor with tert-
butyl ester 2.12 (several grams of this product were available in the lab35) were submitted 
to the same conditions and A-ring model 1.148 was synthesised in 68% yield  (Scheme 
2.10). 
Scheme 2.10: Synthesis of both models of the A-ring  
Despite furnishing both A-ring models, the RCM suffers from two limitations: moderate 
yields and important quantities of expensive catalyst used (7.0 to 10 mol%). These 
limitations are the results of steric and electronic factors. One of the alkenes being 
trisubstituted and doubly deactivated due to the conjugation with the two electron 
withdrawing groups, this problem could be circumvented by installing a gem-disubstituted 
alkene instead of a trisubstituted alkene to limit steric effects. A method developed for direct 
α-methylenation of carbonyls mediated by diisopropylammonium trifluoroacetate was 
applied to our substrate.44 Attempts to purify the product only led to complete 
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decomposition, thus the crude product was used without purification in RCM step. The 
desired cyclopentene 1.147 was recovered in a comparable yield than the previous method 
(Scheme 2.11). Without a major increase of the overall yield and due to the difficulty to 
prepare the new precursor, it was decided to go back to the previously developed method, 
using the trisubstituted alkene. 
Scheme 2.11: RCM with gem-disubstituted alkene 
In summary, TMSE A-ring 1.147 was synthesised from D-Phenylalanine in 10 steps in 16% 
overall yield as a single diastereomer. tert-Butyl A-ring 1.148 was synthesised from the 
available RCM precursor 2.12 in 68% yield (Scheme 2.12). 
 
Scheme 2.12: Formation of two different A rings 
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2.1.2 Synthesis of the C ring 
Using a method developed in the group, the desired C-ring 1.130 could be formed by a 
conjugated addition from the known enone 2.14 (Scheme 2.13). 45 
 
Scheme 2.13: Retrosynthesis of C-ring 1.130 
The synthesis of ketone 2.14 started, as described in the litterature, by the ketal protection 
of D-Ribose followed by Wittig methylenation to give diol 2.15 in 76% yield over 2 steps. 
Oxidative cleavage of compound 2.16 furnished the volatile aldehyde 2.16 in very good 
yield. The yield of this reaction was improved (50–60% to 89%) by the use of Pentane/Et2O 
as a solvent system during the purification by flash chromatography (Scheme 2.14).  
 
Scheme 2.14: Synthesis of volatile aldehyde 2.16 in 3 steps 
Addition of vinylmagnesium bromide to aldehyde 2.16 gave allylic alcohol 2.17, which was 
submitted to ring-closing metathesis in presence of Grubbs’ first generation catalyst to 
provide cyclic alcohol 2.18 as a 2:1 mixture of diastereomers in near quantitative yield 
(Scheme 2.15). 
 
Scheme 2.15: Synthesis of cyclic allylic alcohol 2.18  
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Product 2.18 was then submitted to a TEMPO/BAIB oxidation, where TEMPO is the primary 
oxidant and BAIB ((bis(acetoxy)iodo)benzene) the sacrificial or secondary oxidant.  
Surprisingly, a mixture of ketone 2.14 and starting material was recovered. It appeared that 
only the trans isomer reacted with TEMPO to give ketone 2.14. This difference in reactivity 
is most likely due to the steric hindrance of the cyclic ketal, making the cis isomer cis-2.18 
less reactive (Scheme 2.16). 
 
Scheme 2.16: Difference of reactivity between cis/trans isomers 
Submitting acyclic alcohol 2.17 to RCM, followed by a Swern oxidation, provided cyclic 
ketone 2.14 in very good yield without any traces of unreacted cis isomer. The final step for 
the synthesis of the C-ring was a conjugated addition of isopropenyl magnesium bromide 
in the presence of copper(I) iodide and TMSCl to furnish silyl enol ether 1.130 and ketone 
2.19 with complete stereocontrol. Instability of the silyl enol ether during the purification was 
limited by the use of an oven-dried silica. Ketone 2.19 can be be easily converted into 
corresponding silyl enol ether 1.130 in one step (Scheme 2.17). 
 
Scheme 2.17: Production of silyl enol ether 1.130 
In summary, the C-ring model 1.130 was synthesised from D-Ribose in 27% overall yield 
over 7 steps, which is a net improvement compared to the previous synthesis (9% overall 
yield over 7 steps35) (Scheme 2.18). 
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Scheme 2.18: Summary of the synthesis of product 1.130 
2.1.3 Formation of the ABC tricycle 
With both precursors in hand, the next step of the project was a diastereoselective Michael 
reaction. Previous studies in the group had shown that both steric hindrance of the ester 
and the polarity of the solvent are paramount for the diastereoselectivity of this reaction.33–
36 Previous reaction with tert-butyl ester 1.148 in a 4:1 mixture of DMF/THF exhibited an 
excellent diastereoselectivity, leading to the synthesis of a single stereoisomer. Surprisingly, 
when this reaction was repeated, a mixture of two diastereomers with a 3:1 ratio in favor of 
the desired stereoisomer 2.21 was obtained. The reasons behind the decrease of the 
diastereoselectivity are unclear and need to be investigated (Scheme 2.19). 
 
Scheme 2.19: Diastereoselective Michael addition  
In order to close the B-ring, a Snider cyclisation was performed on the mixture of bicycles 
2.20/2.20’. Tricycle 1.150 was obtained in 46% yield and as a single diastereomer after 
radical cyclisation. The undesired diastereomer decomposed during the Snider cyclisation 
(Scheme 2.20). 
 
Scheme 2.20: Snider reaction on substrates 2.20/2.20’ 
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A few reaction conditions were then carried out for the cleavage of the tert-butyl ester. First 
of all, treatment with TFA only led to a mixture of starting material and decomposition 
products. Addition of triethylsilane acting as a cation scavenger to the previous conditions 
produced a mixture of starting material 1.150 and the TBS ether cleaved product. 
TMSOTf/2,6–lutidine are well-known conditions for the deprotection of tert-butyl esters, 
ethers and Boc protecting groups.46 Additionaly, CeCl3/NaI in CH3CN is also a known 
method for selective deprotection of tert-butyl esters.47 Both conditions were tested, 
however only starting material was recovered. Another attempt was made using ZnBr2 in 
dichloromethane but unfortunately no β-ketoacid 2.1 was observed (Table 1.3).48 
Conditions Temperature Results 
CH2Cl2/TFA (10:1) RT SM/decomposition 
CH2Cl2/TFA (10:1)/Et3SiH RT SM/free hydroxyl (9:1) 
TMSOTf/2,6–
lutidine/dioxane 
RT to 101 °C SM 
CeCl3/NaI/CH3CN RT to 82 °C SM 
ZnBr2/CH2Cl2 RT SM 
Table 1.3: Attempts for the formation of β-ketoacid 2.1 
Due to the unsuccessful formation of β-ketoacid 2.1 from tert-butyl ester 1.150, it was then 
decided to synthesise the corresponding tricycle incorporating a TMSE ester. Previous 
attempts in the group to produce the bicycle with the TMSE ester moiety only furnished the 
desired product in very poor yield (<5%).35 Pleasingly, when the diastereoselective Michael 
reaction between conjugated ketoester 1.147 and silyl enol ether 1.130 was repeated, 
bicycle 2.21 was obtained in 35% yield and as a 3:1 mixture of diastereomers (Scheme 
2.21).  
 
Scheme 2.21: Diastereoselective Michael reaction to furnish product 2.21 
Radical cyclisation of bicycle 2.21 gave the corresponding tricycle 1.149 in 30% yield and 
as a single diastereomer. An attempt to cleave the TMSE ester with TBAF was made but 
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only the deprotected alcohol 2.22 was observed, without any evidence of the formation of 
the carboxylic acid 2.1 (Scheme 2.22). 
 
Scheme 2.22: Formation of tricycle 1.149 and attempts of fluorolysis of TMSE ester 
2.1.4 Conclusion and future work 
Unfortunately, due to the production of small of quantities of tricycle 1.149, no further 
attempts for the formation of carboxylic acid were made. The synthesis needs to be 
repeated with larger quantities of starting material. In conclusion, two ABC tricycles with 
different esters were generated: tert-butyl ester tricycle 1.150 was synthesised in 17% yield 
over 3 steps from available diene 2.12; TMSE ester tricycle 1.149 was generated as a single 
diastereomer with an overall yield of 1.7% over 12 steps in the longest linear sequence 
(Scheme 2.23).  
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Scheme 2.23: Summary of the ABC tricycle syntheses 
 
The ester cleavage/decarboxylation reaction has proven to be difficult. Further tests are 
necessary in order to continue the synthesis of the ABC tricycle 1.125. 
2.2 Synthesis of CDEF model 
The CDEF model 1.134 could be obtained using a synthetic sequence with two key-steps: 
the closure of the nine-membered ring followed by an oxa-Michael reaction to give the CDF 
tricycle 1.136. Our first efforts were first focused on the development of a method to produce 
the 5/9 bicycle 1.138 using cyclopentenone as an achiral model C-ring (Scheme 2.24). 
 
Scheme 2.24: Key-steps for the synthesis of CDEF tetracycle 1.134 
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2.2.1 Aldol pathway 
This part of the project started by repeating the work previously developed in the group.35 
The cyclisation precursor 1.140 would be formed by a Michael reaction between fragment 
1.126 and cyclopentenone. Ketoester 1.126 could be produced by a Roskamp 
homologation from aldehyde 2.23, which would be obtained by cleavage of the auxiliary in 
aldol 2.24. Aldol 2.24 would be synthesised by a diastereoselective aldol reaction between 
the acylated Crimmins auxiliary 2.4 and 4-penten-1-al 2.25 (Scheme 2.25). 
 
Scheme 2.25: Retrosynthesis of precursor 1.140 
4-Penten-1-al was previously synthesised in the group in 60% yield over two steps from 
glycidol.35 This method was replaced by a TEMPO/BAIB oxidation of commercially available 
4-penten-1-ol to furnish the corresponding aldehyde in 65% yield. 4-Penten-1-al reacted 
with compound 2.4 to furnish aldol 2.26, which was then protected as a TBS ether in near 
quantitative yield. The two diastereomers were separated by flash chromatography as this 
stage. The protected aldol 2.24 was transformed into the corresponding aldehyde 2.23 by 
reductive cleavage using DIBAL-H. Aldehyde 2.23 was then submitted to a Roskamp 
homologation in the presence of ethyl diazoacetate (ethyl diazoacetate was synthesised 
from ethyl acetoacetate and p-ABSA in 51% yield over one step)49 to give the corresponding 
ethyl β-ketoester 1.126 as a single diastereomer in 26% yield over five steps. The next step 
was a Michael addition between β-ketoester 1.126 and cyclopentenone. Michael reactions 
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carried out previously in the lab with potassium carbonate usually needed 1.5 equivalents 
of β-ketoester 1.126 and appeared to be difficult to reproduce (7 to 40% yield). Fortunately, 
after further optimisations, the Michael addition delivered product 2.27 as a mixture of four 
diastereisomers in a very good yield, using a reasonable amount of fragment 1.126 (1.1 
equiv). The order of addition of the reagents was crucial for total conversion of 1.126 (β-
ketoester/cyclopentenone then catalytic amount of K2CO3) (Scheme 2.26). 
 
Scheme 2.26: Synthesis of Wacker oxidation precursor 2.27 
A Wacker oxidation was carried out to transform the terminal alkene into the corresponding 
ketone. In the presence of PdCl2, CuCl in DMF/H2O under oxygen atmosphere, product 
2.27 was converted into the corresponding ketone 1.140 in 78% yield. Protection of the β-
ketoester with triethylsilyl trifluoromethanesulfonate at very low temperature led to the 
formation of the silyl enol ether 1.145. Due to its instability, compound 1.145 was not purified 
and used directly in the next step. The geometry of the silyl enol ether was not determined 
by NMR; it has been previously reported in the literature that treatment of β-ketoesters 
under kinetic conditions led exclusively to of the Z silyl enol ethers.50,51 Different conditions 
for the formation of the nine-membered ring were attempted; sodium hydroxide in a diluted 
mixture of THF/EtOH were the only one to give interesting results. Unfortunately, formation 
of the nine-membered ring was not observed but product 2.28 was obtained in 40% yield. 
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Generation of compound 2.28 was more likely the result of a retro Michael reaction (Scheme 
2.27). 
 
Scheme 2.27: Formation of silyl enol ether 1.145 and retro Michael product 2.28 
Another approach was envisaged, using the retro Michael product 2.28 as a cyclisation 
precursor in a Michael aldol cascade. First of all, a Michael reaction between 2.28 and 
cyclopentenone would occur, leading to the formation of the desired enolate. Secondly, this 
enolate would react in an aldol reaction followed by crotonisation and formation of the nine-
membered ring 1.138 (Scheme 2.28). 
 
Scheme 2.28: Mechanism of the envisaged cascade 
Different bases (t-BuOK, NaH, DBU) were tried, but all of them gave the adduct 1.140 
without any traces of nine-membered ring (Scheme 2.29). 
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Scheme 2.29: Michael addition between product 2.28 and cyclopentenone  
When product 1.140 was directly treated with a base, retro-Michael compound 2.30 was 
obtained. Due to the aldol pathway being unsuccessful, it was decided to try a new approach 
for the formation of nine-membered ring 1.138 
2.2.2 Reformatsky pathway 
The Reformatsky reaction is a method where α-halo esters react with aldehydes and 
ketones using different metals, such as zinc or samarium, to produce β-hydroxy esters. 
Formation of medium-size rings and in particular nine-membered rings using the 
Reformatsky reaction has been previously described in the literature.52 Inanaga et al. 
published a method to obtain medium- and large-size lactones from α-bromo ester with the 
aid of samarium(II) iodide. The mechanism for the formation of a nine-membered lactone is 
described below: α-bromo ester 2.29 containing an aldehyde moiety at the end of the linear 
chain reacted with SmI2 in a single electron transfer to form a radical in the α position of the 
ester. This radical was reduced by another equivalent of SmI2 to furnish a samarium 
enolate, which attacked the aldehyde to give the corresponding β-hydroxy lactone. The β-
hydroxy lactone was converted into the corresponding β-acetate lactone 2.30 for easier 
purification (Scheme 2.30). 
 
Scheme 2.30: Reformatsky reaction applied to the formation of nine-membered lactone 
65 
 
A Reformatsky reaction to close the desired nine-membered ring 1.138 from α-bromo 
ketone 2.31 was envisaged. α-Bromo ketone 2.31 could be obtained by a Wacker oxidation 
and a Michael addition between fragment 1.126 and bromocyclopentenone 2.32. 
Bromocyclopentenone 2.32 would be synthesised from the commercially available 
cyclopentenone (Scheme 2.31). 
 
Scheme 2.31: Retrosynthesis of the Reformatsky pathway 
Bromocyclopentenone 2.32 was obtained from cyclopentenone in the presence of bromine 
and triethylamine in 82% yield. Michael reaction between ketoester 1.126 and 
bromocyclopentenone 2.32 furnished compound 2.33 in good yield. The slight decrease of 
yield between the Michael reaction with cyclopentenone and bromocyclopentenone 2.32 is 
probably due to a more acidic proton in the case of the bromoketone. This pKa difference 
probably slows down the reprotonation step and increases the amount of retro-Michael 
reaction. The next step was a Wacker oxidation to give Reformatsky precursor 2.31 in very 
good yield (Scheme 2.32).  
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Scheme 2.32: Formation of Reformatsky precursor 2.31 
Samarium-promoted Reformatsky reaction was then attempted. A solution of samarium(II) 
iodide was prepared by addition of 1,2-diiodoethane to samarium powder, followed by slow 
addition (pseudo high-dilution) of product 2.31. Unfortunately, the reaction only gave a 
mixture of starting material and reduced product 1.140 (Scheme 2.33). 
 
Scheme 2.33: Samarium-promoted Reformatsky 
Other conditions were tested, such as Zn/CeCl3.7H2O and SnCl2/LiAlH4.53,54 Only the 
starting material was recovered in both cases. Previous experiments with SmI2 have shown 
that the α-bromo ketone could be reduced to the corresponding ketone, via a radical 
intermediate (Scheme 2.34). 
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Scheme 2.34: Mechanism for the formation of the reduced bromo ketone 
In light of these results, it was decided to change the synthetic pathway and to use the 
radical intermediate in the cyclisation step. 
2.2.3 Radical pathway 
A new synthetic approach was then considered which involves using an alkyne instead of 
a ketone. Nine-membered ring 1.138 could be obtained by isomerisation of the alkene from 
product 2.34, which would be synthesised by radical cyclisation from product 2.35. 
Compound 2.35 could be obtained by a Michael reaction between previously synthesised 
bromoketone 2.32 and alkyne 2.36. Alkyne 2.36 could be formed by a 
dihydroxylation/oxidative cleavage of the alkene from fragment 1.126 followed by a 
Bestmann-Ohira reaction of the resulting aldehyde (Scheme 2.35). 
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Scheme 2.35: Proposed radical cyclisation route 
In order to test this radical cyclisation, transformation of alkene 1.126 into the corresponding 
alkyne 2.36 was attempted. Surprisingly, when alkene 1.126 was submitted to a one-pot 
dihydroxylation/oxidative cleavage, instead of obtaining the desired aldehyde, only the 
cyclic aldol 2.37 was produced (Scheme 2.36).55 
 
Scheme 2.36: One-pot dihydroxylation/oxidative cleavage 
It was decided to investigate and determine which step was responsible for the formation 
of the undesired seven-membered ring. Isolation of diol 2.38 after an Upjohn dihydroxylation 
was successful (Scheme 2.37) 
 
Scheme 2.37: Upjohn dihydroxylation 
Attempts to cleave diol 2.38 using BAIB or Pb(OAc)4 only led to the formation of cyclic aldol 
2.37.56,57 Ozonolysis of alkene 1.126 also produced undesired aldol 2.37. It was then 
decided to start the synthesis of ester 2.36 by a Crimmins aldol reaction using 4-pentyn-1-
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al 2.39. Aldehyde 2.39 was obtained from the 4-pentyn-1-ol by a TEMPO/BAIB oxidation 
(Scheme 2.38). 
 
Scheme 2.38: Oxidation of 4-pentyn-1-ol 
Diastereoselective Crimmins reaction gave aldol 2.40 in very good yield and diastereomeric 
ratio. Aldol protection proceeded this time in the presence of TBSOTf and Et3N to furnish 
TBS ether 2.41 as a single diastereomer in 90% yield. This new protection method reduced 
the reaction time (3 days with TBSCl, 2 hours with TBSOTf).  Cleavage of the Crimmins 
auxiliary with DIBAL-H yielded aldehyde 2.42 and Roskamp homologation of aldehyde 2.42 
furnished β-ketoester 2.36 in very good yield for both steps. Michael reaction between β-
ketoester 2.36 and bromocyclopentenone 2.32 furnished product 2.35 as a mixture of 8 
diastereomers in 10% overall yield over 5 steps. The moderate overall yield is mainly due 
to the Michael addition step where most of the starting material was left unreacted (Scheme 
2.39). 
 
Scheme 2.39: Synthesis of radical cyclisation precursor 2.35 
The cyclisation tests carried out using different conditions are summarised below (Table 
2.1). 
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Reagents Temperature Addition Result 
Indium(I) iodide, 
Sonication,CH3CN58 
 
40 °C 
 
Normal 
 
Starting material 
TTMSS, ACCN, 
Benzene 
 
80 °C 
 
Normal 
Starting material + 
reduced product 
TTMSS, ACCN, 
Benzene 
 
80 °C 
 
Slow 
 
Starting material  
Bu3SnH, ACCN, 
Benzene 
 
80 °C 
 
Normal 
Starting material + 
reduced product 
Bu3SnH, ACCN, 
Benzene 
 
80 °C 
 
Slow 
Starting material + 
mixture of products 
Table 2.1: Conditions for the radical cyclisation 
Only tributyltin hydride with ACCN (1,1′-Azobis(cyclohexanecarbonitrile)) as an initiator 
added very slowly gave interesting results. A mixture of products was obtained, and high 
resolution mass spectroscopy suggested formation of the desired cyclisation product. Due 
to the very small quantity of material being obtained, consisting of a complex mixture of 
diastereomers and a possible mixture of nine- and ten-membered rings, full characterisation 
was not possible. When this reaction was carried on larger scale the same products were 
not observed. Unfortunately, this reaction proved to be irreproducible.  
It was then decided to modify the route and use the TMS-protected alkyne 2.43. The TMS 
group has been shown to stabilise radicals at the α-position.59 The presence of the TMS 
group should increase the stability of the vinyl radical but also direct the cyclisation to a 9-
exo dig instead of 10-endo dig cyclisation (Scheme 2.40). 
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Scheme 2.40: Proposed radical cyclisation with TMS-protected alkyne 2.44 
The coupling partner 2.45 for the Crimmins aldol reaction was synthesised from 4-pentyn-
1-ol starting with the addition of n-BuLi to deprotonate both alcohol and alkyne. Both 
positions were silylated by addition of TMSCl then the TMS ether was selectively cleaved 
by addition of a 1M aqueous solution of HCl. The free alcohol was finally oxidised by a 
mixture of TEMPO/BAIB to furnish aldehyde 2.45 in excellent yield over 2 steps (Scheme 
2.41). 
 
Scheme 2.41: Synthesis of aldol partner 2.45 
Diastereoselective aldol reaction between chiral auxiliary 2.7 and TMS-protected 4-pentyn-
1-al 2.45 gave aldol 2.46 in excellent yield and with a good diastereomeric ratio. Formation 
of TBS ether using TBSOTf gave protected aldol 2.47 as a single diastereomer in 80% yield. 
Cleavage of the Crimmins auxiliary produced aldehyde 2.48 in excellent yield. The cleavage 
step was followed by a Roskamp homologation to furnish β-ketoester 2.49 as a single 
diastereomer in 45% yield over 6 steps from 4-pentyn-1-ol (Scheme 2.42). 
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Scheme 2.42: Synthesis of β-ketoester 2.49 
Michael addition between β-ketoester 2.49 and bromocyclopentenone 2.32 furnished 
radical cyclisation precursor 2.43 in moderate yield. A part of the starting material was left 
unreacted (Scheme 2.43). 
 
Scheme 2.43: Formation of cyclisation precursor 2.43 
The decrease in yield for the previous Michael addition in the presence of 
bromocyclopentenone 2.32 was not acceptable; as previously stated, it was believed that 
this decrease was more likely due to a more acidic proton at the α-position of the ester and 
bromide. This problem could be solved by addition of a cosolvent with a lower pKa, which 
would accelerate the protonation of the intermediary enolate and avoid a retro-Michael 
reaction. This theory was later confirmed; addition of one equivalent of trifluorethanol led to 
the formation of product 2.43 in 74% yield (Scheme 2.44).  
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Scheme 2.44: Increase of yield by addition of trifluroethanol 
With precursor 2.43 in hand, the radical cyclisation was investigated. The previous 
conditions used with unprotected alkyne were tested on compound 1.138 (Table 2.2). 
 
Reagents Temperature Addition Result 
 
Bu3SnH, ACCN, 
Benzene 
 
80 °C 
 
Normal 
 
Starting material 
 
Bu3SnH, ACCN, 
Benzene 
 
80 °C 
 
Slow 
 
Starting material  
 
TTMSS, ACCN, 
Benzene 
 
80 °C 
 
Slow 
    Starting material 
+ 
  reduced product 
Table 2.2: Increase of yield by addition of trifluroethanol 
Unfortunately, only the starting material and traces of the reduced product were observed. 
With the radical pathway being unsuccessful, it was decided to investigate another synthetic 
route. 
2.2.4 Michael-Isomerisation pathway 
After these disappointing results, another approach was envisaged. In 1986, 
Deslongchamps and Roy published a synthetic method to produce nine- and ten-membered 
rings by intramolecular Michael addition of malonate to enones and ynones.60 The 
publication showed some interesting results, with the formation of medium size rings in 25–
50% yield. One substrate caught our attention: ynone 2.50 was submitted to Michael 
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addition conditions in the presence of caesium carbonate in a THF/DMF mixture; the result 
was the formation of nine-membered ring 2.51 in an acceptable 35% yield (Scheme 2.45).  
 
Scheme 2.45: Intramolecular Michael addition  
Based on these results, a new retrosynthesis was designed, where the key step would be 
an intramolecular Michael addition. The nine-membered ring 1.138 could be synthesised by 
an intramolecular Michael reaction and isomerisation of the double bond from compound 
2.52, which could be prepared by a Stille coupling between bromo alkene 2.53 and α-
stannylated ketone 2.54. Bromo alkene 2.53 could be synthesised by selective 
hydrobromination of alkyne 2.36 and α-stannylated ketone 2.54 by bromination Stille 
coupling of the conjugated double bond of the commercially available cyclopentenone 
(Scheme 2.46). 
  
Scheme 2.46: Retrosynthesis for Michael-isomerisation route  
The previously synthesised bromoketone 2.32 was submitted to Pd(PPh3)4 and 
hexamethyldistannane to give the Stille coupling partner 2.54 in 79% yield (Scheme 2.47). 
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Scheme 2.47: Synthesis of the Stille coupling partner 2.54 
With the stannylated ketone 2.54 in hand, synthesis of the bromo alkene 2.53 was 
investigated. Conditions for the selective bromination of the alkyne 2.36 to form the α isomer 
were tested. The first try involved boron tribromide followed by addition of acetic acid. The 
first step of this reaction would be a borobromination of the alkyne followed by protonolysis 
of the boron to furnish expected bromo alkene product 2.53.61 Due to electronic effects, the 
boron is most likely to attack on the terminal position leading to the desired isomer (Scheme 
2.48). 
 
Scheme 2.48: Proposed mechanism for the formation of bromo alkene 2.53 
When alkyne 2.36 was submitted to boron tribromide and acetic acid, only the elimination 
product 2.55 was observed. This is most likely due to the strong acidic conditions and to 
the formation of a stable, conjuguated product (Scheme 2.49). 
 
Scheme 2.49: Formation of conjugated alkene 2.55 
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Reaction with LiBr, TMSCl and tetraethylammonium bromide in acetonitrile under 
microwave activation is known to be an efficient way to brominate alkynes.62 When applied 
to our substrate, a mixture of starting material and conjuguated alkene 2.55 was recovered 
(Scheme 2.50). 
 
Scheme 2.50: Microwave assisted bromination 
The synthetic strategy was modified. It was then decided to swap Stille coupling partners. 
Iodocyclopentenone 2.57 was easily prepared; the next step was to synthesise the α-
stannylated alkene 2.56 (Scheme 2.51). 
 
Scheme 2.51: Envisaged Stille coupling 
It was first decided to try different methods of hydrostannation on a model alkyne, TBS-
protected pent-4-ynol 2.58, in order to optimise the ratio of α/β isomers.63 Three different 
catalysts were tested in the presence of Bu3SnH and the results are described below (Table 
2.3).64–66  
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Catalyst Mol% Solvent Temperature Time SM/α/β 
Pd(PPh3)4 5 THF 66 °C 12 h 2/1/2 
Mo(CO)3(NC-t-Bu)3 20 THF 66 °C 24 h 8/1.25/1 
[(Cp*)Ru(NCCH3)3][PF6] 5 CH2Cl2 RT 20 min 0/1/0 
Table 2.3: Hydrostannation attempts 
After 12 h the palladium catalyst after only gave a mixture of starting material 2.58 and β-
isomer 2.59’ as major products. When the molybdenum catalyst was used, the ratio was 
slightly in favour of the α-isomer 2.59 but a good part of the starting material 2.58 was left 
unreacted, even after 24 h. In the presence of the ruthenium catalyst, full conversion was 
observed and the desired isomer 2.59 was obtained as a single product. A mechanism for 
the ruthenium catalysed hydrostannation is described below and is mostly an extrapolation 
of the ruthenium-catalysed hydrosilylation mechanism described by Trost et al.67,68 Firstly, 
the stannane is activated through a σ-complex A, which reacts in a concerted hydride 
insertion and oxidative addition to furnish the corresponding η2-vinylruthenium or 
metallacyclopropene B. The hydride insertion occurs on the less hindered alkyne carbon to 
furnish the Markovnikov intermediate over the anti-Markovnikov one. The final step is the 
α-stannyl insertion C to release the desired stannylated alkene and regenerate the catalyst 
(Figure 2.1). 
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Figure 2.1: Proposed mechanism for the regioselective hydrostannation 
The ruthenium-catalysed hydrostannation was applied to our substrate 2.36. Pleasingly, 
after 2 h, the starting material was entirely consumed and only the desired product 2.56 was 
obtained (Scheme 2.52). The product was used in the next step without purification. 
 
Scheme 2.52: Regioselective hydrostannation on alkyne 2.36 
Different conditions for the Stille coupling were tested; the best conditions were found to be 
a method developed by Fürstner et al. for sensitive substrates.69 In the presence of copper(I) 
thiophene-2-carboxylate (CuTc), tetrabutylammonium diphenylphosphinate as additives 
and iodocyclopentenone 2.57 (synthesised in one step from cyclopentenone using iodine 
and pyridine), Stille coupling furnished the desired Michael precursor 2.52 in 40% yield over 
2 steps (Scheme 2.53). 
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Scheme 2.53: Modified Stille coupling 
Compound 2.52 was then submitted to different test conditions for the intramolecular 
Michael reaction (Table 2.4). 
 
Reagent Solvent Time Result 
K2CO3 Ethanol 24 h SM 
Cs2CO3 DMF/THF 5 h SM 
FeCl3.6H2O CH2Cl2 24 h Decomposition 
Mn(OAc)3.2H2O Ethanol 24 h SM 
Table 2.4: Tests for the formation of the nine-membered ring 
The previous conditions used in our group for Michael additions with a catalytic amount of 
potassium carbonate in ethanol were attempted. Unfortunately product 2.52 was left 
unreacted. The conditions reported by Deslongchamps and Roy was applied to our 
substrate, but only the starting material was recovered after 24 h.60 In 2000, Christoffers 
and Oertling published a novel method using iron(III) chloride hexahydrate to catalyse 
intramolecular Michael reaction for the formation of seven-membered rings. When this 
method was tried on enone 2.52, only decomposition was observed.70 A final test in the 
presence of manganese(III) acetate led to the recovery of starting material 2.52.  
 
With the Michael reaction pathway being unsuccessful, it was decided to rethink our 
strategy for the formation of nine-membered ring 1.138. 
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2.2.5 Relay ring-closing metathesis pathway 
After the previous attempts, it was hypothesised that one of the reason behind these 
disappointing results might be the reversibility of the key cyclisation step. In all our previous 
attempts (e.g. Michael addition), the formation of the intermediate during the cyclisation was 
reversible and could go two different pathways: either formation of the desired strained 
bicycle or return to its previous state. In order to circumvent this difficulty, it was decided to 
investigate a synthetic strategy where the cyclisation step would be irreversible, pushing 
the equilibrium towards the formation of the nine-membered ring 1.138.  
RCM is a powerful tool to close rings of different sizes. In most cases, the newly formed 
double bond is less reactive than the precursors and therefore less likely to react in another 
metathesis. In our case, due to steric hindrance, the tetrasubstituted alkene would be 
completely inert towards a secondary metathesis reaction. Unfortunately, a direct RCM 
between two gem disubstituted alkenes to produce a tetrasubstituted alkene can be very 
difficult, it was then decided to focus our efforts on a relay ring-closing metathesis (RRCM). 
RRCM is a method recently developed to produce hindered or electronically deactivated 
alkenes that are difficult to synthesise by direct RCM. Instead of an intermolecular initiation 
of the catalytic cycle to install the ruthenium carbene on the desired alkene, the 
metallocarbene is generated by an intramolecular reaction with the aid of a temporary tether 
incorporating a more reactive olefin.71 An example is described in more detail below. In 
order to form the desired butenolide 2.62, a direct RCM from 2.60 was not feasible due to 
the steric hindrance of both alkenes and electronic deactivation of the conjugated alkene. 
Hoye et al. decided to install a tether containing a terminal alkene 2.61, which reacted first 
with the ruthenium catalyst to produce a metallocarbene.72 The second step was the 
kinetically favored formation of a five-membered ring to place the metallocarbene at the α-
position of the ester, a more hindered and deactivated position. The final step was a classic 
RCM to regenerate the catalyst and furnish the desired butenolide 2.62 (Scheme 2.54). 
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Scheme 2.54: Formation of butenolide 2.62 by RRCM 
It was decided to apply RRCM to our strategy. Our envisaged retrosynthesis started by the 
formation of nine-membered ring 1.138 by RRCM of precursor 2.63. Product 2.63 could be 
obtained by a Michael/elimination reaction between β-ketoester 2.64 and β-
chlorocyclopentenone 2.65. β-Ketoester 2.64 would be formed by a series of reactions 
previously developed, starting from a Crimmins aldol reaction with aldehyde 2.66. β-
Chlorocyclopentenone 2.65 would be produced by a Morita-Baylis-Hillman (MBH) reaction 
between cyclopentenone and aldehyde 2.67 followed by a chlorination (Scheme 2.55). 
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Scheme 2.55: Retrosynthesis for RRCM pathway 
The forward synthesis started with the TEMPO/BAIB oxidation of hex-5-en-1-ol  to give the 
corresponding aldehyde 2.67 in 70% yield. The next step was a Morita-Baylis-Hillman 
reaction between aldehyde 2.67 and commercially available cyclopentenone. The best 
conditions were found to be the ones developed by Iguchi et al. using dimethylphenyl 
phosphine as a catalyst in a chloroform/methanol mixture.73 This reaction furnished the 
desired MBH product 2.68 in an excellent 94% yield in only 1 h. The β-hydroxy enone 2.68 
was submitted to an addition of mesyl chloride and triethylamine to produce the unstable β-
chlorocyclopentenone 2.65 that was used in the next step without purifcation (Scheme 
2.56). 
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Scheme 2.56: Formation of fragment 2.65 
With chlorocyclopentenone 2.65 in hand, it was decided to try the Michael addition with the 
already available β-ketoester 1.126 before embarking the synthesis of the desired ketoester 
2.64 containing a 1,1-disubstituted alkene. Two sets of conditions were tested and the 
results are described below (Table 2.5). 
 
Conditions Temperature Time Results 
NaH, THF RT 24 h SM recovered 
Pd(PPh3)4, NaH, 
THF 
RT 5 min Full conversion 
Table 2.5: Conditions tested 
When sodium hydride was added to a mixture of both products, no reaction occured and 
only the starting materials were recovered after 24 h. Pleasingly, after addition of a catalytic 
amount of Pd0 to the crude mixture, the reaction was complete and full conversion was 
observed by NMR after only 5 min. It was then decided to use this Tsuji-Trost reaction in 
the synthesis of the envisaged RRCM precursor 2.63. 
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Aldehyde 2.66, crucial partner in the Crimmins aldol reaction, could be formed by a Negishi 
carboalumination and TEMPO/BAIB oxidation of the commercially available alcohol 
(Scheme 2.57). 
 
Scheme 2.57: Retrosynthesis of aldehyde 2.66 
After optimisation, the conditions that led to the best results were found to be the addition 
of a catalytic amount of zirconocene dichloride, trimethylaluminium and 1.5 equivalents of 
water in refluxing CH2Cl2.74 The crude alcohol was immediately oxidised with a mixture of 
TEMPO/BAIB to furnish the corresponding aldehyde 2.66. Unfortunately, in addition to 
safety concerns during the addition of water in the zirconium/trimethylaluminium mixture, 
the Negishi carboalumination proved to be quite difficult to reproduce (Scheme 2.58).  
 
Scheme 2.58: 2 steps process for the synthesis of aldehyde 2.66 
The synthesis was modified and a longer but more reliable route was developed. Reduction 
of commercially available methacrylate followed by Johnson-Claisen rearrangement 
furnished the corresponding γ,δ-unsaturated ester. The ester moiety was reduced by lithium 
aluminium hydride and the resulting alcohol transformed by Swern oxidation into the desired 
aldehyde 2.66 in 38% yield over 4 steps (Scheme 2.59). 
 
Scheme 2.59: 4 steps process for the synthesis of aldehyde 2.66 
Diastereoselective aldol between acylated Crimmins auxiliary 2.4 and aldehyde 2.66 led to 
the production of the aldol 2.70 in good yield and diastereomeric ratio. Formation of the TBS 
ether 2.71 followed by cleavage of the auxiliary furnished aldehyde 2.72 in excellent yield 
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over 2 steps. Aldehyde 2.72 underwent Roskamp homologation and gave β-ketoester 2.64 
in 55% yield over 4 steps (Scheme 2.60).  
 
Scheme 2.60: Synthesis of Tsuji-Trost precursor 2.64 
β-Ketoester 2.64 and β-chlorocyclopentenone 2.65 reacted together in the presence of Pd0 
to furnish RRCM precursor 2.63 in very good yield and with a perfect regioselectivity 
(scheme 132). By comparison to published NMR data for similar compounds, the newly 
formed alkene was determined to be exclusively the E-isomer (Scheme 2.61).75 
 
Scheme 2.61: Tsuji-Trost coupling 
Product 2.63 was submitted to RRCM conditions using different catalysts such as Hoveyda-
Grubbs II catalyst or the more reactive catalyst Zhan-1B, but the fourteen-membered ring 
2.73 was obtained exclusively (scheme 2.62).  
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Scheme 2.62: Attempts of RRCM  
As expected, the first step of the catalytic cycle was the reaction between the more reactive 
terminal alkene with the ruthenium catalyst to produce a metallocarbene at the terminal 
position. The formation of macrocycle 2.73 indicates that the ruthenium carbene at the 
terminal position reacted preferentially with the most electron-rich gem-disubstituted alkene. 
The absence of the desired nine-membered ring 1.138 or the truncated product 2.74 
confirmed that no reaction occured between the conjugated alkene and the metallocarbene 
(Scheme 2.63). 
 
Scheme 2.63: Different possible pathways  
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These results are more likely due to the conjugated alkene being too electron deficient and 
therefore, unreactive towards metathesis. A possible solution to this problem is the 
reduction of the enone moiety into the corresponding allylic alcohol. Indeed, allylic alcohols 
being more electron rich, their reactivities towards metathesis increase. RRCM precursor 
2.63 was submitted to Luche reduction conditions using sodium borohydride and cerium(III) 
chloride heptahydrate. Pleasingly, the enone was selectively reduced to furnish allylic 
alcohol 2.75 in 66% yield without any sign of the reduced ketoester. The selectivity was 
hypothesised to be the results of the formation of a cerium enolate, acting as temporary 
protection against reduction. The allylic alhocol 2.75 reacted with the Grela catalyst at 
different temperatures and speed of addition but only decomposition was observed 
(Scheme 2.64). 
 
Scheme 2.64: RRCM trials on product 2.75 
These last results have shown that obtention of the nine-membered ring 1.138 using a 
RRCM as a key-step was not possible and forced us to change our general strategy. 
2.2.6 Michael/Tsuji-Trost pathway 
During our last synthetic effort, a Michael/Tsuji-Trost reaction was used to produce the 
RRCM precursor 2.63. This reaction allowed the formation of the desired product in good 
yield and with a short reaction time (< 5 min). This method could be applied to the key 
cyclisation step. Nine-membered ring 1.138 would be closed by a Michael/Tsuji-trost 
reaction from a precursor containing a leaving group (e.g. chloride, acetate) in the α position 
of the enone. This precursor could be formed from the corresponding bis-allylic alcohol 
product 2.76 by several functional group interconversions. This bis-allylic alcohol product 
2.76 could be obtained by a coupling reaction between readily available retro Michael 
product 2.28 and a protected bromocyclopentenol 2.77 easily available from 
bromocyclopentenone 2.32 (Scheme 2.65). 
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Scheme 2.65: Retrosynthesis for Michael/Tsuji-Trost pathway 
Bromoketone 2.32 was reduced using DIBAL-H to furnish the corresponding allylic alcohol, 
which was immediately converted into TES ether 2.77 in 77% yield over two steps (Scheme 
2.66). 
 
Scheme 2.66: Formation of fragment 2.77 
It was decided to test first the viability of the synthetic route on a model ketone, 
cyclohexanone. Cerium(III) chloride heptahydrate was slowly dried under high vacuum (120 
°C for 2 h, 140 °C for 2 h and 160 °C for 3 h, <1 mbar) to give anhydrous cerium(III) chloride. 
Bromide/lithium exchange occured between protected bromocyclopentenol 2.77 and n-BuLi 
followed by formation of the corresponding organocerium reagent. When an organocerium 
reagent is prepared via a Grignard reagent, the reagent formed is an ate complex (R-
MgX·CeCl3). In the case of an organocerium prepared from an organolithium source, a true 
organocerium specie (R-CeCl2) is believed to be formed.  Cyclohexanone was added to the 
newly formed organocerium reagent to produce tertiary allylic alcohol 2.78 in 72% yield 
(Scheme 2.67). 
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Scheme 2.67: Addition of the organocerium reagent 
Clevage of the TES ether was realised in the presence of HF.pyridine with a large excess 
of pyridine at 0 °C to furnish the corresponding bis-allylic alcohol that was used in the next 
step without purification. Swern oxidation only led to the decomposition of the starting 
material. Ley-Griffith conditions were found to be the best to produce the desired enone 
2.79 in very good yield over two steps (Scheme 2.68). 
 
Scheme 2.68: Deprotection and oxidation of product 2.78 
Acetylation of the tertiary alcohol was then attempted and the different tests are described 
below (Table 2.6). Unfortunately, all the conditions tested led to either formation of the 
elimination product or decomposition. 
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Source of acetate Additives Solvent Results 
Acetic anhydride Et3N/DMAP / Elimination 
Acetic anhydride DMAP Toluene SM + elimination 
Acetic anhydride  Sc(OTf)3 CH3CN SM + elimination 
Acetyl chloride n-BuLi THF SM + decomposition 
Table 2.6: Conditions tested for the acetylation 
It was decided to apply to our substrate a method developed in 2004 by Baba et al. for the 
chlorination of tertiary alcohols.76 The envisaged mechanism is described in more details 
below. Dimethylchlorosilane first chlorinates benzil to form intermediate A, which reacts with 
the alcohol to liberate hydrogen and furnish intermediate B. Intermediate B quickly 
collapses to produce chlorosilyl ether C, which in the presence of indium(III) chloride 
generates the desired tertiary chloride E (Scheme 2.69). 
 
Scheme 2.69: Mechanism for the indium catalysed chlorination 
When this chlorination method was applied to compound 2.79, complete formation of 
tertiary chloride 2.81 was observed in 15 min. Due to its instability, the product was used in 
the next step without purification and was immediatly submitted to Tsuji-Trost conditions in 
the presence of ethyl acetoacetate to give tetrasubstitued alkene product 2.82 in 40% yield 
over two steps. When the same reaction was attempted without a source of Pd0, the desired 
product was obtained after 24 h in 10% yield over two steps (Scheme 2.70). 
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Scheme 2.70: Chlorination followed by Tsuji-Trost reaction 
With the synthetic pathway validated on a model system, it was decided to apply this 
synthesis to our real substrate. The previously synthesised β-ketoester 2.64 was quickly 
converted into fragment 2.28 incorporating a terminal ketone, by a one-pot 
dihydroxylation/oxidative cleavage. In the presence of osmium(VIII) oxide, sodium 
periodate and 2,6-lutidine as a buffer, product 2.28 was obtained in 87% yield (Scheme 
2.71). 
 
Scheme 2.71: Dihydroxylation/oxidative cleavage 
With both fragments in hand, ketone 2.28 and bromo product 2.77 were combined using 
the previous organocerium reaction to furnish tertiary alcohol compound 2.76 in 62% yield 
(Scheme 2.72). It is worth noticing that no addition to the ketoester moiety was observed, 
which suggests once again the formation of a transitory cerium enolate protecting the 
ketoester. 
  
Scheme 2.72: Organocerium addition 
Cleavage of TES ether in the presence of HF.pyridine with an excess of pyridine gave bis-
allylic alcohol 2.83 in 90% yield. When Ley-Griffith conditions were applied to our substrate, 
enone 2.84 was obtained in poor yield. Decomposition of product 2.84 occurred during the 
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purification by flash chromatography. Allylic oxidation using manganese(II) oxide followed 
by a quick filtration through a short pad of celite to remove inorganic impurities produced 
enone 2.84 in 89% yield. Enone 2.84 was then submitted to indium-catalysed chlorination 
conditions, but unfortunately only a mixture of unidentified products was recovered, with no 
sign of the tertiary chloride. Pleasingly, a second attempt using a mixture of dimethyl sulfide 
and N-chlorosuccinimide led to the formation of the desired product 2.85 in 89% yield. The 
product was purified by flash chromatography after neutralisation of the silica gel with 
triethylamine (Scheme 2.73). 
 
Scheme 2.73: Cleavage, oxidation and chlorination to form product 2.87 
Conditions for the cyclisation step were investigated. Classic Tsuji-Trost using palladium 
tetrakis(triphenylphosphine)palladium(0) and sodium hydride only led to decomposition. 
Clarke et al. have shown that the addition of 1,2-bis(diphenylphosphino)ethane (dppe) as a 
ligand for the Tsuji-Trost reaction greatly improves the yield of nine-membered ring 
formation.29 Unfortunately, when product 2.85 was submitted to Clarke’s conditions, 
degradation was observed. Addition of Pd0 being detrimental to our substrate, it was 
decided to try a more classic Michael/elimination cascade. In the presence of caesium 
carbonate in dry DMF, the desired nine-membered product 1.138 was finally obtained as a 
mixture of 4 diastereomers in 64% yield (Scheme 2.74).  
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Scheme 2.74: Formation of nine-membered ring 1.138 
With the nine-membered ring in hand, conditions for the formation of the DF-ring system 
were explored. Formation of the enolate followed by an oxa-Michael addition would give the 
desired tricycle 1.136. Unfortunately, when product 1.138 was treated with caesium 
carbonate in DMF at different temperatures, only the starting material was recovered. When 
iodoetherification using Clarke’s conditions was tried, the starting material was left 
unreacted (Scheme 2.75). 
 
Scheme 2.75: Failed attempts of DF-ring system closure 
There are numerous examples in the literature of metal-assisted heterocyclisations using 
iron, gold or palladium.77–79 Allylic alcohols can be transformed by a metal-catalysed SN2’ 
into the corresponding tetrahydropyrans in excellent yields. It was decided to investigate 
these methods for the formation of the desired tricycle (Scheme 2.76). 
 
Scheme 2.76: General scheme for metal-assisted heterocyclisations 
When nine-membered ring 1.138 was submitted to a Luche reduction, formation of the 
desired allylic alcohol 2.87 occured in moderate yield (Scheme 2.77). 
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 Scheme 2.77: Luche reduction 
Allylic alcohol 2.87 was then treated with iron(III) chloride in CH2Cl2.77 A product was 
obtained but due to the small quantity (<1 mg) and the complexity of the 1H NMR, it was not 
possible to clearly identify it. When compound 2.87 was submitted to a mixture of 
chloro(triphenylphosphine)gold(I) and silver(I) triflate, only the elimination product 2.89 was 
observed in the crude NMR (Scheme 2.78).78 
 
Scheme 2.78: Cyclisation tests with gold/silver and iron 
Fortunately, treatement of allylic alcohol 2.87 with bis(acetonitrile)dichloropalladium(II) led 
to the formation of the CDF tricycle containing a bridged hemiketal.79 This product was 
obtained as a 1:1 separable mixture of 2 diastereomers (2.90 and 2.90’) in 41% yield 
(Scheme 2.79). It was not possible to determine the relative configuration of the 2 
diastereomers using 2D NMR experiments at this stage. 
 
Scheme 2.79: Palladium catalysed formation of CDF tricycle 
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The mechanism is hypothesised below: first, the alkene and the hydroxyl are coordinated 
to the palladium. The enol form of the ketone may be responsible for the nucleophilic attack 
on the olefin, which provokes the elimination of water. Tricycle 2.91 contains an excellent 
Michael acceptor, which reacts quickly with a molecule of water to furnish the corresponding 
hemiketal product 2.90 and 2.90’ (Scheme 2.80). 
 
Scheme 2.80: Envisaged mechanism for the formation of CDF tricycle 2.90 and 2.90’ 
The next step was the hydrogenation of the double bond to give the corresponding 
saturated tricycles 2.92 and 2.92’. The hydrogenation was diastereoselective and furnished 
the desired product 2.92 as a 4:1 mixture of 2 diastereomers and the major diastereomer 
was isolated. Product 2.92’ was not purified by flash chromatography and left as a mixture 
of 2 diastereomers (Scheme 2.81). 
 
Scheme 2.81: Hydrogenation of 2.90 and 2.90’ 
For the last steps of the synthesis, a one-pot TBS cleavage then lactonisation was 
attempted using TBAF but unfortunately only the starting material was recovered (Scheme 
2.82).  
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Scheme 2.82: Attempts of TBS deprotection/lactonisation 
The next attempt was the saponification of the ethyl ester in the presence of potassium 
trimethylsilanolate to furnish the corresponding carboxylic acid.80 Only complete 
decomposition of the starting material 2.92 was observed. When tricycle 2.92 was submitted 
to TBS cleavage conditions using hydrofluoric acid in acetonitrile, a complex mixture of 
products was recovered. Only one product (2.94) was identified by mass spectrometry and 
could be the result of an acidic hemiketal opening and OTBS elimination (Scheme 2.83). 
  
Scheme 2.83: Attempts of saponification and TBS deprotection 
Unfortunately, these tests were the only ones I could tried due to very small quantities of 
product 2.92 and 2.92’ available. 
2.2.7 Conclusion and future work 
Different approaches to close the nine-membered ring 1.138 were attempted: radical 
cylisation, Reformatsky reaction, relay ring-closing metathesis, Michael/isomerisation and 
aldolisation but none of them proved to be successful (Scheme 2.84). 
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Scheme 2.84: Unsuccessful approaches 
A novel method was then developed for the formation of the desired bicycle. The key steps 
are the selective chlorination of the tertiary alcohol followed by a Michael/elimination 
reaction to produce the desired bicycle in 57% yield over two steps. The enone was then 
selectively reduced and a palladium catalysed cyclisation was successful to produce the 
corresponding CDF tricycle as a mixture of 2 separable diastereomers. Tests were carried 
out to furnish the final product but unfortunately none of them were conclusive (Scheme 
2.85). 
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Scheme 2.85: Successful synthesis of CDF tricycles 2.92 and 2.92’ 
In the future, development of the last steps of the synthesis is necessary to obtain a CDEF 
tetracycle model 2.93. A multigram synthesis is also crucial to finalise the synthesis. 
Hopefully, a crystal structure of one of the the final product could be obtained and X-ray 
analysis could allow us to determine the relative configuration of tricycle products, which is 
currently unknown. The ethyl ester would be replaced by a tert-butyl  ester in order to try 
conditions developed by Clarke et al. for the ester cleavage and lactonisation (Scheme 
2.86).81  
 
Scheme 2.86: Future work 
2.3 Synthesis of a chiral C-ring model 
Cyclopentenone was used as a commercially available C-ring model, but the 
Michael/elimination cyclisation step occurred with no facial selectivity, giving a mixture of 4 
diastereomers. In parallel with the synthesis of a CDEF tetracycle model 2.93, a synthesis 
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of a chiral C-ring model was envisaged. Diastereoselectivity during the Michael/elimination 
step would require the use of a hindered group (e.g isopropyl) in the α position of the 
conjugated olefin. Diastereoselectivity during this step would hopefully allow the formation 
later on of a CDF tricycle as a single diastereomer. Nine-membered ring 2.96 could be 
synthesised following the same retrosynthesis as before (Scheme 2.87). 
 
Scheme 2.87: Retrosynthesis of product 2.96 
The synthesis of a chiral C-ring has already been investigated in the Prunet group. C-ring 
2.99 would be formed by the bromination of the alkene, reduction of the ketone and 
subsequent formation of TES ether from ketone 2.100. Ketone 2.100 could be synthesised 
by a cuprate addition that would produce the trans product, followed by elimination of the 
acetate from compound 2.101, as described by Trauner et al. in 2005.82. Ketone 2.101 was 
readily available from cyclopentanediene (Scheme 2.88). 
 
Scheme 2.88: Retrosynthesis of chiral C-ring 2.99 
The synthesis began by cracking bicyclopentadiene, to furnish cyclopentadiene via a retro 
Diels-Alder reaction. Cyclopentadiene was then submitted to a mixture of rose bengal as a 
photosensitizer and singlet oxygen produced by UV irradiation to undergo [4+2] 
cycloaddition to furnish, after reduction of the endoperoxide by thiourea, diol 2.102. The 
reaction mixture was difficult to purify due to residual rose bengal; therefore, the crude 
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mixture was used in the next step without purification. Diol 2.102 was acetylated using acetic 
anhydride, pyridine and DMAP to give diacetate 2.103 in 27% yield over two steps (Scheme 
2.89). 
 
Scheme 2.89: Synthesis of diacetate 2.103 
The next step was the enzymatic desymmetrization of diacetate 2.103. In the presence of 
electric eel acetylcholinesterase, sodium azide and an aqueous phosphate buffer (pH = 
6.85), one of the acetate was selectively cleaved to produce compound 2.104, which was 
used in the next step without purification. The allylic alcohol was converted into the 
corresponding enone using TEMPO/BAIB conditions. Enone 2.101 was obtained in 81% 
yield over two steps (Scheme 2.90).  
 
Scheme 2.90: Formation of enone 2.101 
Cuprate addition to enone 2.101 using a mixture of i-PrMgBr, CuBr.Me2S, HMPA and 
TMSCl in THF led to the formation of intermediate 2.105 with excellent diastereoselectivity. 
Intermediate 2.105 underwent acetate elimination under acidic conditions to give enone 
2.100 in excellent yield and enantiomeric ratio (the enantiomeric ratio was based on the 
measured optical rotation) (Scheme 2.91). 
 
Scheme 2.91: Cuprate addition followed by elimination to furnish enone 2.100 
Enone 2.100 was then brominated to produce bromoketone 2.106 in 72% yield. This 
bromoketone was reduced by DIBAL-H and the resulting alcohol was immediately 
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transformed into the TES ether, furnishing chiral C-ring 2.199 as a 7:3 mixture of 
diastereomers in 81% yield over two steps (Scheme 2.92). 
 
Scheme 2.92: Synthesis of the desired chiral C-ring 2.99 
In summary, chiral C-ring 2.99 was synthesised from cyclopentadiene in 10% yield over 8 
steps (Scheme 2.93). 
 
Scheme 2.93: Summary of the synthesis of product 2.99 
In the future, organocerium reaction between fragment 2.28 and product 2.99 will be 
attempted followed by cleavage of the TES ether, oxidation of the corresponding alcohol 
and chlorination of the tertiary alcohol to hopefully furnish precursor 2.97. Finally, cyclisation 
will be tested and the diastereoselectivity will be assessed (Scheme 2.94). 
 
Scheme 2.94: Future work 
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Chapter 3: Diastereoselective synthesis of 
trisubstituted olefins by RCM using an O-
Si-C tether 
3.1 Previous work in the Prunet group 
Studies towards the total synthesis of dolabelide C (3.1) are currently on progress in the 
Prunet group (Figure 3.1).83,84 
 
Figure 3.1: Dolabelide C 
A novel strategy employing an intramolecular RCM instead of an intermolecular CM, with 
the aid of a temporary O-Si-C tether, provided the trisubstituted alkene of the C16-C30 
fragment with the correct geometry.85 The C16-C30 fragment could be obtained by cleavage 
of the O-Si-C tether from a six-membered oxysilanes. The six-membered rings could be 
closed by a RCM from a diene compounds, which would be produced by a coupling reaction 
between a silane and an allylic alcohol (Scheme 3.1). 
  
Scheme 3.1: General retrosynthesis for the synthesis of C16-C30 fragment  
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This methodology was first developed by Stéphane Wittmann on different models.86 Starting 
from protected β-hydroxyl-esters and ethyl caproate, a novel Peterson olefination using 
chloromethyl(dimethyl)silane furnished several allysilanes with good yields. The best 
conditions were found to be the use of an organocerium reagent, which was produced by 
the addition of a Grignard reagent onto dry cerium(III) chloride. Addition of the organocerium 
onto different esters led to the formation of tertiary alcohol intermediates, which eliminated 
in the presence of a slurry of silica in CH2Cl2 to furnish the corresponding allylsilanes in 
moderate to good yields (Scheme 3.2). 
  
Scheme 3.2: Peterson olefinations  
The next step was a dehydrogenative coupling between the previously synthesised silanes 
and allylic alcohol 3.8.87,88 In the presence of (Xantphos)CuCl and lithium tert-butoxide in 
toluene, oxysilane were obtained in very good yields (Scheme 3.3). 
 
Scheme 3.3: Dehydrogenative couplings  
The mechanism of the dehydrogenative coupling is described below. Addition of the 
different reagents led to the formation of copper(I) hydride A species, which is in equilibrium 
between dimer B and higher aggregates C. Hydride A reacts in a σ-bond metathesis with a 
free alcohol to produce alkoxocopper(I) D and to release dihydrogen. A second metathesis 
occurs between product D and an equivalent of silane to furnish the silylated alcohol and to 
regenerate copper(I) hydride A (Figure 3.2). 
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Figure 3.2: Mechanism of the (Xantphos)CuCl catalysed coupling 
The newly formed oxysilanes were submitted to RCM conditions using Grubbs’ second 
generation catalyst to generate cyclic alkenes. The six-membered rings were then opened 
by cleaving the O-Si bond by addition of methyllithium to give TMS substrates in good to 
excellent yields (Scheme 3.4). 
 
Scheme 3.4: Transformation of oxysilanes into allylic TMS substrates 
The final step of this methodology was the TBAF-promoted desilylation to obtain a mixture 
of desired trisubstituted E alkenes and undesired isomerised alkenes (ratios between 1:1 
and 2:1) (Scheme 3.5).  
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Scheme 3.5: Final step of the synthesis 
This method was applied to the synthesis of the C16-C30 fragment of dolabelide C (3.1). 
Coupling between alcohol 3.24 and silane 3.25 gave oxysilane 3.26 in 60% yield. Oxysilane 
3.26 was subjected to RCM to furnish cyclic product 3.27 in 43% yield. Only one attempt of 
RCM was made, additional optimisations are necessary. Opening of the oxysilane 3.27 
followed by desilylation produced the desired trisubstituted E olefin as the major product in 
57% yield over two steps (Scheme 3.6). 
 
Scheme 3.6: Application of the methodology to the synthesis of dolabelide C (3.1) 
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3.2 Application of the methodology to homoallylic 
alcohols 
Development of the methodology was first solely focused on allylic alcohols. The same 
strategy could be applied to homoallylic alcohols. Homoallylic alcohols with the desired E 
alkenes would be synthesised by oxysilane opening and desilylation from seven-membered 
rings. The cyclic oxysilanes could be closed by RCM from acyclic precursors, which would 
be formed by dehydrogenative couplings between homoallylic alcohols and hydrosilanes 
(Scheme 3.7). 
 
Scheme 3.7: Proposed general retrosynthesis 
The first part of the synthesis was the formation of silanes via Peterson olefinations. 
Chloromethyl(dimethyl)silane being a very expensive reagent, it was synthesised by 
selective reduction of chloro(chloromethyl)dimethylsilane using lithium aluminium hydride 
(Scheme 3.8).89  
 
Scheme 3.8: Selective reduction of chloro(chloromethyl)dimethylsilane 
Esters 3.2 and 3.3, which were already available in the laboratory, were subjected to 
Peterson olefination conditions to obtain the corresponding allylsilanes 3.5 and 3.6 in 
excellent yield (Scheme 3.9).  
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Scheme 3.9: Peterson olefination 
Dehydrogenative coupling between homoallylic alcohols (3.31 and 3.32) and allysilanes 
(3.5 and 3.6) furnished oxysilanes (3.33, 3.34 and 3.35) in very good yields (Scheme 3.10). 
 
Scheme 3.10: Dehydrogenative coupling 
Acyclic oxysilanes (3.33, 3.34 and 3.35) were submitted to RCM conditions to give the 
corresponding seven-membered rings (3.36, 3.37 and 3.38) in excellent yields (Scheme 
3.11). 
 
Scheme 3.11: RCM metathesis 
Direct cleavage of the tether and formation of the trisubstituted alkene was then attempted. 
When 3.37 was submitted to TBAF deprotection conditions, isomerised alkene 3.39 was 
observed as a major product with only traces of the desired product. When subjected to 
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HF.pyridine with or without an excess of pyridine, only fluorosilane 3.40 was observed by 
NMR before rapid decomposition (Scheme 3.12). 
 
Scheme 3.12: Attempts of direct tether cleavage 
Oxysilane 3.37 reacted with methyl lithium to furnish the corresponding opened product 
3.41 in very good yield (Scheme 3.13). 
 
Scheme 3.13: Tether cleavage with MeLi 
Conditions for the removal of the TMS group were tested. When the previous conditions 
optimised for the six-membered ring using TBAF/H2O were tried, a 1:1 mixture of the 
desired alkene 3.42 and the undesired 1,1-disubstituted alkene 3.39 was obtained. 
Products 3.42 and 3.39 could not be separated by flash chromatography. More acidic 
conditions such as HF.pyridine and HF in CH3CN only led to the formation of the undesired 
alkene 3.39. Only starting material was recovered when using potassium carbonate in 
methanol. Anhydrous caesium fluoride gave a 2:3 mixture of 3.42/3.39 in favour of the 
undesired product. Caesium fluoride with water furnished the same 1:1 ratio than TBAF with 
water (Table 3.1). 
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Conditions Solvent Temperature Desired (290)/ 
Undesired (287) 
TBAF/H2O DMF 65 °C  1/1 
HF.Pyr CH2Cl2 RT 0/1 
HF (5%) CH3CN RT 0/1 
K2CO3 MeOH 65 °C - 
CsF DMF RT to 65 °C 2/3 
CsF/H2O DMF RT to 65 °C 1/1 
Table 3.1: Results of the desilylation tests 
After these unsuccessful attempts, it was decided to modify the end game. In 2001, Takeda 
et al. used a Tamao-Kumada oxidation to convert different seven-membered oxysilanes 
into the corresponding diols.90 This method could be used to obtain diol products, where the 
difference of reactivity between the newly formed primary allylic alcohol and the secondary 
homoallylic alcohol would allow the selective substitution and reduction of the allylic alcohol. 
This method would also prevent the formation of the undesired gem-disubstituted alkene 
(Scheme 3.14).  
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Scheme 3.14: Envisaged end game 
Tamao-Kumada oxidation using Takeda’s condtions led to the formation of corresponding 
diols in very good yields (Scheme 3.15). 
 
 
Scheme 3.15: Tamao-Kumada oxidation 
Diols 3.43, 3.44 and 3.45 were treated with a mixture of carbon tetrabromide, 
triphenylphosphine and 2,6-lutidine in acetonitrile to furnish the corresponding allylic 
bromides, which were used in the next step without purification. The crude products were 
immediately reduced by Super-Hydride® (lithium triethylborohydride) in THF to give the final 
products 3.46, 3.47 and 3.48 with the desired trans geometry (Scheme 3.16). 
 
Scheme 3.16: Bromination followed by reduction 
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3.3 Conclusion and future work 
In summary, it has been shown that the previously developed methodology could be 
partially applied to homoallylic alcohols. The two-step process using MeLi and TBAF only 
gave poor results on our substrates for the cleavage of the oxysilanes. A three-step method 
to remove the tether was developed and permitted the obtention of trisubstituted alkenes 
with the desired geometry without any sign of isomerised olefins (Scheme 3.17). 
 
Scheme 3.17: Summary of the work 
In the future, the three-step method could be applied to six-membered oxysilanes to 
prevent the formation of the isomerised product (Scheme 3.18). 
 
Scheme 3.18: Future work 
Formation of the allylsilane 3.49 derived from ethyl acetate could also allow the synthesis 
of trisubstituted Z alkenes (Scheme 3.19). 
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Scheme 3.19: Possible formation of cis alkenes 
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Chapter 4: Experimental 
Apparatus: 
 
NMR spectra were recorded using a Bruker DPX-400 spectrometer (1H NMR: 400 MHz, 13C 
NMR: 101 MHz) and a Bruker DPX-500 spectrometer (1H NMR: 500 MHz, 13C NMR: 126 
MHz). Deuterated chloroform (CDCl3) was used as the solvent for both 1H and 13C NMR, 
with residual solvent peak δ 7.26 being used for calibration of 1H NMR and CDCl3 peak at 
δ 77.16 for 13C. Signal splitting patterns are described as: singlet (s), doublet (d), triplet (t), 
quartet (q), quintet (quint), sextet (sext), octet (oct), nonet (non), multiplet (m), broad singlet, 
or any combination of the above. Two dimensional experiments (COSY, HSQC, HMBC, 
and HMQC) were recorded, where necessary, for assignment. Sn-H and Sn-C couplings 
were averaged over 117/119Sn. IR spectra were recorded using a Golden GateTM 
attachment, utilizing a type IIa diamond as a single reflection element, allowing for the direct 
reading of powder and oil samples. High resolution mass spectra were recorded under FAB, 
ESI and CI conditions by the University of Glasgow analytical service. 
 
Chromatography: 
Flash chromatography was executed under forced flow conditions, using the indicated 
solvent system and the EMD Geduran silica gel 60 as solid support. Thin layer 
chromatography (TLC) was carried out on Merck silica gel 60 covered aluminium sheets, 
and monitored by UV-light or by staining with a solution of anisaldehyde or KMnO4 mixture. 
 
Solvents and reagents: 
Reactions were collected from an in-house solvent purification system (THF, CH2Cl2, Et2O, 
CH3CN, and toluene). Chromatography solvents were HPLC grade solvents, stored in 
Winchester bottles. All reagents were used directly from supplier, unless prior purification 
is explicitly stated. 
 
General conditions: 
Air or moisture sensitive reactions were carried out in pre-dried glassware; either overnight 
in an oven (125 °C) or by flame drying under vacuum. Argon was used to create an inert 
atmosphere. Degassing solvent was done using freeze and thaw method. 
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Reagents and catalysts: 
 
Copper-(I)-thiophen-2-carboxylate (CuTc).91 
 
 
 
A solution of Cu2O (2.8 g, 20 mmol) and thiophen-2-carboxylic acid (10 g, 80 mmol, 4 equiv) 
in toluene (30 mL) was heated to reflux on a Dean-Stark trap overnight. After cooling to RT, 
the slurry was filtered under argon. The residue was first washed with MeOH (30 mL) and 
then repeatedly washed with anhydrous Et2O until the filtrate was completely colorless (~ 
1  L). After washing with hexanes (15 mL), the powder was dried to furnish a red powder 
(5.6 g, 75%). 
 
Tetrabutyl ammoniumdiphenylphosphinate.92 
 
 
 
Diphenylphosphinic acid (4 g, 18.3 mmol) was dissolved in MeOH (20 mL), a 1 M solution 
of tetra-n-butylammonium hydroxide in MeOH (18.3 mL, 18.3 mmol, 1.00 equiv) was added 
and the mixture stirred for 5 min. After filtration through a pad of celite, the solvent was 
removed under reduced pressure to yield a yellow oil, which was recrystallised from diethyl 
ether to give colorless, hygroscopic needles (4.32 g, 51%). Tetrabutyl 
ammoniumdiphenylphosphinate was dried prior to use by azeotropic removal of water using 
benzene. 
 
(Xantphos)CuCl.88 
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To a suspension of dry CuCl (109 mg, 1.10 mmol) in CH2Cl2 (10 mL) was added Xantphos 
(578 mg, 1.00 mmol) and resultant clear solution was stirred for 10 min. The solvent was 
removed under vacuum and the precipitated solid was triturated in dry and degassed 
acetonitrile (3 mL). The suspension was vigorously stirred for 4 h and filtered under Argon 
atmosphere. The wet cake was washed with acetonitrile (3 x 5 mL) and dried under vacuum 
to afford an off-white powder (380 mg, 56%). 
 
Samarium(II) iodide.93 
 
1,2-Diiodoethane (815 mg, 2.89 mmol) was dissolved in Et2O (30 mL) and the organic 
solution was washed with a saturated aqueous solution of sodium thiosulfate (25 mL). The 
phases were separated, the organic layer was dried over magnesium sulfate and 
concentrated under vacuum. The powder was dried in the dark under high vacuum for 6 h. 
Samarium (541 mg, 3.61 mmol, 1.25 equiv) was flame dried under high vacuum and let to 
cool down under argon. 1,2-diiodoethane and THF (29 mL) were subsequently added and 
the green solution was left to stirr overnight. The dark blue solution of samarium(II) iodide 
in THF (29 mL, 29 mmol) was used without further manipulation.  
 
Diisopropylammonium 2,2,2-trifluoroacetate 
 
 
 
To a stirred mixture of diisopropylamine (1.4 mL, 10 mmol) in Et2O (10 mL) at 0 °C was 
added dropwise trifluoroacetic acid (1.1 mL, 10 mmol, 1.0 equiv). The reaction mixture is 
stirred at 0 °C for 5 min. The crystals were filtered and washed with Et2O (10 mL), dried 
under vacuum to afford white crystals (1.8 g, 83%). 
 
Ethyl 2-diazoacetate.94 
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Ethyl acetoacetate (3.8 mL, 30 mmol), 4-acetamidobenzenesulfonyl azide (7.2 g, 30 mmol, 
1.0 equiv) and tetrabutylammonium bromide (0.19 g, 0.60 mmol, 0.02 equiv) were dissolved 
in pentane (100 mL) and left to stir at RT for 5 min then cooled to 0 °C. Then a 3 M aqueous 
solution of potassium hydroxide (30 mL) was added slowly (over 10 min) and the mixture 
left to stir for 4 h at RT. Once the reaction was complete, the mixture was diluted with water 
(50 mL) and Et2O (50 mL). The organic phase was isolated and the aqueous layer extracted 
with Et2O (3 x 80 mL). The combined organic layers were dried over magnesium sulfate, 
filtered and concentrated under vacuum to give the ethyl 2-diazoacetate as a bright yellow 
oil (1.45 g, 51%). 
 
(Chloromethyl)dimethylsilane.89 
 
C3H9ClSi 
Mol. Wt. = 108.64 g/mol 
 
 
 
 
To a mixture of lithium aluminium hydride (1.86 g, 48.9 mmol, 0.500 equiv) in Et2O (90 mL) 
at 0 °C was added dropwise (over 4 h) chloro(chloromethyl)dimethylsilane (18.6 mL, 97.8 
mmol). The mixture was warmed to RT and left to stir overnight. The reaction was quenched 
with a 1 M aqueous solution of hydrochloric acid (90 mL) then the layers were separated. 
The aqueous phase was extracted with Et2O (3 × 90 mL), dried over magnesium sulfate, 
filtered and carefully concentrated under vacuum (25 °C, 180 mbar). The crude was purified 
by distillation (81–83 °C) to furnish (chloromethyl)dimethylsilane (5.56 g, 43%) as a 
colourless liquid. 
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(R)-4-Benzyl-3-propionylthiazolidine-2-thione (2.4).35 
 
C13H15NOS2  
Mol. Wt = 265.35 g/mol 
 
In a 3-necked flask, sodium borohydride (13.8 g, 365 mmol, 2.40 equiv) was dissolved in 
THF (400 mL). (R)-Phenylalanine (25.0 g, 150 mmol) was added in one portion then the 
mixture was cooled to 0 °C. A solution of iodine (38.0 g, 150 mmol, 1.00 equiv) in THF (100 
mL) was added dropwise via the addition funnel (over 45 min). After the addition was 
complete the flask was heated to reflux and left to stir overnight. The flask was then allowed 
to cool down and methanol was added cautiously until the mixture became clear. The 
solvent was then removed under vacuum giving a white paste, which was dissolved in a 
20% aqueous solution of potassium hydroxide (300 mL). The crude mixture was left to stir 
at RT for 3 h, then the aqueous phase was extracted with CH2Cl2 (3 x 300 mL). The 
combined organic layers were dried over sodium sulfate and concentrated under vacuum 
giving (R)-phenylalaninol as a white solid which was used in the next step without 
purification. 
 
Crude (R)-phenylalaninol was dissolved in a 3 M aqueous solution of potassium hydroxide 
(400 mL) and left to stir for 30 min. Carbon disulfide (45 mL, 0.75 mol, 5.0 equiv) was then 
added dropwise, the mixture was warmed to 110 °C and stirred overnight. The flask was 
then cooled to RT and the reaction mixture was extracted with CH2Cl2 (3 x 300 mL). The 
combined organic layers were dried over sodium sulfate, filtered and concentrated under 
vacuum. The crude product 2.5 (29 g, 94% over 2 steps) was then used in the next step 
without further purification. 
 
(The aqueous phase was diluted and the glassware rinsed with a solution of bleach and 
potassium hydroxide to remove any traces of carbon sulfide). 
 
(R)-4-Benzylthiazolidine-2-thione 2.5 (8.1 g, 40 mmol) was dissolved in CH2Cl2 (200 mL) 
followed by addition of freshly distilled triethylamine (14.0 mL, 100 mmol, 2.50 equiv). The 
reaction was cooled to 0 °C followed by addition of propionyl chloride (5.6 mL, 60 mmol, 1.5 
equiv) over 5 min. The reaction was left to stir at RT overnight, after which the mixture was 
diluted with CH2Cl2 (200 mL) and water (400 mL). The aqueous phase was extracted with 
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CH2Cl2 (3 × 200 mL) and the organic layer was dried over magnesium sulfate, filtered and 
concentrated under vacuum. The crude product was purified by recrystallisation from 
acetonitrile to furnish 2.4 (8.8 g, 87%) as a bright yellow solid. 
 
Mp: 98–100 °C. lit. 105 °C 
 
1H NMR (CDCl3, 400 MHz) δ 7.39–7.29 (m, 5H, HAr), 5.43–5.38 (m, 1H, H4), 3.50–3.39 (m, 
3H, H5/H8), 3.26–3.04 (m, 2H, H5/H6), 2.91 (d, J = 11.6 Hz, 1H, H6), 1.22 (t, J = 7.3 Hz, 3H, 
H9). 
 
13C NMR (CDCl3, 101 MHz) δ 201.1 (C1), 175.0 (C7), 136.7 (CAr), 129.5 (CAr), 129.0 (CAr), 
127.3 (CAr), 68.7 (C4), 36.8 (C8), 32.4 (C5), 32.0 (C6), 8.9 (C9). 
 
In agreement with literature data.95 
 
4-Penten-1-al (2.25).35 
C5H8O 
Mol Wt. = 84.13 g/mol 
 
 
To a solution of 4-penten-1-ol (2.30 mL, 22.3 mmol) in CH2Cl2 (100 mL) was added BAIB 
(7.90 g, 24.5 mmol, 1.10 equiv) and TEMPO (348 mg, 2.23 mmol, 0.100 equiv). The mixture 
was then stirred at RT for 3 h. The reaction was then diluted with water (100 mL) and the 
two layers were separated. The aqueous layer was extracted with Et2O (3 × 70 mL). The 
organic layer was dried over magnesium sulfate, filtered and concentrated under vacuum 
(28  °C, 180 mbar). The crude mixture was purified by column chromatography (90:10 
Pentane/Et2O) to furnish 2.25 as a colourless liquid (1.19 g, 65%). 
 
1H NMR (CDCl3, 400 MHz) δ 9.82 (t, J = 1.6 Hz, 1H, H1), 5.87 (ddt, J = 16.6, 10.2, 6.4 Hz, 
1H, H4), 5.13–5.04 (m, 2H, H5), 2.61–2.57 (m, 2H, H2), 2.46–2.40 (m, 2H, H3). 
 
In agreement with literature data.35 
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 Hex-5-en-1-al (2.67). 96  
 
C6H10O 
Mol Wt. = 98.14 g/mol 
 
 
 
Aldehyde 2.67 (colourless liquid) was obtained from the corresponding alcohol according 
to the procedure described above for aldehyde 2.25. 
Purification by flash column chromatography (90:10 Pentane/Et2O). 
Scale: 39.9 mmol. 
Yield: 70%. 
 
1H NMR (CDCl3, 500 MHz) δ 9.78 (t, J = 1.7 Hz, 1H, H1), 5.77 (ddt, J = 16.9, 10.2, 7.1 Hz, 
1H, H5), 5.07–4.97 (m, 2H, H6), 2.45 (td, J = 7.3, 1.7 Hz, 2H, H2), 2.10 (q, J = 7.1 Hz, 2H, 
H4), 1.74 (p, J = 7.4 Hz, 2H, H3). 
 
13C NMR (CDCl3, 126 MHz) δ 202.6 (C1), 137.7 (C5), 115.7 (C6), 43.3 (C2), 33.1 (C4), 21.3 
(C3). 
 
In agreement with literature data.96  
 
Pent-4-ynal (2.39).97 
 
C5H6O 
Mol. Wt. = 82.1 g/mol 
 
 
 
Aldehyde 2.39 (colourless liquid) was obtained from the corresponding alcohol according 
to the procedure described above for aldehyde 2.25. 
Purification by flash column chromatography (90:10 Pentane/Et2O). 
Scale: 32.0 mmol. 
Yield: 71%. 
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1H NMR (CDCl3, 400 MHz) δ 9.76 (t, J = 1.1 Hz, 1H, H1), 2.70–2.62 (m, 2H, H2), 2.48 (td, J 
= 7.2, 2.7 Hz, 2H, H3), 1.97 (t, J = 2.7 Hz, 1H, H5). 
 
13C NMR (CDCl3, 101 MHz,) δ 200.1 (C1), 82.4 (C4), 69.3 (C5), 42.4 (C2), 11.7 (C3). 
 
In agreement with literature data.97 
 
5-(Trimethylsilyl)pent-4-ynal (2.45). 98 
 
C8H14OSi 
Mol. Wt. = 154.28 g/mol 
 
 
 
To a solution of pent-4-ynol (4.0 g, 47 mmol) in THF (200 mL) cooled to −78 °C was added 
dropwise a 2 M solution of n-BuLi in hexanes (50.0 mL, 100 mmol, 2.20 equiv). The reaction 
was stirred for an additional 45 min then trimethylsilyl chloride (13.7 mL, 108 mmol, 2.30 
equiv) was added and the mixture was warmed to RT over 1 h 30. A 1:1 solution of 1 M 
aqueous hydrochloric acid and Et2O (200 mL) was then added and the mixture stirred 
overnight. A saturated aqueous solution of sodium bicarbonate (100 mL) was added and the 
aqueous phase was extracted with Et2O (3 × 200 mL). The organic phases were combined, 
dried over magnesium sulfate, filtered and concentrated under vacuum. The product (7.4 g) 
was used in the next step without further purification. 
 
To a solution of crude alcohol (7.4 g, 47 mmol) in CH2Cl2 (60 mL) was added BAIB (16.8 g, 
52.2 mmol, 1.10 equiv) and TEMPO (0.74 g, 4.7 mmol, 0.10 equiv). The reaction was stirred 
for 4 h before being quenched by the addition of water (50 mL). The aqueous phase was 
extracted with CH2Cl2 (3 × 50 mL), the organic phases were combined, dried over 
magnesium sulfate and concentrated under vacuum. The product was then purified by flash 
chromatography (95:5 PE/Et2O) to give 2.45 as a yellow oil (6.2 g, 85% over 2 steps). 
 
1H NMR (CDCl3, 500 MHz) δ 9.81 (s, 1H, H1), 2.69 (t, J = 7.2 Hz, 2H, H2), 2.56 (t, J = 7.2 
Hz, 2H, H3), 0.15 (s, 9H, TMS). 
 
13C NMR (CDCl3, 126 MHz) δ 200.2 (C1), 104.5 (C5), 85.6 (C4), 42.4 (C2), 13.0 (C3), −0.1 
(TMS). 
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In agreement with literature data.98  
 
4-Methylpent-4-enal (2.66). 99 
 
C6H10O 
Mol. Wt. = 98.14 g/mol 
 
 
 
 
 
 
To a solution of lithium aluminium hydride (9.49 g, 250 mmol, 1.00 equiv) in Et2O (400 mL) 
at 0 °C was added slowly methyl methacrylate (26.7 mL, 250 mmol). The mixture was 
warmed to RT and stirred for 4 h. The reaction was then cooled to 0 °C and cautiously 
quenched with a 1 M aqueous solution of hydrochloric acid (250 mL). The layers were 
separated and the aqueous layer was extracted with Et2O (3 × 200 mL). The organic extract 
was dried over magnesium sulfate, filtered and concentrated under vacuum (28 °C, 180 
mbar) to give methallyl alcohol. The crude product (9.70 g) was used in the next step without 
further purification. 
 
In a flask connected to a Dean-Stark apparatus, crude methallyl alcohol (9.70 g, 135 mmol) 
was dissolved in triethyl orthoacetate (120 mL) and propionic acid (6.0 mL, 80 mmol, 0.67 
equiv) was added. The reaction was heated to 160 °C for 15 h. The mixture was cooled to 
RT and was diluted with Et2O (200 mL). The organic phase was washed with a 2 M aqueous 
solution of hydrochloric acid (200 mL), a saturated aqueous solution of sodium bicarbonate 
(2 × 200 mL) and brine (150 mL). The organic layer was dried over magnesium sulfate, 
filtered and concentrated under vacuum (28 °C, 180 mbar) to furnish crude ethyl 4-
methylpent-4-enoate. The crude product (19.1 g) was used in the next step without further 
purification. 
 
Ethyl 4-methylpent-4-enoate (19.1 g, 134 mmol) was added dropwise (over 1 h)  to a 
solution of lithium aluminium hydride (5.10 g, 134 mmol, 1.00 equiv) in Et2O (400 mL) at 
0  °C. The slurry was allowed to warm up to RT and was stirred for an additional 40 min. 
The reaction was cooled to 0 °C and quenched with water (300 mL). The layers were 
separated and the aqueous layer was extracted with Et2O (3 × 300 mL). The combined 
organic layers were combined, dried over magnesium sulfate, filtered and concentrated 
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under vacuum to yield 4-methylpent-4-en-1-ol (11.5 g) as a colourless liquid that was used 
without further purification. 
 
Oxalyl chloride (13.6 mL, 161 mmol, 1.40 equiv) in CH2Cl2 (400 mL) was cooled to −78 °C 
then DMSO (23 mL, 0.32 mol, 2.8 equiv) in CH2Cl2 (25 mL) was added. The solution was 
stirred for 20 min and a solution of 4-methylpent-4-en-1-ol (11.5 g, 115 mmol) in CH2Cl2  (50 
mL) was added dropwise. The reaction was left to stir for 1 h at −78 °C then triethylamine 
(89 mL, 0.64 mol, 5.6 equiv) was added and the reaction was allowed to warm up to RT 
over 1 h. The reaction was quenched by addition of a 2 M aqueous solution of hydrochloric 
acid (250 mL), the layers were separated and the organic phase was washed with a 1 M 
aqueous solution of hydrochloric acid (2 × 250 mL), a saturated aqueous solution of sodium 
bicarbonate (500 mL) and brine (300 mL). The organic layer was dried over magnesium 
sulfate, filtered and concentrated under vacuum (28 °C, 180 mbar). The crude mixture was 
then purified by distillation (99–101 °C) to give aldehyde 2.66 (9.36 g, 38% over four steps) 
as a colourless liquid. 
 
(The aqueous phase was diluted and the glassware rinsed with a solution of bleach and 
potassium hydroxide to remove any traces of dimethyl sulfide). 
 
1H NMR (CDCl3, 400 MHz) δ 9.78 (t, J = 1.7 Hz, 1H, H1), 4.77 (s, 1H, H5), 4.68 (s, 1H, H5), 
2.58 (td, J = 7.5, 1.7 Hz, 2H, H2), 2.34 (t, J = 7.5 Hz, 2H, H3), 1.74 (s, 3H, H6). 
13C NMR (CDCl3, 126 MHz) δ 202.3 (C1), 143.9 (C4), 110.8 (C5), 41.9 (C2), 30.0 (C3), 22.7 
(C6). 
In agreement with literature data.99  
123 
 
(2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-hydroxy-2-
methylpent-4-en-1-one (2.7).36 
 
C16H19NO2S2 
Mol. Wt. = 321.45 g/mol 
 
 
 
To a solution of (R)-4-Benzyl-3-proponylthiazolidin-2-thione 2.4 (15.0 g, 56.5 mmol) in 
CH2Cl2 (250 mL) at 0 °C was added titanium tetrachloride (6.20 mL, 56.5 mmol, 1.00 equiv). 
The mixture was stirred 15 min at 0 °C then diisopropylethylamine (9.90 mL, 56.5 mmol, 
1.00 equiv) was added. The reaction was stirred for 1 h then cooled to −78 °C and N-methyl-
2-pyrrolidinone (5.40 mL, 56.5 mmol, 1.00 equiv) was added. The reaction was stirred for 1 
h followed by dropwise addition of acrolein (4.10 mL, 62.0 mmol, 1.10 equiv). The reaction 
was stirred for 1 h at −78 °C then warmed to RT over 1 h. The reaction was then quenched 
with a saturated aqueous solution of ammonium chloride (200 mL). The aqueous phase 
was extracted with CH2Cl2 (3 × 200 mL) and the combined organic extracts were dried over 
magnesium sulfate, filtered and concentrated under vacuum. The crude was purified by 
flash chromatrography (80:20 PE/EtOAc) to furnish a yellow oil 2.7 as a single diastereomer 
(11.8 g, 65%). 
 
1H NMR (CDCl3, 500 MHz) δ 7.33–7.22 (m, 5H, HAr), 5.81 (ddd, J = 17.1, 10.6, 5.4 Hz, 1H, 
H4), 5.33–5.24 (m, 2H, H9 /H5trans), 5.18 (dt, J = 10.6, 1.3 Hz, 1H, H5cis), 4.54 (dq, J = 6.8, 4.1 
Hz, 1H, H2), 4.46–4.42 (m, 1H, H3), 3.36 (dd, J = 11.4, 7.1 Hz, 1H, H10), 3.20 (dd, J = 13.2, 
3.8 Hz, 1H, H8), 3.02 (dd, J = 13.2, 10.6 Hz, 1H, H8), 2.87 (d, J = 11.4 Hz, 1H, H10), 2.53 (d, 
J = 3.3 Hz, 1H, OH), 1.22 (d, J = 6.8 Hz, 3H, H6). 
 
13C NMR (CDCl3, 126 MHz) δ 201.6 (C7), 177.6 (C1), 137.8 (C4), 136.6 (CAr), 129.6 (CAr), 
129.1 (CAr), 127.4 (CAr), 116.5 (C5), 73.7 (C3), 69.1 (C9), 44.0 (C2), 36.9 (C8), 32.4 (C10), 11.2 
(C6). 
 
[α]D25 −163.1 (c = 1.0, CHCl3), literature [α]D25 −166 (c = 1.0, CHCl3). 
 
In agreement with literature data.36  
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 (2R,3S)-1-((R)-4’-Benzyl-2-thioxothiazolidin-3-yl)-3-hydroxy-2-
methyl-hept-6-en-1-one (2.26).35 
 
C18H23NO2S2 
Mol. Wt. = 349.45 g/mol 
 
 
Aldol 2.26 (yellow oil) was obtained from the corresponding Crimmins auxiliary 2.4 and 
aldehyde 2.25 according to the procedure described above for aldol 2.7. 
Purification by flash column chromatography (80:20 PE/EtOAc). 
Scale: 54.0 mmol. 
Yield: 78%, dr = 95:5. 
 
1H NMR (CDCl3, 400 MHz) δ 7.29−7.19 (m, 5H, HAr), 5.75 (ddt, J = 16.6, 10.1, 6.6 Hz, 1H, 
H6), 5.28 (ddd, J = 10.5, 7.2, 3.8 Hz, 1H, H11), 4.98 (dq, J = 16.6, 1.5 Hz, 1H, H7trans), 4.98 
(ddd, J = 10.1, 3.0, 1.1 Hz, 1H, H7cis), 4.41 (qd, J = 6.9, 3.3 Hz, 1H, H2), 3.95 (dq, J = 7.5, 
3.3 Hz, 1H, H3),  3.33 (dd, J = 11.5, 7.2 Hz, 1H, H12), 3.14 (dd, J = 13.2, 3.8 Hz, 1H, H10), 
2.97 (dd, J = 13.2, 10.5 Hz, 1H, H10), 2.83 (d, J = 11.5 Hz, 1H, H12), 2.62 (d, J = 3.3 Hz, 1H, 
OH),  2.19−2.12 (m, 1H, H4), 2.08−2.01 (m, 1H, H4), 1.62−1.54 (m, 1H, H5), 1.44−1.37 (m, 
1H, H5), 1.19 (d, J = 6.9 Hz, 3H, H8). 
 
13C NMR (CDCl3, 101 MHz) δ 201.5 (C9), 178.5 (C1), 138.2 (C6), 136.5 (CAr), 129.6 (CAr), 
129.1 (CAr), 127.4 (CAr), 115.2 (C7), 71.8 (C11), 68.9 (C3), 43.4 (C2), 36.9 (C10), 33.5 (C12), 
32.2 (C4), 30.3 (C5), 10.6 (C8). 
 
In agreement with literature data.35 
 
 (2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-hydroxy-2-
methylhept-6-yn-1-one (2.40). 
 
C18H21NO2S2 
Mol. Wt. = 347.49 g/mol 
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Aldol 2.40 (yellow oil) was obtained from the corresponding Crimmins auxiliary 2.4 and 
aldehyde 2.39 according to the procedure described above for aldol 2.7. 
Purification by flash column chromatography (80:20 PE/EtOAc). 
Scale: 18.0 mmol. 
Yield: 78%, dr = 90:10. 
 
1H NMR (CDCl3, 500 MHz) δ 7.39–7.27 (m, 5H, HAr), 5.39 (ddd, J = 10.6, 6.9, 3.9 Hz, 1H, 
H11), 4.47 (qd, J = 6.9, 2.9 Hz, 1H, H2), 4.08 (br d, J = 9.5 Hz, 1H, H3), 3.42 (dd, J = 11.6, 
6.9 Hz, 1H, H12), 3.21 (dd, J = 13.2, 3.9 Hz, 1H, H10), 3.05 (dd, J = 13.2, 10.6 Hz, 1H, H10), 
2.91 (d, J = 11.6 Hz, 1H, H12), 2.87 (s, 1H, OH), 2.40–2.33 (m, 2H, H5), 1.98 (t, J = 2.7 Hz, 
1H, H7), 1.77 (ddt, J = 13.1, 9.5, 6.5 Hz, 1H, H4), 1.67–1.55 (m, 1H, H4), 1.28 (d, J = 6.9 Hz, 
3H, H8). 
 
13C NMR (CDCl3, 126 MHz) δ 201.3 (C9), 178.5 (C1), 136.7 (CAr), 129.8 (CAr), 129.3 (CAr), 
127.7 (CAr), 84.2 (C6), 71.4 (C11), 69.3 (C7), 69.0 (C3), 43.7 (C2), 37.2 (C10), 33.2 (C12), 32.5 
(C4), 15.6 (C5), 11.15 (C8). 
 
IR (thin film) 3290, 2924, 2854, 1697, 1494, 1340, 1296, 1192, 1163, 1138, 1101 cm-1. 
 
HRMS (ESI) for C18H21NNaS2O2: 370.0906, found: 370.0892. 
 
(2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-hydroxy-2-
methyl-7(trimethylsilyl) hept-6-yn-1-one (2.46). 
 
C21H29NO2S2Si 
Mol. Wt. = 419.67 g/mol 
 
 
 
 
 
 
Aldol 2.46 (yellow oil) was obtained from the corresponding Crimmins auxiliary 2.4 and 
aldehyde 2.45 according to the procedure described above for aldol 2.7. 
Purification by flash column chromatography (90:10 PE/EtOAc). 
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Scale: 18.0 mmol. 
Yield: 89%, dr = 90:10. 
 
1H NMR (CDCl3, 400 MHz,) δ 7.39–7.28 (m, 5H, HAr), 5.37 (ddd, J = 10.5, 6.7, 4.0 Hz, 1H, 
H11), 4.52 (qd, J = 6.9, 3.0 Hz, 1H, H2), 4.06 (dq, J = 9.6, 3.3 Hz, 1H, H3), 3.44–3.37 (m, 1H, 
H12), 3.22 (dd, J = 13.1, 4.0 Hz, 1H, H10), 3.05 (dd, J = 13.1, 10.5 Hz, 1H, H10), 2.91 (d, J = 
11.5 Hz, 1H, H12), 2.80 (d, J = 3.0 Hz, 1H, OH), 2.46–2.29 (m, 2H, H5), 1.82–1.70 (m, 1H, 
H4), 1.66–1.57 (m, 1H, H4), 1.27 (d, J = 6.9 Hz, 3H, H8), 0.15 (s, 9H, TMS). 
 
13C NMR (CDCl3, 126 MHz) δ 201.4 (C9), 178.0 (C1), 136.5 (CAr), 129.6 (CAr), 129.1 (CAr), 
127.4 (CAr), 106.7 (C7), 85.6 (C6), 71.6 (C11), 69.0 (C3), 43.6 (C2), 36.9 (C10), 33.3 (C12), 32.2 
(C4), 16.9  (C5), 10.8 (C8), 0.27 (TMS). 
 
IR (thin film) 2956, 2173, 1675, 1454, 1340, 1248, 1156, 1136, 1030 cm−1. 
 
HRMS (ESI) for C21H29NNaO2S2Si: 442.1288, found: 442.1301. 
 
 (2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-hydroxy-2,6-
dimethylhept-6-en-1-one (2.70). 
 
C19H25NO2S2 
Mol. Wt. = 363.53 g/mol 
 
 
 
 
 
 
Aldol 2.70 (yellow oil) was obtained from the corresponding Crimmins auxiliary 2.4 and 
aldehyde 2.66 according to the procedure described above for aldol 2.7. 
Purification by flash column chromatography (90:10 PE/EtOAc). 
Scale: 16.7 mmol. 
Yield: 72%, dr = 90:10. 
 
1H NMR (CDCl3, 500 MHz) δ 7.39–7.27 (m, 5H, HAr ), 5.36 (ddd, J = 10.5, 7.1, 3.9 Hz, 1H, 
H12), 4.73 (s, 1H, H7), 4.72 (s, 1H, H7), 4.50 (qd, J = 6.9, 3.0 Hz, 1H, H2), 3.94 (ddd, J = 7.9, 
4.5, 3.0 Hz, 1H, H3), 3.41 (dd, J = 11.5, 7.1 Hz, 1H, H13), 3.22 (dd, J = 13.2, 3.9 Hz, 1H, 
H11), 3.05 (dd, J = 13.2, 10.5 Hz, 1H, H11), 2.91 (d, J = 11.5 Hz, 1H, H13), 2.71 (brs, 1H, OH), 
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2.19 (ddd, J = 15.0, 10.1, 5.5 Hz, 1H, H5), 2.07 (ddd, J = 15.0, 9.4, 6.2 Hz, 1H, H5), 1.74 (s, 
3H, H8), 1.72–1.64 (m, 1H, H4), 1.54 (dddd, J = 14.0, 10.1, 6.2, 4.5 Hz, 1H, H4), 1.28 (d, J 
= 6.9 Hz, 3H, H9). 
 
13C NMR (CDCl3, 126 MHz) δ 201.5 (C10), 178.5 (C1), 145.5 (C6), 136.5 (CAr), 129.8 (CAr), 
129.1 (CAr), 127.4 (CAr), 110.5 (C7), 72.1 (C12), 68.9 (C3), 43.4 (C2), 37.0 (C11), 34.2 (C5), 
32.3 (C13), 32.2 (C4), 22.6 (C8), 10.7 (C9). 
 
IR (thin film) 3464, 2932, 1690, 1257, 1026 cm−1. 
 
HRMS (CI+) for C19H26O2S2: 364.1399, found: 364.1405. 
 
(2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-((tert-
butyldimethylsilyl)oxy)-2-methylpent-4-en-1-one (2.8).36 
 
C22H24NO2S2Si 
Mol. Wt. = 435.72 g/mol 
 
 
Method 1: 
 
A solution of 2.7 (10.6 g, 32.9 mmol) and TBSCl (9.92 g, 65.8 mmol, 2.00 equiv) in 
anhydrous DMF (80 mL) was cooled to 0 °C then freshly distilled 2,6-lutidine (15.3 mL, 132 
mmol, 5.00 equiv) and DMAP (0.40 g, 3.3 mmol, 0.10 equiv) were added. The mixture was 
left to stir at RT for 72 h, followed by dilution with water. The mixture was extracted with 
Et2O (3 × 70 mL), and the combined organic extracts were washed with a saturated aqueous 
solution of copper sulfate (3 × 50 mL). The organic extracts were then dried over 
magnesium sulfate, filtered and the solvent concentrated under vacuum. The crude product 
was purified by flash chromatography (97:3 PE/EtOAc) furnishing 2.8 as a bright yellow oil 
(12.8 g, 87%) and as a single diastereomer. 
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1H NMR (CDCl3, 500 MHz) δ 7.36–7.27 (m, 5H, HAr), 5.85 (ddd, J = 17.2, 10.4, 6.7 Hz, 1H, 
H4), 5.16 (d, J = 17.2 Hz, 1H, H5trans), 5.14–5.07 (m, 2H, H5cis/H9), 4.59 (quin, J = 6.7 Hz, 1H, 
H2), 4.32 (t, J = 6.7 Hz, 1H, H3), 3.33–3.25 (m, 2H, H8/ H10), 3.04 (dd, J = 13.2, 10.8 Hz, 1H, 
H8), 2.88 (d, J = 11.5 Hz, 1H, H10), 1.23 (d, J = 6.7 Hz, 3H, H6), 0.88 (s, 9H, H13), 0.02 (s, 
6H, H11/H11’). 
 
13C NMR (CDCl3, 126 MHz)  δ 201.4 (C7), 176.4 (C1), 139.4 (C4), 136.8 (CAr), 129.6 (CAr), 
129.0 (CAr), 127.3 (CAr), 115.9 (C5), 76.6 (C3), 69.6 (C9), 46.0 (C2), 36.7 (C8), 32.4 (C10), 25.9 
(C13), 18.3 (C12), 12.7 (C6), −4.2 (C11), −4.9 (C11’). 
 
 [α]D25 −169.6 (c = 1.0, CHCl3), literature [α]D25 −180.0 (c = 1.0, CHCl3). 
 
In agreement with literature data.36 
 
(2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-(tert-
butyldimethylsilyloxy)-2-methylhept-6-en-1-one (2.24). 35  
 
C24H37NO2S2Si 
Mol. Wt. = 463.77 g 
 
 
TBS protected aldol 2.24 (yellow oil) was obtained from the corresponding aldol 2.26 
according to the procedure (method 1) described above for TBS protected aldol 2.8. 
Purification by flash column chromatography (97:3 PE/EtOAc). 
Scale: 14 mmol. 
Yield: 95% as a single isomer. 
 
1H NMR (CDCl3, 400 MHz) δ 7.31–7.19 (m, 5H, HAr), 5.78 (ddt, J = 16.9, 10.2, 6.5 Hz, 1H, 
H6), 5.17 (ddd, J = 10.8, 6.6, 3.4 Hz, 1H, H11), 5.01 (dq, J = 16.9, 1.6 Hz, 1H, H7trans), 4.93 
(dq, J = 10.2, 1.6 Hz, 1H, H7cis), 4.53 (qd, J = 6.7, 5.5 Hz, 1H, H2), 3.98 (q, J = 5.5 Hz, 1H, 
H3), 3.33–3.25 (m, 2H, H10/H12),  3.01 (dd, J = 13.1, 10.8 Hz, 1H, H10), 2.87 (d, J = 11.7 Hz, 
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1H, H12), 2.09–2.03 (m, 2H, H4/H5), 1.69–1.59 (m, 1H, H4), 1.59–1.49 (m, 1H, H5), 1.20 (d, 
J = 6.7 Hz, 3H, H8), 0.87 (s, 9H, H15), 0.04 (s, 3H, H13), 0.02 (s, 3H, H13’). 
 
13C NMR (CDCl3, 101 MHz) δ 200.9 (C9), 176.8 (C1), 138.6 (C6), 136.7 (CAr), 129.6 (CAr), 
129.0 (CAr), 127.3 (CAr), 114.6 (C7), 73.9 (C11), 69.6 (C3), 44.3 (C2), 36.6 (C10), 34.6 (C12), 
32.2 (C5), 29.2 (C4), 25.9 (C15), 18.2 (C14), 12.7 (C8), -4.0 (C13), -4.5 (C13’). 
 
[α]D25 −92.6 (c = 0.5, CHCl3), literature [α]D25 −67.0 (c = 0.28, CHCl3). 
 
In agreement with literature data.35  
 
(2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-((tert-
butyldimethylsilyl)oxy)-2-methylhept-6-yn-1-one (2.41). 
 
C24H35NO2S2Si 
Mol. Wt. = 461.75 g/mol 
 
 
Method 2: 
 
A solution of aldol 2.40 (5.27 g, 15.2 mmol) in CH2Cl2 (60 mL) was cooled to −78 °C then 
triethylamine (3.20 mL, 22.7 mmol, 1.50 equiv) and tert-butyldimethylsilyl 
trifluoromethanesulfonate (5.30 mL, 22.7 mmol, 1.50 equiv) were added dropwise to the 
reaction. The mixture was stirred at −78 °C for 1 h then warmed to 0 °C and stirred for an 
additional 1 h. The reaction was quenched by addition of water (50 mL) and the aqueous 
layer was extracted with CH2Cl2 (3 × 60 mL). The combined organic layers were dried over 
magnesium sulfate, filtered and concentrated under vacuum. The crude was purified by 
flash column chromatography (95:5 PE/Et2O) to give product 2.41 (6.31 g, 90%) as a yellow 
oil and as a single diastereomer. 
 
1H NMR (CDCl3, 400 MHz) δ 7.30–7.27 (m, 5H, HAr), 5.21 (ddd, J = 10.6, 6.7, 3.6 Hz, 1H, 
H11), 4.58–4.51 (m, 1H, H2), 4.06 (dd, J = 10.5, 5.9 Hz, 1H, H3), 3.43–3.33 (m, 1H, H12), 
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3.28 (dd, J = 13.1, 3.6 Hz, 1H, H10), 3.05 (dd, J = 13.1, 10.6 Hz, 1H, H10), 2.90 (d, J = 11.5 
Hz, 1H, H12), 2.25 (ddd, J = 15.3, 8.4, 2.6 Hz, 2H, H5), 1.96 (t, J = 2.6 Hz, 1H, H7), 1.90–
1.73 (m, 2H, H4), 1.25 (d, J = 6.8 Hz, 3H, H8), 0.89 (s, 9H, H15), 0.09 (s, 3H, H13), 0.06 (s, 
3H, H13’). 
 
13C NMR (CDCl3, 126 MHz) δ 201.4 (C9), 176.9 (C1), 137.0 (CAr), 129.9 (CAr), 129.3 (CAr), 
127.6 (CAr), 84.6 (C6), 73.7 (C11), 69.8 (C7), 69.1 (C3), 44.6 (C2), 36.9 (C10), 34.1 (C12), 32.5 
(C4), 26.2 (C15), 18.4 (C14), 14.8 (C5), 13.5 (C8), – 4.0 (C13), – 4.2 (C13’). 
 
[α]D25 −141.9 (c = 0.50, CHCl3). 
 
IR (thin film) 3306, 2953, 2928, 1699, 1361, 1340, 1257, 1192, 1163, 1030 cm−1. 
 
HRMS (ESI) for C24H35NNaS2O2Si: 484.1771, found: 484.1749. 
 
(2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-((tert-
butyldimethylsilyl)oxy)-2-methyl-7-(trimethylsilyl)hept-6-yn-1-one 
(2.47). 
 
C27H43NO2S2Si2 
Mol. Wt. = 533.94 g/mol 
 
 
 
TBS protected aldol 2.47 (yellow oil) was obtained from the corresponding aldol 2.46 
according to the procedure (method 2) described above for TBS protected aldol 2.41. 
Purification by flash column chromatography (97:3 PE/EtOAc). 
Scale: 16.1 mmol. 
Yield: 80% as a single diastereomer. 
 
1H NMR (CDCl3, 500 MHz,) δ 7.39–7.29 (m, 5H, HAr), 5.19 (ddd, J = 10.5, 6.8, 3.6 Hz, 1H, 
H11), 4.58 (qd, J = 6.8, 4.8 Hz, 1H, H2), 4.05 (dt, J = 6.7, 4.8 Hz, 1H, H3), 3.34 (dd, J = 11.5, 
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6.8 Hz, 1H, H12), 3.28 (dd, J = 13.1, 3.6 Hz, 1H, H10), 3.04 (dd, J = 13.1, 10.5 Hz, 1H, H10), 
2.89 (d, J = 11.5 Hz, 1H, H12), 2.33–2.21 (m, 2H, H5), 1.88–1.74 (m, 2H, H4), 1.22 (d, J = 
6.8 Hz, 3H, H8), 0.89 (s, 9H, H15), 0.14 (s, 9H, HTMS), 0.10 (s, 3H, H13), 0.05 (s, 3H, H13’). 
 
13C NMR (CDCl3, 126 MHz) δ 201.1 (C9), 176.6 (C1), 136.8 (CAr), 129.6 (CAr), 129.0 (CAr), 
127.3 (CAr), 107.0 (C7), 85.3 (C6), 73.4 (C11), 69.6 (C3), 44.4 (C2), 36.6 (C10), 33.9 (C12), 32.1 
(C4), 25.9 (C15), 18.2 (C14), 16.4 (C5), 12.6 (C8), 0.3 (TMS), -4.2 (C13), -4.5 (C13’). 
 
[α]D25 −143.7 (c = 1.0, CHCl3). 
 
IR (thin film) 2958, 2857, 2178, 1701, 1341, 1257, 1249, 1028 cm−1. 
 
HRMS (ESI) for C27H43NNaO2S2Si2: 556.2166, found: 556.2144. 
 
 (2R,3S)-1-((R)-4-Benzyl-2-thioxothiazolidin-3-yl)-3-((tert-
butyldimethylsilyl)oxy)-2,6-dimethylhept-6-en-1-one (2.71). 
 
C25H39NO2S2Si 
Mol. Wt. = 477.80 g/mol 
 
 
 
TBS protected aldol 2.71 (yellow oil) was obtained from the corresponding aldol according 
to the procedure (method 2) described above for TBS protected aldol 2.41. 
Purification by flash column chromatography (97:3 PE/EtOAc). 
Scale: 9.3 mmol. 
Yield: 85% as a single diastereomer. 
 
1H NMR (CDCl3, 500 MHz) δ 7.37–7.33 (m, 2H, HAr), 7.32–7.28 (m, 3H, HAr), 5.17 (ddd, J = 
10.5, 6.8, 3.4 Hz, 1H, H12), 4.69 (s, 1H, H7), 4.68 (s, 1H, H7), 4.56 (app quint, J = 6.6 Hz, 
1H, H2), 4.04 (app q, J = 5.4 Hz, 1H, H3) , 3.36–3.26 (m, 2H, H11/H13), 3.05 (dd, J = 13.1, 
10.5 Hz, 1H, H11), 2.89 (d, J = 11.4 Hz, 1H, H13), 2.07–2.00 (m, 2H, H5), 1.77–1.66 (m, 1H, 
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H4), 1.73 (s, 3H, H8), 1.63–1.56 (m, 1H, H4), 1.25 (d, J = 6.6 Hz, 3H, H9), 0.90 (s, 9H, H16), 
0.07 (s, 3H, H14), 0.05 (s, 3H, H14’). 
 
13C NMR (CDCl3, 126 MHz) δ 201.1 (C10), 177.0 (C1), 146.1 (C6), 136.8 (CAr), 129.6 (CAr), 
129.1 (CAr), 127.3 (CAr), 109.7 (C7), 74.2 (C3), 69.6 (C12), 44.2 (C2), 36.7 (C11), 33.6 (C4), 
33.0 (C5), 32.3 (C13), 26.0 (C16), 22.8 (C8), 18.2 (C15), 12.8 (C9), −4.0 (C14), −4.5 (C14’). 
 
[α]D25 −156.7 (c = 1.0, CHCl3). 
 
IR (thin film) 2947, 2855, 1697, 1250, 1088, 1026 cm−1. 
 
HRMS (CI+) for C25H40NO2S2Si: 478.2264, found: 478.2270. 
  
(2R,3S)-3-((tert-Butyldimethylsilyl)oxy)-2-methylpent-4-enal (2.3).36 
 
C12H24O2Si 
Mol. Wt. = 228.41 g/mol 
 
 
 
A solution of 2.8 (12.8 g, 29.4 mmol) in CH2Cl2 (250 mL) was cooled to ‒78 °C and a 1 M 
solution of diisobutylaluminium hydride in hexanes (59 mL, 59 mmol, 2.0 equiv) was added 
dropwise. The mixture was left to stir until the bright yellow colour disappeared, then the 
reaction was quenched with EtOAc (40 mL) and warmed to RT. The mixture was then 
diluted with a 10% Rochelle’s salt aqueous solution (250 mL) and stirred for 4 h until the 
organic phase became clear. The mixture was then extracted with Et2O (3 × 200 mL), and 
the combined organic extracts were dried over magnesium sulfate, filtered and 
concentrated under vacuum. The crude product was purified by flash chromatography (95:5 
PE/Et2O) furnishing 2.3 as a colourless oil (5.42 g, 82%). 
 
1H NMR (CDCl3, 400 MHz) δ 9.76 (d, J = 1.4 Hz, 1H, H1), 5.83 (ddd, J = 17.1, 10.4, 6.1 Hz, 
1H, H4), 5.25 (dt, J = 17.1, 1.4 Hz, 1H, H5), 5.17 (dt, J = 10.4, 1.3 Hz, 1H, H5), 4.53 (ddt, J 
= 6.1, 4.2, 1.3 Hz, 1H, H3), 2.47 (qdd, J = 7.0, 4.2, 1.4 Hz, 1H, H2), 1.07 (d, J = 7.0 Hz, 3H, 
H6), 0.88 (s, 9H, H9), 0.05 (s, 3H, H7), 0.04 (s, 3H, H7’). 
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13C NMR (CDCl3, 101 MHz) δ 204.7 (C1), 138.5 (C4), 116.1 (C5), 73.8 (C3), 52.7 (C2), 25.9 
(C9), 18.3 (C8), 8.5 (C6), −4.1 (C7), −4.9 (C7’). 
 
[α]D25 −88.2 (c = 1.0, CHCl3), literature [α]D25 −87.0 (c = 1.0, CHCl3). 
 
In agreement with literature data.36 
 
(2R,3S)-3-(tert-Butyldimethylsilyloxy)-2-methyl-6-heptenal (2.23).35 
 
C14H28O2Si 
Mol. Wt. = 256.45 g/mol 
 
 
Aldehyde 2.23 (colourless oil) was obtained from the corresponding TBS protected aldol 
2.24 according to the procedure described above for aldehyde 2.3. 
Purification by flash column chromatography (90:10 PE/Et2O). 
Scale: 13.0 mmol. 
Yield: 69%. 
 
1H NMR (CDCl3, 400 MHz) δ 9.70 (d, J = 1.0 Hz, 1H, H1), 5.72 (ddt, J = 16.9, 10.1, 6.4 Hz, 
1H, H6), 4.96 (dq, J = 16.9, 1.6 Hz, 1H, H7), 4.98 (dq, J = 10.1, 1.6 Hz, 1H, H7), 4.05 (td, J 
= 6.6, 3.6 Hz, 1H, H3), 2.43 (qdd, J = 7.0, 3.6, 1.0 Hz, 1H, H2), 2.12–1.94 (m, 2H, H4/H5), 
1.62–1.48 (m, 2H, H4/H5), 1.02 (d, J = 7.0 Hz, 3H, H8), 0.83 (s, 9H, H11), 0.03 (s, 3H, H9), 
0.00 (s, 3H, H9’). 
 
13C NMR (CDCl3, 101 MHz) δ 205.4 (C1), 138.0 (C6), 115.1 (C7), 71.7 (C3), 51.3 (C2), 33.8 
(C5), 30.1 (C4), 25.9 (C11), 18.2 (C10), 7.9 (C8), −4.1 (C9), −4.4 (C9’). 
 
[α]D25 −93.3 (c = 1.0, CHCl3), literature [α]D25 −98.0 (c = 1.0, CHCl3). 
 
In agreement with literature data.35  
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(2R,3S)-3-((tert-Butyldimethylsilyl)oxy)-2-methylhept-6-ynal (2.42). 
 
C14H26O2Si 
Mol. Wt. = 254.44 g/mol 
 
 
 
Aldehyde 2.42 (colourless oil) was obtained from the corresponding TBS protected aldol 
2.41 according to the procedure described above for aldehyde 2.3. 
Purification by flash column chromatography (90:10 PE/Et2O). 
Scale: 13.6 mmol. 
Yield: 81%. 
 
1H NMR (CDCl3, 500 MHz) δ 9.81 (d, J = 0.9 Hz, 1H, H1), 4.26 (ddd, J = 7.6, 5.3, 3.8 Hz, 
1H, H3), 2.53 (qdd, J = 7.0, 3.8, 0.9 Hz, 1H, H2), 2.26 (tt, J = 7.1, 2.6 Hz, 2H, H5), 1.99 (t, J 
= 2.6 Hz, 1H, H7), 1.78–1.65 (m, 2H, H4), 1.08 (d, J = 7.0 Hz, 3H, H8), 0.88 (s, 9H, H11), 0.12 
(s, 3H, H9), 0.08 (s, 3H, H9’). 
 
13C NMR (CDCl3, 126MHz) δ 205.1 (C1), 83.6 (C6), 71.1 (C3), 69.4 (C7), 51.6 (C2), 33.1 (C4), 
26.0 (C11), 18.3 (C10), 15.2 (C5), 8.3 (C8), −4.16 (C9) , −4.31 (C9’). 
 
[α]D25 −18.7 (c = 0.50, CHCl3). 
 
IR (thin film) 3314, 2955, 2930, 1737, 1366 cm−1. 
 
HRMS (ESI) for C14H26NaO2Si: 277.1594, found: 277.1583. 
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(2R,3S)-3-((tert-Butyldimethylsilyl)oxy)-2-methyl-7-
(trimethylsilyl)hept-6-ynal (2.48). 
 
C17H34O2Si2 
Mol. Wt. = 326.63 g/mol 
 
 
 
Aldehyde 2.48 (colourless oil) was obtained from the corresponding TBS protected aldol 
2.47 according to the procedure described above for aldehyde 2.3. 
Purification by flash column chromatography (95:5 PE/Et2O). 
Scale: 12.8 mmol. 
Yield: 92%. 
 
1H NMR (CDCl3, 400 MHz,) δ 9.81 (d, J = 0.8 Hz, 1H, H1), 4.27 (ddd, J = 7.6, 5.6, 3.6 Hz, 
1H, H3), 2.54 (qdd, J = 7.0, 3.6, 0.8 Hz, 1H, H2), 2.29 (t, J = 7.0 Hz, 2H, H5), 1.78–1.60 (m, 
2H, H4), 1.07 (d, J = 7.0 Hz, 3H, H8), 0.88 (s, 9H, H11), 0.16 (s, 9H, HTMS), 0.12 (s, 3H, H9), 
0.08 (s, 3H, H9’). 
 
13C NMR (CDCl3, 126 MHz) δ 204.8 (C1), 106.0 (C7), 85.5 (C6), 70.8 (C3), 51.2 (C2), 32.7 
(C5), 25.7 (C11), 17.9 (C10), 16.3 (C4), 7.9 (C8), -0.03 (TMS), −4.48 (C9), −4.70 (C9’). 
 
[α]D25 −85.2 (c = 1.0, CHCl3). 
 
IR (thin film) 2955, 2928, 2857, 1728, 1250, 839 cm−1. 
 
HRMS (ESI) for C17H34NaO2Si2: 349.1990, found: 349.1973 
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(2R,3S)-3-((tert-Butyldimethylsilyl)oxy)-2,6-dimethylhept-6-enal 
(2.72). 
 
C15H30O2Si 
Mol. Wt. = 270.49 g/mol 
 
 
 
Aldehyde 2.72 (colourless oil) was obtained from the corresponding TBS protected aldol 
2.71 according to the procedure described above for aldehyde 2.3. 
Purification by flash column chromatography (90:10 PE/Et2O). 
Scale: 15.0 mmol. 
Yield: 98%. 
 
1H NMR (CDCl3, 500 MHz) δ 9.79 (d, J = 1.0 Hz, 1H, H1), 4.74 (s, 1H, H7), 4.69 (s, 1H, H7), 
4.13 (td, J = 6.5, 3.6 Hz, 1H, H3), 2.49 (qdd, J = 7.0, 3.6, 1.0 Hz, 1H, H2), 2.12–2.04 (m, 1H, 
H5), 2.01–1.93 (m, 1H, H5), 1.74 (s, 3H, H8), 1.72–1.59 (m, 2H, H4), 1.08 (d, J = 7.0 Hz, 3H, 
H9), 0.88 (s, 9H, H12), 0.09 (s, 3H, H10), 0.05 (s, 3H, H10’). 
 
13C NMR (CDCl3, 126 MHz) δ 205.4 (C1), 145.2 (C6), 110.4 (C7), 71.9 (C3), 51.3 (C2), 34.0 
(C5), 32.6 (C4), 25.9 (C12), 22.6 (C8), 18.2 (C11), 7.8 (C9), −4.1 (C10), −4.4 (C10’). 
 
[α]D25 −41.5 (c = 1.0, CHCl3). 
 
IR (thin film) 2932, 2855, 1728, 833 cm−1. 
 
HRMS (ESI) for C15H30NaO2Si: 293.1907, found: 293.1900. 
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Ethyl (4R,5S)-5-(tert-butyldimethylsilyloxy)-4-methyl-3-oxonon-8-
enoate (1.126).35 
 
C18H34SiO4 
Mol Wt = 342.54 g/mol 
 
 
 
To a solution of ethyl 2-diazoacetate (0.53 mL, 5.0 mmol, 2.0 equiv) in CH2Cl2 (15 mL) was 
added tin(II) chloride (0.24 g, 1.3 mmol, 0.50 equiv). The reaction was stirred at RT for 5 
min then a solution of aldehyde 2.23 (0.65 g, 2.5 mmol) in CH2Cl2 (5 mL) was added 
dropwise and the mixture was left to stir at RT for 3 h. The crude mixture was concentrated 
under vacuum and purified by flash column chromatography (95:5 PE/Et2O) to yield a 3:1 
mixture of ketoester 1.126 and enol form as a colourless oil (0.75 g, 86%). 
 
Ketoester form is described below: 
 
1H NMR (CDCl3, 400 MHz) δ 5.71 (ddt, J = 17.2, 10.2, 6.5 Hz, 1H, H8), 4.92–4.85 (m, 2H, 
H9), 4.10 (q, J = 7.1 Hz, 2H, H11), 3.82 (dt, J = 7.1, 4.1 Hz, 1H, H5), 3.50 (s, 2H, H2), 2.76 
(qd, J = 7.1, 4.1 Hz, 1H, H4), 1.95 (m, 2H, H7), 1.50 (m, 1H, H6), 1.35 (m, 1H, H6), 1.19 (t, J 
= 7.1 Hz, 3H, H12), 1.00 (d, J = 7.1 Hz, 3H, H10), 0.82 (s, 9H, H15), 0.01 (s, 3H, H13), 0.00 (s, 
3H, H13’). 
 
13C NMR (CDCl3, 101 MHz) δ 205.4 (C3), 167.6 (C1), 138.1 (C8), 115.0 (C9), 73.4 (C5), 61.3 
(C11), 51.8 (C4), 49.6 (C2), 33.4 (C7), 30.0 (C6), 26.0 (C15), 18.2 (C14), 14.3 (C12), 11.8 (C10), 
–4.3 (C13), –4.3 (C13’). 
 
[α]D25 −63.0 (c = 1.0, CHCl3), literature [α]D25 −187 (c = 0.27, CHCl3). 
 
In agreement with literature data.35 
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 Methyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-4-methyl-3-
oxohept-6-enoate (2.9).36  
 
C15H28O4Si 
Mol. Wt. = 300.47 g/mol 
 
 
 
Ketoester 2.9 (colourless oil) was obtained from the corresponding aldehyde 2.3 and methyl 
2-diazoacetate according to the procedure described above for ketoester 1.126. 
Purification by flash column chromatography (95:5 PE/Et2O) 
Scale: 7.0 mmol 
Yield: 81% as a 3:1 mixture of ketoester 2.9 and enol form. 
 
Ketoester form is described below: 
 
1H NMR (CDCl3, 400 MHz) δ 5.74 (ddd, J = 17.0, 10.4, 6.5 Hz, 1H, H6), 5.19 (dt, J = 17.1, 
1.4 Hz, 1H, H7), 5.13 (dt, J = 10.4, 1.4 Hz, 1H, H7), 4.26 (ddt, J = 6.6, 5.3, 1.2 Hz, 1H, H5), 
3.72 (s, 3H, H9), 3.60 (d, J = 15.9 Hz, 1H, H2), 3.54 (d, J = 15.9 Hz, 1H, H2), 2.87 (qd, J = 
7.0, 5.3 Hz, 1H, H4), 1.09 (d, J = 7.0 Hz, 3H, H8), 0.90 (s, 9H, H12), 0.07 (s, 3H, H10), 0.03 
(s, 3H, H10’). 
 
13C NMR (CDCl3, 101 MHz) δ 204.4 (C3), 167.6 (C1), 138.2 (C6), 116.4 (C7), 75.5 (C5), 52.2 
(C4), 52.1 (C9), 49.8 (C2), 25.8 (C12), 17.8 (C11), 12.1 (C8), −4.4 (C10), −4.6 (C10’). 
 
In agreement with literature data.36 
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Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-4-methyl-3-oxonon-8-
ynoate (2.36). 
 
C18H32O4Si 
Mol. Wt. = 340.53 g/mol 
 
 
 
Ketoester 2.36 (colourless oil) was obtained from the corresponding aldehyde 2.42 and 
ethyl 2-diazoacetate according to the procedure described above for ketoester 1.126. 
Purification by flash column chromatography (95:5 PE/Et2O) 
Scale: 8.6 mmol 
Yield: 81% as a 3:1 mixture of ketoester 2.36 and enol form. 
 
Ketoester form is described below: 
 
1H NMR (CDCl3, 400MHz) δ 4.20 (q, J = 7.1 Hz, 2H, H10), 4.01 (dt, J = 8.0, 4.1 Hz, 1H, H5), 
3.60 (s, 2H, H2), 2.89 (qd, J = 7.0, 4.2 Hz, 1H, H4), 2.29–2.19 (m, 2H, H7), 1.96 (t, J = 2.6 
Hz, 1H, H9), 1.79–1.64 (m, 1H, H6), 1.59–1.48 (m, 1H, H6), 1.27 (t, J = 7.1 Hz, 3H, H11), 1.08 
(d, J = 7.0 Hz, 3H, H12), 0.91 (s, 9H, H15), 0.12 (s, 3H, H13) 0.11 (s, 3H, H13’). 
 
13C NMR (CDCl3, 126MHz) δ 204.7 (C3), 167.2 (C1), 83.4 (C8), 72.2 (C5), 68.8 (C9), 61.0 
(C10), 51.4 (C4), 49.4 (C2), 32.2 (C6), 25.6 (C15), 17.8 (C14), 14.6 (C7), 13.9 (C12), 11.7 (C11), 
−4.6 (C13), −4.9 (C13’). 
 
[α]D25 −40.8 (c = 0.50, CHCl3). 
 
IR (thin film) 3628, 2955, 2929, 2272, 1749, 1717, 1647, 1636, 1313, 1255, 1026 cm−1. 
 
 
HRMS (ESI) for C18H32NaO4Si: 363.1962, found: 363.1980. 
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Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-4-methyl-3-oxo-9-
(trimethylsilyl)non-8-ynoate (2.49). 
 
C21H40O4Si2 
Mol. Wt. = 412.71 g/mol 
 
 
 
Ketoester 2.49 (colourless oil) was obtained from the corresponding aldehyde 2.48 and 
ethyl 2-diazoacetate according to the procedure described above for ketoester 1.126. 
Purification by flash column chromatography (90:10 PE/Et2O) 
Scale: 5.9 mmol 
Yield: 81% as a 3:1 mixture of ketoester 2.49 and enol form. 
 
Ketoester form is described below: 
 
1H NMR (CDCl3, 500 MHz,) δ 4.20 (q, J = 7.2 Hz, 2H, H10), 4.05–4.00 (m, 1H, H5), 3.61 (s, 
2H, H2), 2.90 (qd, J = 7.1, 3.8 Hz, 1H, H4), 2.34–2.19 (m, 2H, H7), 1.70–1.63 (m, 1H, H6), 
1.51 (dt, J = 14.0, 6.6 Hz, 1H, H6), 1.28 (t, J = 7.2 Hz, 3H, H11), 1.08 (d, J = 7.1 Hz, 3H, H12), 
0.91 (s, 9H, H15), 0.15 (s, 9H, HTMS), 0.13 (s, 3H, H13), 0.11 (s, 3H, H13’). 
 
13C NMR (CDCl3, 126 MHz) δ 205.1 (C1), 167.6 (C3), 90.0 (C9), 85.7 (C8), 72.8 (C5), 61.3 
(C2), 51.9 (C4), 49.8 (C10), 32.6 (C7), 26.0 (C15), 18.2 (C14), 16.6 (C6), 14.3 (C11), 11.9 (C12), 
0.2 (TMS), −4.2 (C13), −4.5 (C13’). 
 
[α]D25 −60.8 (c = 0.50, CHCl3). 
 
IR (thin film) 2957, 2931, 2897, 1749, 1715, 1626, 1421, 1249, 1097, 1026 cm−1. 
 
HRMS (ESI) for C21H40NaO4Si2: 435.2357, found: 435.2339. 
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Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-4,8-dimethyl-3-
oxonon-8-enoate (2.64). 
 
C19H36O4Si 
Mol. Wt. = 356.58 g/mol 
 
 
 
Ketoester 2.64 (colourless oil) was obtained from the corresponding aldehyde 2.72 and 
ethyl 2-diazoacetate according to the procedure described above for ketoester 1.126. 
Purification by flash column chromatography (95:5 PE/Et2O) 
Scale: 14.8 mmol 
Yield: 92% as a 3:1 mixture of ketoester 2.64 and enol form. 
 
Ketoester form is described below: 
 
1H NMR (CDCl3, 500 MHz) δ 4.72 (s, 1H, H10), 4.67 (s, 1H, H10), 4.19 (q, J = 7.1 Hz, 2H, 
H12), 3.90 (ddd, J = 7.2, 5.0, 4.2 Hz, 1H, H5), 3.59 (s, 1H, H2), 3.59 (s, 1H, H2), 2.85 (qd, J 
= 7.0, 4.2 Hz, 1H, H4), 2.13–2.01 (m, 1H, H7), 2.01–1.91 (m, 1H, H7), 1.72 (s, 3H, H9), 1.67–
1.58 (m, 1H, H6), 1.52–1.43 (m, 1H, H6), 1.28 (t, J = 7.1 Hz, 3H, H13), 1.09 (d, J = 7.0 Hz, 
3H, H11), 0.91 (s, 9H, H16), 0.09 (s, 3H, H14), 0.08 (s, 3H, H14’). 
 
13C NMR (CDCl3, 126 MHz) δ 205.3 (C3), 167.6 (C1), 145.4 (C8), 110.3 (C10), 73.6 (C5), 61.3 
(C12), 51.8 (C4), 49.6 (C2), 33.9 (C7), 32.3 (C6), 26.0 (C16), 22.7 (C9), 18.2 (C15), 14.3 (C13), 
11.7 (C11), −4.2 (C14), −4.3 (C14’). 
 
[α]D25 −38.0 (c = 1.0, CHCl3). 
 
IR (thin film) 3078, 2932, 2862, 1744, 1713, 1643, 833 cm−1. 
 
HRMS (CI+) for C15H30NaO2Si: 357.2456, found: 357.2461. 
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tert-Butyl (3S,4R)-3-((tert-butyldimethylsilyl)oxy)-4-methyl-5-
oxocyclopent-1-ene-1-carboxylate (1.148).34,35 
 
C17H30O4Si 
Mol. Wt. = 326.51 g/mol 
 
 
 
Compound 2.12 (2.0 g, 5.4 mmol) was dissolved in dry degassed CH2Cl2 (110 mL). Grubbs 
2nd generation catalyst (0.23 g, 0.27 mmol, 0.05 equiv) was added in one portion and the 
solution was heated under reflux for 24 h. An additional portion of Grubbs 2nd generation 
catalyst was added (92 mg, 0.11 mmol, 0.02 equiv) and the mixture heated under reflux for 
a further 12 h. The solvent was removed under vacuum and the product purified by column 
chromatography (70:30 PE/Et2O) furnishing the product 1.148 as a pale brown oil (1.2 g, 
68%). 
 
1H NMR (CDCl3, 500 MHz) δ 7.82 (d, J = 2.1 Hz, 1H, H2), 4.48 (dd, J = 3.1, 2.1 Hz, 1H, H3), 
2.42 (qd, J = 7.4, 3.1 Hz, 1H, H4), 1.54 (s, 9H, H9), 1.25 (d, J = 7.4 Hz, 3H, H7), 0.93 (s, 9H, 
H12), 0.17 (s, 3H, H10), 0.15 (s, 3H, H10’). 
 
13C NMR (CDCl3, 101MHz) δ 201.0 (C5), 165.9 (C6), 160.9 (C2), 137.3 (C1), 82.2 (C8), 76.1 
(C3), 52.6 (C4), 28.0 (C9), 25.6 (C12), 18.0 (C11), 12.4 (C7), −4.7 (C10), −4.7 (C10’). 
 
In agreement with literature data.35 
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(4S,5S)-2,2-Dimethyl-5-vinyl-[1,3]-dioxolane-4-carbaldehyde 
(2.16).45  
 
C8H12O3 
Mol. Wt. = 156.18 g/mol 
 
 
 
 
To a suspension of D-Ribose (24.9 g, 166 mmol) in acetone (300 mL) was added dropwise 
concentrated sulfuric acid (0.90 mL, 17 mmol, 0.10 equiv). The crude mixture was stirred 
for 3 h, then solid sodium bicarbonate was added to neutralise the solution. The mixture 
was then filtered, dried over magnesium sulfate and concentrated under vacuum to furnish 
the protected product as a yellow oil (31.5 g). The product was used in the next step without 
further purification. 
 
To a stirred suspension of methyltriphenylphosphonium bromide (86.3 g, 242 mmol, 3.50 
equiv) in THF (250 mL) at 0 °C was added potassium tert-butoxide (27.1 g, 242 mmol, 3.50 
equiv). The yellow mixture was stirred at 0 °C for 30 min then stirred at RT for an additional 
1 h. The mixture was cooled to 0 °C and a solution of protected D-Ribose (13 g, 69 mmol) 
in THF (50 mL) was added dropwise. The reaction was stirred at RT for 12 h then was 
quenched by addition of water (250 mL). The aqueous phase was extracted with EtOAc (3 
× 250 mL), the combined organic phases were dried over magnesium sulfate, filtered then 
concentrated under vaccum. The crude material was purified by column chromatography 
(30:70 PE/EtOAc) to furnish a mixture of triphenylphosphine oxide and product 2.15 (9.6 g, 
76% over 2 steps) that was used in the next step without further purification. 
 
To a solution of 2.15 (18.6 g, 98.8 mmol) in CH2Cl2 (320 mL) was added a solution of sodium 
periodate (31.7 g, 148 mmol, 1.50 equiv) in water (160 mL). The reaction was stirred at RT 
for 2 h then was diluted with CH2Cl2 (200 mL) and water (100 mL). The two layers were 
separated and the organic phase was dried over magnesium sulfate, filtered and 
concentrated carefully under vacuum (25 °C and 180 mbar). The crude material was purified 
by column chromatography (80:20 Pentane/Et2O) to furnish compound 2.16 as a pale oil 
(13.3 g, 89%). 
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1H NMR (CDCl3, 400 MHz) δ 9.57 (d, J = 3.1 Hz, 1H, H6), 5.77 (ddd, J = 17.1, 10.4, 6.9 Hz, 
1H, H7), 5.48 (dt, J = 17.1, 1.3 Hz, 1H, H8), 5.34 (dt, J = 10.4, 1.3 Hz, 1H, H8), 4.90–4.85 
(m, 1H, H5), 4.42 (dd, J = 7.5, 3.1 Hz, 1H, H4), 1.64 (s, 3H, H1), 1.46 (s, 3H, H1). 
 
13C NMR (CDCl3, 126 MHz) δ 200.8 (C6), 131.4 (C7), 119.9 (C8), 111.4 (C2), 82.4 (C5), 79.2 
(C4), 27.5 (C1), 25.5 (C1). 
 
In agreement with literature data.45 
 
1-((4R,5S)-2,2-Dimethyl-5-vinyl-[1,3]-dioxolan-4-yl)prop-2-en-1-ol 
(2.17).45 
 
C10H16O3 
Mol. Wt. = 184.24 g/mol 
 
 
 
 
To a solution of aldehyde 2.16 (13.3 g, 85.1 mmol) in THF (350 mL) at –78 °C was added 
dropwise a 0.7 M solution of vinylmagnesium bromide in THF (200 mL, 140 mmol, 1.65 
equiv). The mixture was stirred at –78 °C for 10 min then warmed to 0 °C and left stirring 
for 1 h. The reaction was quenched at 0 °C with a saturated aqueous solution of ammonium 
chloride (300 mL), allowed to warm up to RT, then the aqueous phase extracted with Et2O 
(3 × 250 mL). The combined organic phases were dried over magnesium sulfate, filtered 
then concentrated under vacuum. The crude material was purified by column 
chromatography (70:30 PE/Et2O) to furnish 2.17 as a colourless oil and as an inseparable 
2:1 mixture of two diastereomers (11.4 g, 73%). 
 
Major diastereomer is described below: 
 
1H NMR (CDCl3, 500 MHz) δ 6.12–5.98 (m, 1H, H7), 5.86 (ddd, J = 17.2, 10.6, 5.4 Hz, 1H, 
H9), 5.51–5.19 (m, 4H, H8/H10), 4.62 (dd, J = 7.7, 6.6 Hz, 1H, H6), 4.16–4.12 (m, 1H, H5), 
4.10 (dd, J = 6.6, 5.3 Hz, 1H, H4), 1.55 (s, 3H, H1), 1.41 (s, 3H, H1).  
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13C NMR (CDCl3, 126 MHz) δ 136.9 (C7), 134.1 (C9), 119.6 (C8 or C10), 117.2 (C8 or C10), 
109.0 (C2), 80.8 (C4), 79.1 (C6), 70.7 (C5), 27.5 (C1), 25.1 (C1).  
 
In agreement with literature data.45 
 
 (3aS,6aS)-2,2-Dimethyl-3a,6a-dihydro-4H-
cyclopenta[d][1,3]dioxol-4-one (2.14).45 
 
C8H10O3 
Mol. Wt. = 154.16 g/mol 
 
 
 
To a degassed solution of allylic alcohol 2.17 (1.0 g, 5.4 mmol) in CH2Cl2 (40 mL) was added 
Grubbs’ 1st generation catalyst (89 mg, 0.11 mmol, 0.020 equiv). The reaction was heated 
under reflux for 12 h, the crude product was concentrated under vacuum and used in the 
next step without purification (0.85 g). 
 
To a solution of oxalyl chloride (0.64 mL, 7.6 mmol, 1.4 equiv) in CH2Cl2 (20 mL) at –78 °C 
was added dropwise a mixture of DMSO (1.1 mL, 15 mmol, 2.8 equiv) and CH2Cl2 (5 mL). 
The mixture was stirred at −78 °C for 30 min then a solution of cyclic alcohol 2.18 (0.85 g, 
5.4 mmol) in CH2Cl2 (5 mL) was added. The reaction was stirred at −78 °C for 1 h, then 
triethylamine was added (4.2 ml, 30 mmol, 5.6 equiv) and the mixture was allowed to warm 
up to RT over 1 h. The reaction was quenched with a 1 M aqueous solution of hydrochloric 
acid (25 mL) and the aqueous phase was extracted with CH2Cl2 (3 × 25 ml). The combined 
organic phases were washed with a 1 M aqueous solution of hydrochloric acid (2 × 50 mL), 
a saturated aqueous solution of sodium bicarbonate (50 mL), then dried over magnesium 
sulfate, filtered and concentrated under vacuum. The crude material was purified by column 
chromatography (70:30 PE/Et2O) to furnish compound 2.14 as a white foam (0.69 g, 83% 
over 2 steps). 
 
1H NMR (CDCl3, 500 MHz) δ 7.61 (dd, J = 5.9, 2.0 Hz, 1H, H4), 6.23 (d, J = 5.9 Hz, 1H, H5), 
5.28 (dd, J = 5.5, 2.0 Hz, 1H, H3), 4.48 (d, J = 5.5 Hz, 1H, H2), 1.43 (s, 3H, H7), 1.42 (s, 3H, 
H7). 
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13C NMR (CDCl3, 126 MHz) δ 203.1 (C1), 159.7 (C4), 134.5 (C5), 115.7 (C6), 78.7 (C3), 76.7 
(C4), 27.6 (C7), 26.3 (C7). 
 
[α]D25 +70.9 (c = 1.0, CHCl3), literature [α]D25 +73 (c = 1.0, CHCl3). 
 
In agreement with literature data.45  
 
(((3aS,4S,6aS)-2,2-Dimethyl-4-(prop-1-en-2-yl)-3a,6a-dihydro-4H-
cyclopenta[d][1,3]dioxol-6-yl)oxy)trimethylsilane (1.130).36 
 
C14H24O3Si 
Mol. Wt. = 268.43 g/mol 
 
 
 
To a suspension of copper(I) iodide (2.23 g, 11.7 mmol, 0.300 equiv) in THF (100 mL) at 
0 °C was added TMEDA (12.8 mL, 85.9 mmol, 2.20 equiv). The mixture was cooled to 
−78 °C, a 0.5 M solution of isopropenyl magnesium bromide in THF (86 mL, 44 mmol, 1.1 
equiv) was added and the reaction stirred at −78 °C for 1 h. A mixture of enone 2.14 (6.0 g, 
39 mmol) and TMSCl (14.8 mL, 117 mmol, 3.00 equiv) in THF (100 mL) was added 
dropwise. After 30 min, TMSCl (9.9 mL, 78 mmol, 2.0 equiv) and triethylamine (11 mL, 78 
mmol, 2.0 equiv) were added and the crude mixture stirred for 1 h at −78 °C, 1 h at −40 °C 
and 2 h at 0 °C. The reaction was quenched by addition of a saturated solution of sodium 
carbonate (150 mL) and the aqueous phase was extracted with Et2O (3 × 150 mL). The 
organic phases were washed with brine (5 × 100 mL), dried over sodium sulfate, filtered 
and concentrated under vacuum. The crude material was purified by a very short pad of 
oven-dried silica gel (silica was dried for 24 h at 150 °C and cooled under inert atmosphere) 
(95:5 PE/Et2O) to give silyl enol ether 1.130 (6.95 g, 67%) and 2.19 (1.96 g, 25%) as 
colourless oils. 
 
1H NMR (CDCl3, 400 MHz) δ 4.81 (dd, J = 6.1, 1.1 Hz, 1H, H5), 4.78–4.74 (m, 2H, H7), 4.65–
4.63 (m, 1H, H2), 4.32 (dt, J = 6.1, 0.9 Hz, 1H, H4), 3.21 (m, 1H, H3), 1.76 (s, 3H, H8), 1.49 
(s, 3H, H10), 1.36 (s, 3H, H10), 0.27 (s, 9H, H11). 
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13C NMR (CDCl3, 126 MHz) δ 153.7 (C1), 146.8 (C6), 111.1 (C7), 111.0 (C9), 106.0 (C2), 83.0 
(C4), 81.6 (C5), 54.5 (C3), 27.6 (C8), 25.9 (C10), 21.3 (C10), 0.2 (C11). 
 
[α]D25 −28.8 (c = 1.0, CHCl3), literature [α]D25 −32.8 (c = 1.0, CHCl3). 
 
In agreement with literature data.36 
 
(3aS,6S,6aS)-2,2-Dimethyl-6-(prop-1-en-2-yl)tetrahydro-4H-
cyclopenta[d][1,3]dioxol-4-one (2.19).36 
 
C11H16O3 
Mol. Wt. = 196.24 g/mol 
 
 
 
1H NMR (CDCl3, 500 MHz) δ 4.86 (d, J = 0.8 Hz, 1H, H7), 4.67 (d, J = 5.4 Hz, 1H, H5), 4.64 
(s, 1H, H7), 4.24 (d, J = 5.4 Hz, 1H, H4), 2.96 (d, J = 9.1 Hz, 1H, H2), 2.89–2.81 (m, 1H, H3), 
2.35–2.29 (m, 1H, H2), 1.83 (s, 3H, H8), 1.46 (s, 3H, H10), 1.36 (s, 3H, H10). 
 
13C NMR (CDCl3, 126 MHz) δ 213.5 (C1), 145.0 (C6), 112.4 (C7), 111.8 (C9), 80.9 (C5), 78.2 
(C4), 43.7 (C3), 39.2 (C2), 27.0 (C10), 25.0 (C10), 22.3 (C8). 
 
[α]D25 +131.0 (c = 1.0, CHCl3), literature [α]D25 +167.0 (c = 1.0, CHCl3). 
 
In agreement with literature data.36 
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tert-Butyl (1R,2R,3S,4R)-3-((tert-butyldimethylsilyl)oxy)-2-
((3aS,5R,6S,6aS)-2,2-dimethyl-4-oxo-6-(prop-1-en-2-yl)tetrahydro-
4H-cyclopenta[d][1,3]dioxol-5-yl)-4-methyl-5-oxocyclopentane-1-
carboxylate (2.20).34,35 
 
C28H46O7Si 
Mol. Wt. = 522.75 g/mol 
 
 
 
Silyl enol ether 1.130 (0.93 g, 3.5 mmol, 3.0 equiv) was dissolved in THF (5 mL) then cooled 
to 0 °C and a 2.1 M solution of n-BuLi in hexane (1.8 mL, 3.8 mmol, 3.3 equiv) was added 
dropwise. The reaction was stirred at 0 °C for 1 h then cooled to −78 °C and a mixture of 
ZnCl2 (174 mg, 1.27 mmol, 1.10 equiv) and enone 1.148 (342 mg, 1.16 mmol) in DMF (15 
mL) was added over 30 min to the reaction mixture. The mixture was stirred at −78 °C for 1 
h, −40 °C for 1 h, −20 °C for 1 h and 0 °C for 1h. The crude was then quenched with a 
saturated aqueous solution of ammonium chloride (15 mL) and diluted with THF (15 mL). 
The aqueous phase was extracted with Et2O (3 × 15 mL), the organic phases combined 
and dried over magnesium sulfate, filtered then concentrated under vacuum. The crude 
material was purified by column chromatography (90:10 PE/Et2O) to furnish a 3:1 mixture 
of inseparable diastereomers of 2.20/2.20’ as a yellow oil (315 mg, 53%). 
 
Major diastereomer is described below: 
 
1H NMR (CDCl3, 400 MHz) δ 5.01–4.99 (m, 1H, H15), 4.95 (m, 1H, H15), 4.57 (dd, J = 6.3, 
1.1 Hz, 1H, H10), 4.43 (dd, J = 6.3, 3.0 Hz, 1H, H11), 3.83 (t, J = 8.2 Hz, 1H, H4), 3.22–3.11 
(m, 2H, H2/H3), 2.96 (ddd, J = 10.0, 2.9, 1.5 Hz, 1H, H8), 2.81 (dd, J = 10.0, 3.0 Hz, 1H, H12), 
2.43 (dq, J = 8.9, 7.0 Hz, 1H, H5), 1.87 (s, 3H, H14), 1.49 (s, 3H, H17), 1.47 (s, 9H, H19), 1.34 
(s, 3H, H17), 1.16 (d, J = 7.0 Hz, 3H, H6), 0.88 (s, 9H, H22), 0.09 (s, 3H, H20), 0.08 (s, 3H, 
H20’). 
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13C NMR (CDCl3, 126 MHz) δ 211.2 (C1 or C9), 208.6 (C1 or C9), 167.6 (C7), 143.7 (C13), 
113.7 (C15), 112.9 (C16), 82.2 (C18), 79.3 (C10), 79.2 (C11), 77.5 (C4), 57.6 (C2), 52.3 (C5), 
49.6 (C8), 49.2 (C12), 45.2 (C3), 27.8 (C19), 26.7 (C17), 25.7 (C22), 25.0 (C17), 20.2 (C14), 17.9 
(C21), 12.1 (C6), −3.6 (C20), −3.9 (C20’). 
 
In agreement with literature data.35 
 
tert-Butyl (1S,2R,3aR,5aS,5bS,8aS,9aS,9bR)-1-((tert-
butyldimethylsilyl)oxy)-2,7,7-trimethyl-5-methylene-3,9-
dioxodecahydro-as-indaceno[2,3-d][1,3]dioxole-3a(1H)-
carboxylate (1.150).34,35 
 
C28H44O7Si 
Mol. Wt. = 520.74 g/mol 
 
 
 
 
To a degassed solution of bicycle 2.20/2.20’ (204 mg, 0.390 mmol) in a 10:1 mixture of 
trifluoroethanol/acetic acid (11 mL) was added copper(II) acetate hydrate (156 mg, 0.780 
mmol, 2.00 equiv). The mixture was stirred at RT for 30 min and manganese(III) acetate 
dihydrate (209 mg, 0.780 mmol, 2.00 equiv) was added. The reaction was stirred for 1 h 30, 
then diluted with water (10 mL) and Et2O (10 mL) and neutralised with solid potassium 
carbonate. The aqueous phase was extracted with Et2O (3 × 10 mL), the organic phases 
were dried over magnesium sulfate, filtered and concentrated under vacuum. The crude 
material was purified by column chromatography (90:10 PE/Et2O) to give tricycle 1.150 as 
a colourless oil (93 mg, 46%) and as a single diastereomer. 
 
1H NMR (CDCl3, 500 MHz) δ 5.09–5.04 (m, 2H, H14), 4.78 (t, J = 7.7 Hz, 1H, H11), 4.57 (d, J 
= 7.7 Hz, 1H, H10), 3.98 (dd, J = 3.0, 2.0 Hz, 1H, H4), 3.05 (m, 1H, H3), 2.90 (d, J = 14.8 Hz, 
1H, H15), 2.51–2.43 (m, 2H, H15 and H5), 2.34–2.22 (m, 1H, H12), 1.68–1.60 (m, 1H, H8),  
1.50 (s, 3H, H17), 1.42 (s, 9H, OC(CH3)3), 1.37 (s, 3H, H17), 1.11 (d, J = 7.7 Hz, 3H, H6), 0.91 
(s, 9H, SiC(CH3)3), 0.17 (s, 3H, Si(CH3)2), 0.14 (s, 3H, Si(CH3)2). 
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13C NMR (CDCl3, 126 MHz) δ 211.7 (C1 or C9), 205.1 (C1 or C9), 170.0 (C7), 140.9 (C13), 
115.1 (C16), 108.6 (C14), 82.4 (OC(CH3)3), 78.8 (C11), 77.4 (C4), 75.3 (C10), 62.0 (C2), 53.0 
(C8), 50.6 (C5), 49.4 (C12), 46.7 (C3), 36.44 (C15), 27.7 (OC(CH3)3), 26.8 (C17), 25.8 
(SiC(CH3)3), 25.0 (C17), 18.0 (SiC(CH3)3), 14.4 (C6), −4.6 (Si(CH3)), −4.8(Si(CH3)). 
 
[α]D25 −28.2 (c = 1.0, CHCl3), literature [α]D25 −31.1 (c = 1.0, CHCl3). 
 
In agreement with literature data.35 
 
2-(Trimethylsilyl)ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-4-
methyl-3-oxohept-6-enoate (2.10).35 
 
C19H38O4Si2 
Mol. Wt. = 386.68 g/mol 
 
 
 
To a solution of 2.9 (1.73 g, 5.75 mmol) and 2-(trimethylsilyl)ethanol (8.24 mL, 57.5 mmol, 
10 equiv) in toluene (35 mL) was added ZnO (94 mg, 1.2 mmol, 0.20 equiv). The mixture 
was heated under reflux for 12 h, then the solvent was concentrated under vacuum and the 
crude material was purified by column chromatography (95:5 PE/EtOAc) to furnish the 
transesterification product 2.10 (2.0 g, 90%). 
 
1H NMR (CDCl3, 400 MHz) δ 5.74 (ddd, J = 17.1, 10.4, 6.5 Hz, 1H, H6), 5.18 (dt, J = 17.1, 
1.4 Hz, 1H, H7), 5.13 (dt, J = 10.4, 1.4 Hz, 1H, H7), 4.28–4.24 (m, 1H, H5), 4.23–4.18 (m, 
2H, H9), 3.57 (d, J = 15.8 Hz, 1H, H2), 3.49 (d, J = 15.8 Hz, 1H, H2), 2.87 (qd, J = 7.0, 5.4 
Hz, 1H, H4), 1.09 (d, J = 7.0 Hz, 3H, H8), 1.03–0.97 (m, 2H, H10), 0.90 (s, 9H, H15), 0.07 (s, 
3H, H13), 0.05 (s, 3H, H13’), 0.03 (s, 9H, H11). 
 
13C NMR (CDCl3, 101 MHz) δ 205.1 (C3), 167.7 (C1), 138.1 (C6), 116.4 (C7), 75.8 (C5), 63.6 
(C9), 53.0 (C4), 50.5 (C2), 26.0 (C15), 18.3 (C14), 17.5 (C10), 12.4 (C8), −1.4 (C11), −4.2 (C13), 
−4.9 (C13’). 
 
In agreement with literature data.35  
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(4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-methyl-2-(3 
(trimethylsilyl)propanoyl)cyclopent-2-en-1-one (2.11).35 
 
C21H40O4Si2 
Mol. Wt. = 412.72 g/mol 
 
 
 
To a stirred solution of titanium(IV) chloride (1.02 mL, 9.30 mmol, 1.8 equiv) in THF (25 mL) 
at 0 °C was added  freshly  distilled  acetaldehyde  (1.30 mL,  23.3  mmol,  4.50  equiv),  a  
solution of  2.10  (2.00 g, 5.20 mmol) in THF (25 mL), and pyridine (1.46 mL, 18.1 mmol,  
3.50 equiv). The reaction was allowed to warm up to RT and stirred for 3 h. The mixture 
was then  quenched  by  a  slow  addition  of  water  and  extracted  with  Et2O  (3  ×  10  
mL). The organic extracts were dried over magnesium sulfate,  filtered  and the solvent 
concentrated under vacuum. The  crude  material  was  then  purified  by  flash  
chromatography  (95:5  PE/EtOAc)  to furnish  the  product  2.11  as  a  colourless  oil  (2.05 
g,  96%) as an inseparable 1:1  mixture  of diastereomers. 
 
Only one of the diastereomer is described below: 
 
1H NMR (CDCl3, 400 MHz) δ 7.02 (q, J = 7.4 Hz, 1H, H9), 5.87–5.78 (m, 1H, H6), 5.17 (ddd, 
J = 7.8, 1.8, 1.2 Hz, 1H, H7), 5.10–5.06 (m, 1H, H7), 4.37–4.20 (m, 3H, H3/H11), 3.11 (quint, 
J = 6.9 Hz, 1H, H4), 1.98 (d, J = 7.4 Hz, 3H, H10), 1.15 (d, J = 6.9 Hz, 3H, H8), 1.05–1.00 (m, 
2H, H12), 0.88 (s, 9H, H16), 0.06 (s, 9H, H13), 0.04 (s, 3H, H14), 0.00 (s, 3H, H14’). 
 
13C NMR (CDCl3, 101 MHz)  δ 205.2 (C3), 166.7 (C1), 145.2 (C9), 139.5 (C2), 138.7 (C6), 
115.8 (C7), 75.6 (C5), 63.6 (C11), 52.5 (C4), 26.0 (C16), 18.3 (C15), 17.6 (C12), 15.9 (C10), 13.8 
(C8), −1.4 (C14), −4.0 (C14’). 
 
In agreement with literature data.35 
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2-(Trimethylsilyl)ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-2-
ethylidene-4-methyl-3-oxohept-6-enoate (1.147).35 
 
C18H34O4Si2 
Mol. Wt. = 370.20 g/mol 
 
 
 
Cyclic ketoester 1.147 (yellow oil) was obtained from the corresponding ketoester 2.11 
according to the procedure described above for cyclic keto-ester 1.148. 
Purification by flash column chromatography (95:5 PE/Et2O) 
Scale: 4.8 mmol 
Yield: 61%. 
 
1H NMR (CDCl3, 400 MHz) δ 7.91 (d, J = 2.1 Hz, 1H, H3), 4.50 (dd, J = 3.0, 2.1 Hz, 1H, H4), 
4.34 (td, J = 8.3, 1.5 Hz, 2H, H7), 2.44 (qd, J = 7.4, 3.0 Hz, 1H, H5), 1.25 (d, J = 7.4 Hz, 3H, 
H10), 1.13–1.04 (m, 2H, H8), 0.92 (s, 9H, H13), 0.16 (s, 3H, H11), 0.15 (s, 3H, H11’), 0.06 (s, 
9H, H9). 
 
 13C NMR (CDCl3, 101 MHz)  δ 201.0 (C1), 166.9 (C6), 162.0 (C3), 136.5 (C2), 76.4 (C4), 63.8 
(C7), 52.8 (C5), 25.8 (C13), 18.2 (C12), 17.6 (C8), 12.6 (C10), −1.4 (C9), −4.5 (C11/C11’). 
 
[α]D25 +113.2 (c = 1.0, CHCl3), literature [α]D25 +112.0 (c = 1.0, CHCl3). 
 
In agreement with literature data.35 
 
 
  
153 
 
2-(Trimethylsilyl)ethyl (1R,2R,3S,4R)-3-((tert-
butyldimethylsilyl)oxy)-2-((3aS,5R,6S,6aS)-2,2-dimethyl-4-oxo-6-
(prop-1-en-2-yl)tetrahydro-4H-cyclopenta[d][1,3]dioxol-5-yl)-4-
methyl-5-oxocyclopentane-1-carboxylate (2.21). 
 
C29H50O7Si2 
Mol. Wt. = 566.88 g/mol 
 
 
 
 
Bicycle 2.21 (yellow oil) was obtained from the corresponding cyclic keto-ester 1.147 and 
silyl enol ether 1.130 according to the procedure described above for bicycle 2.20. 
Purification by flash column chromatography (95:5 PE/Et2O) 
Scale: 0.81 mmol 
Yield: 35% as a 3:1 mixture of two diastereomers. 
 
Major diastereomer is described below: 
 
1H NMR (CDCl3, 500 MHz) δ 4.99 (t, J = 1.4 Hz, 1H, H15), 4.94 (s, 1H, H15), 4.60–4.52 (m, 
1H, H10), 4.43 (dd, J = 6.4, 3.0 Hz, 1H, H11), 4.28–4.13 (m, 2H, H18), 3.87 (t, J = 8.4 Hz, 1H, 
H4), 3.25 (d, J = 10.4 Hz, 1H, H2), 3.16 (ddd, J = 10.4, 8.4, 3.2 Hz, 1H, H3), 2.95 (ddd, J = 
10.0, 3.2, 1.6 Hz, 1H, H8), 2.84 (dd, J = 10.0, 3.0 Hz, 1H, H12), 2.42 (dq, J = 8.6, 7.0 Hz, 1H, 
H5), 1.86 (s, 3H, H14), 1.48 (s, 3H, H17), 1.33 (s, 3H, H17), 1.17 (d, J = 7.0 Hz, 3H, H6), 1.06–
0.97 (m, 2H, H19), 0.87 (s, 9H, H23), 0.09 (s, 3H, H21), 0.08 (s, 3H, H21’), 0.02 (s, 9H, H20). 
 
13C NMR (CDCl3, 126 MHz) δ 211.6 (C1 or C9), 208.5 (C1 or C9), 168.7 (C7), 143.8 (C13), 
114.0 (C15), 113.2 (C16), 80.4 (C10), 79.5 (C11), 77.3 (C4), 64.3 (C18), 56.7 (C2), 52.7 (C5), 
49.7 (C8), 49.4 (C12), 45.5 (C3), 26.8 (C17), 26.0 (C23), 25.3 (C17), 20.5 (C14), 18.2 (C22), 17.4 
(C19), 12.6 (C6), −1.4 (C20), −3.4 (C21), −3.7 (C21’). 
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IR (thin film) 2954, 2932, 2862, 1754, 1725, 1697, 1641, 1462, 1375, 1147, 1041 cm−1. 
 
HRMS (ESI) for C29H50NaO7Si2: 589.2987, found: 589.2966. 
 
2-(Trimethylsilyl)ethyl (1S,2R,3aR,5aS,5bS,8aS,9aS,9bR)-1-((tert-
butyldimethylsilyl)oxy)-2,7,7-trimethyl-5-methylene-3,9-
dioxodecahydro-as-indaceno[2,3-d][1,3]dioxole-3a(1H)-
carboxylate (1.149). 
 
C29H48O7Si2 
Mol. Wt. = 564.87 g/mol 
 
 
Tricycle 1.149 (colourless oil) was obtained from the corresponding bicyclic ketoester 
2.21/2.21’ according to the procedure described above for tricycle 1.150. 
Purification by flash column chromatography (95:5 PE/Et2O) 
Scale: 0.09 mmol 
Yield: 30% as a single diastereomer. 
 
1H NMR (CDCl3, 500 MHz) δ 5.07 (t, J = 1.8 Hz, 1H, H14), 5.04 (t, J = 1.8 Hz, 1H, H14), 4.79 
(t, J = 7.7 Hz, 1H, H11), 4.56 (d, J = 7.7 Hz, 1H, H10), 4.17–4.11 (m, 2H, H18), 4.09 (t, J = 1.6 
Hz, 1H, H4), 3.00 (t, J = 6.0 Hz, 1H, H3), 2.54–2.49 (m, 1H, H5), 2.49–2.43 (m, 2H, H15), 2.32 
(dd, J = 15.0, 7.7 Hz, 1H, H12), 1.62–1.57 (m, 1H, H8), 1.51 (s, 3H, H17), 1.36 (s, 3H, H17), 
1.10 (d, J = 8.0 Hz, 3H, H6), 0.99–0.93 (m, 2H, H19), 0.88 (s, 9H, H23), 0.18 (s, 3H, H21), 0.13 
(s, 3H, H21’), 0.01 (s, 9H, H20). 
 
13C NMR (CDCl3, 126 MHz) δ 212.4 (C1 or C9), 205.4 (C1 or C9), 171.9 (C7), 140.9 (C13), 
115.5 (C16), 108.9 (C14), 79.0 (C10), 76.5 (C4), 75.4 (C11), 64.5 (C18), 61.5 (C2), 53.0 (C8), 
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50.5 (C5), 49.8 (C12), 48.3 (C3), 36.8 (C15), 27.1 (C17), 25.9 (C23), 25.2 (C17), 18.0 (C22), 17.3 
(C19), 15.1 (C6), −1.4 (C20), −4.6 (C21), −4.9 (C21’). 
 
[α]D25 −56.4 (c = 1.0, CHCl3). 
 
IR (thin film) 2954, 2932, 2860, 1758, 1740, 1675, 1473, 1465, 1252, 1233, 1160, 1042 
cm−1. 
 
HRMS (ESI) for C29H49O7Si2: 565.3011, found: 565.3004. 
 
Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-8,9-dihydroxy-4-
methyl-3-oxononanoate (2.38).  
 
C18H36O6Si 
Mol. Wt. = 376.57 g/mol 
 
 
 
 
To a solution of 1.126 (0.17 g, 0.50 mmol)  in 10/1 acetone:water (5 mL) at RT were added 
2,6-lutidine (0.14 mL, 1.2 mmol, 2.5 equiv), NMO (0.12 g, 1.0 mmol, 2.0 equiv), and a 4% 
aqueous solution of osmium tetroxide (0.06 mL, 0.01 mmol, 0.02 equiv). After stirring for 2 
h, the reaction was quenched with saturated aqueous sodium thiosulfate (5 mL). The 
mixture was extracted with ethyl acetate (3 × 10 mL), washed with saturated aqueous 
copper sulfate (2 × 20 mL), dried over sodium sulfate, filtered and concentrated under 
vacuum. The crude residue was purified by flash column chromatography (80:20 PE/EtOAc) 
to give the product 2.38 as a colourless oil (0.12 g, 61%) as an inseparable 1:1 mixture of 
two diastereomers.  
 
Mixture of diastereomers is described below: 
 
1H NMR (CDCl3, 400 MHz) δ 4.16 (q, J = 7.1 Hz, 2H, H11), 3.95–3.85 (m, 1H, H5), 3.67–3.54 
(m, 4H, H2/H9), 3.40 (dd, J = 10.8, 7.4 Hz, 1H, H8), 2.89–2.79 (m, 1H, H4), 1.56–1.44 (m, 
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2H, H6/H7), 1.43–1.33 (m, 2H, H6/H7), 1.25 (t, J = 7.1 Hz, 3H, H12), 1.07 (dd, J = 7.0, 3.6 Hz, 
3H, H10), 0.91–0.83 (m, 9H, H15), 0.10–0.04 (m, 6H, H13/ H13’). 
 
13C NMR (CDCl3, 126 MHz) δ 205.7 (C3), 167.7 (C1a), 167.6 (C1b), 73.7 (C5a), 73.4 (C5b), 
72.2 (C8a), 72.0 (C8b), 66.7 (C9a), 66.6 (C9b), 61.3 (C11), 51.7 (C4), 49.4 (C2), 30.3 (C7a), 30.1 
(C7b), 28.8 (C14), 25.9 (C15), 18.1 (C6), 14.1 (C12), 12.3 (C10a), 12.1 (C10b), −4.4 (C13a), −4.4 
(C13b), −4.5 (C13a’), −4.5 (C13b’). 
 
IR (thin film) 3410, 3312, 2953, 2929, 2856, 1739, 1710, 1647, 1627, 1307, 1251, 1224, 
1186 cm−1. 
 
HRMS (ESI) for C18H36NaO6Si: 399.2173, found: 399.2177. 
 
Ethyl (3R,4S)-4-((tert-butyldimethylsilyl)oxy)-7-hydroxy-3-methyl-
2-oxocycloheptane-1-carboxylate (2.37). 
 
C17H32O5Si 
Mol. Wt. = 344.52 g/mol 
 
 
 
Ketoester 1.126 (0.1 g, 0.3 mmol) was dissolved in a 3:1 mixture of dioxane/water (8 mL), 
then 2,6-lutidine (60 μL, 0.60 mmol, 2.0 equiv), a 4% aqueous solution of OsO4 (50 μL, 6.0 
μmol, 0.020 equiv) and sodium periodate (0.25 g, 1.2 mmol, 4.0 equiv) were added. The 
reaction was stirred at RT for 12 h then the crude reaction was diluted with CH2Cl2 (5 mL) 
and water (5 mL). The aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The organic 
phases were combined, dried over sodium sulfate, filtered and concentrated under vacuum. 
The crude residue was purified by flash column chromatography (85:15 PE/EtOAc) to give 
the product 2.37 as a colourless oil (67 mg, 67%) and as an inseparable 7:3 mixture of two 
diastereomers. 
 
Major diastereomer is described below: 
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1H NMR (CDCl3, 500 MHz) δ 4.34 (s, 1H, H1), 4.31 (t, J = 3.2 Hz, 1H, H7), 4.27–4.15 (m, 2H, 
H9), 3.91 (dd, J = 6.9, 3.4 Hz, 1H, H4), 3.19 (s, 1H, OH), 2.60–2.52 (m, 1H, H3), 2.22–2.13 
(m, 1H, H6), 1.94–1.87 (m, 1H, H6), 1.75–1.66 (m, 1H, H5), 1.58–1.49 (m, 1H, H5), 1.27 (t, J 
= 7.2 Hz, 3H, H10), 1.13 (d, J = 7.3 Hz, 3H, H11), 0.92 (s, 9H, H14), 0.09 (s, 6H, H12/H12’). 
 
13C NMR (CDCl3, 126 MHz) δ 207.3 (C2), 172.0 (C8), 71.3 (C4), 67.6 (C7), 63.6 (C1), 61.4 
(C9), 54.3 (C3), 28.2 (C5), 25.9 (C14), 24.2 (C6), 18.1 (C13), 14.3 (C10), 14.1 (C11), −4.9 (C12), 
−5.0 (C12’). 
 
2-Iodocyclopent-2-enone.(2.57).100 
 
C5H5IO 
Mol. Wt. = 208.0 g/mol 
 
 
 
To a mixture of 2-cyclopentenone (0.5 mL, 6 mmol) and pyridine (2.5 mL, 33 mmol, 5.5 
equiv) in CH2Cl2 (10 mL) at 0 °C was added a solution of iodine (1.8 g, 6.6 mmol, 1.1 equiv) 
and pyridine (2.5 mL, 33 mmol, 5.5 equiv) in CH2Cl2 (10 mL).  The reaction was warmed to 
RT and stirred for an additional 4 h, then quenched with a 1 M aqueous solution of 
hydrochloric acid (20 mL). The aqueous phase was extracted with CH2Cl2 (3 × 20 mL), the 
organic phases were washed with a saturated aqueous solution of sodium sulfite (2 × 10 
mL), dried over magnesium sulfate, filtered then concentrated under vacuum. The product 
was then purified by flash chromatography (70:30 PE/Et2O) to furnish 2-iodocyclopent-2-
enone 2.57 as a white solid (0.85 g, 68%). 
 
Mp: 66–68 °C. lit. 71 °C 
 
1H NMR (CDCl3, 500 MHz,) δ 8.03 (t, J = 2.9 Hz, 1H, H3), 2.79 (ddd, J = 7.4, 2.9, 2.1 Hz, 
2H, H4), 2.58–2.42 (m, 2H, H5). 
 
13C NMR (CDCl3, 126 MHz) δ 203.9 (C1), 169.3 (C3), 102.8 (C2), 31.1 (C5), 30.8 (C4). 
 
In agreement with literature data.101 
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2-Bromocyclopent-2-enone (2.32).102 
 
C5H5BrO 
Mol. Wt. = 161.0 g/mol 
 
 
 
A solution of 2-cyclopentenone (0.84 mL, 10 mmol) in CH2Cl2 (20 mL) was cooled to 0 °C 
and a mixture of bromine (0.57 mL, 11 mmol, 1.1 equiv) and CH2Cl2 (10 mL) was slowly 
added. The reaction was warmed to RT and stirred for 1 h 30. Triethylamine (2.2 mL, 16 
mmol, 1.6 equiv) was then added and the mixture stirred for an additional 1 h 30. The 
reaction was quenched by addition of a 1 M aqueous solution of hydrochloric acid (20 mL) 
and the aqueous phase was extracted with Et2O (3 × 20 mL). The organic phases were 
combined, washed with brine (2 × 20 mL), dried over magnesium sulfate, filtered and 
concentatred under vacuum. The product was then purified by flash chromatography (90:10 
PE/Et2O) to furnish compound 2.32 as a brown oil (1.34 g, 82%). 
 
1H NMR (CDCl3, 500 MHz) δ 7.79 (t, J = 3.0 Hz, 1H, H3), 2.71 (ddd, J = 7.2, 3.0, 2.1 Hz, 2H, 
H4), 2.60–2.47 (m, 2H, H5). 
 
13C NMR (CDCl3, 126 MHz,) δ 202.1 (C1), 162.1 (C3), 126.7 (C2), 32.8 (C5), 28.4 (C4). 
 
In agreement with literature data.102 
 
2-(Trimethylstannyl)cyclopent-2-en-1-one (2.54).103  
 
C8H14OSn 
Mol. Wt. = 244.91 g/mol 
 
 
 
 
To a degassed mixture of 2-bromocyclopent-2-enone 2.32 (0.32 g, 2.0 mmol) and              
bis(trimethyltin) (1.2 mL, 4.0 mmol, 2.0 equiv) in benzene (15 mL) was added 
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tetrakis(triphenylphosphine)palladium(0) (0.11 g, 0.10 mmol, 0.05 equiv). The reaction was 
heated under reflux for 72 h, then diluted with Et2O (50 mL), filtered through a short pad of 
celite and concentrated under vacuum. The product was then purified by flash 
chromatography (95:5 PE/Et2O) to furnish compound 2.54 as a colourless oil (0.39 g, 79%). 
 
(The aqueous layer was diluted and the glassware was rinsed with a saturated aqueous 
solution of potassium fluoride to remove any traces of tin byproducts). 
 
1H NMR (CDCl3, 400 MHz) δ 7.80 (t, J = 2.5 Hz, JSn-H  =  31.7 Hz, 1H, H3), 2.79–2.70 (m, 2H, 
H4), 2.34–2.32 (m, 2H, H5), 0.25 (s, JSn-H = 56.5 Hz, 9H, SnMe3). 
 
13C NMR (CDCl3, 101 MHz) δ 215.0 (C1), 173.4 (C3), 148.8 (C2), 33.8 (C5), 31.8 (C4), -9.8 
(JSn-C = 352.5 Hz, SnMe3). 
 
In agreement with literature data.103  
 
tert-Butyldimethyl(pent-4-ynyloxy)silane (2.58).63 
 
C11H22OSi 
Mol. Wt. = 198.38 g/mol 
 
 
 
To a stirred solution of 4-pentyn-1-ol (0.33 mL, 3.5 mmol) in DMF (3 mL) was added 
imidazole (0.65 g, 4.3 mmol, 1.2 equiv). After all the solid was dissolved, TBSCl (0.59 g, 8.5 
mmol, 2.4 equiv) was added. The mixture was stirred at RT for 4 h then quenched by 
addition of water (3 mL). The aqueous phase was extracted with Et2O (3 × 5 mL). The 
organic phases were combined, washed with brine (2 × 5 mL), dried over magnesium 
sulfate and concentrated under vacuum to furnish TBS-protected alcohol 2.58 as a 
colourless oil (0.69 g, 100%).  
 
1H NMR (CDCl3, 400 MHz) δ 3.71 (t, J = 6.6 Hz, 2H, H1) 2.28 (td, J = 6.6, 2.8 Hz, 2H, H3) 
1.94 (t, J = 2.8 Hz, 1H, H5) 1.73 (quint, J = 6.6 Hz, 2H, H2) 0.90 (s, 9H, H8) 0.07 (s, 6H, 
H6/H6’). 
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13C NMR (CDCl3, 126 MHz) δ 84.3 (C4), 68.2 (C5), 61.4 (C1), 31.5 (C3), 25.9 (C8), 18.3 (C7), 
14.8 (C2), −5.4 (C6/C6’). 
 
In agreement with literature data.63 
 
Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-4-methyl-3-oxo-8-
(tributylstannyl)non-8-enoate (2.56).66 
 
C30H60O4SnSi 
Mol. Wt. = 631.60 g/mol 
 
 
 
To a solution of pentamethylcyclopentadienyltris (acetonitrile) ruthenium(II) 
hexafluorophosphate (36 mg, 0.07 mmol, 0.05 equiv) in CH2Cl2 (3.5 mL) was added 
dropwise a mixture of alkyne 2.36 (484 mg, 1.42 mmol) and tributyltin hydride (0.420 mL, 
1.56 mmol, 1.10 equiv) in CH2Cl2 (0.5 mL) over 15 min. The reaction was stirred at RT for 
2 h then filtered through a short plug of silica and concentrated under vacuum to give 
stannane 2.56 as a colourless oil. The crude product (430 mg) was used in the next step 
without further purification. 
 
1H NMR (CDCl3, 400 MHz) δ 5.69–5.66 (m, JSn-H = 136.0 Hz, 1H, H9), 5.12–5.08 (m, JSn-H = 
59.2 Hz, 1H, H9), 4.24–4.14 (m, 2H, H11), 3.94 (app q, J = 5.5 Hz, 1H, H5), 3.62 (d, J = 15.7 
Hz, 1H, H2), 3.54 (d, J = 15.8 Hz, 1H, H2), 2.84 (qd, J = 7.0, 3.8 Hz, 1H, H4), 2.31–2.04 (m, 
2H, H7), 1.61–1.38 (m, 8H, H6/SnBu3), 1.35–1.24 (m, 9H, H12/SnBu3), 1.10 (d, J = 7.0 Hz, 
3H, H10), 0.92–0.86 (m, 24H, H15/SnBu3), 0.04 (s, 3H, H13), −0.00 (s, 3H, H13’). 
 
13C NMR (CDCl3, 126 MHz) δ 205.0 (C3), 173.0 (C1), 154.7 (C8), 125.0 (C9), 73.2 (C5), 60.1 
(C11), 51.9 (C4), 49.6 (C2), 36.8 (C7), 34.4 (C6), 29.3 (CSnBu3), 27.6 (C SnBu3), 26.0 (C15), 18.3 
(C14), 14.3 (C12), 13.8 (C SnBu3), 11.5 (C10), 9.7 (C SnBu3), −4.2 (C13), −4.5 (C13’). 
 
HRMS (ESI) for C30H60NaO4SiSn: 655.3175, found: 655.3155. 
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Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-4-methyl-3-oxo-8-(5-
oxocyclopent-1-en-1-yl)non-8-enoate (2.52).69 
 
C23H38O5Si 
Mol. Wt. = 422.64 g/mol 
 
 
 
To a mixture of tetrabutylammonium diphenylphosphinate (1.25 g, 2.72 mmol, 4.00 equiv) 
in DMF (5 mL) was added a solution of stannane 2.56 (430 mg, 0.68 mmol) in DMF (10 mL) 
then 2-iodocyclopent-2-enone (184 mg, 0.88 mmol, 1.30 equiv). 
Tetrakis(triphenylphosphine)palladium(0) (235 mg, 0.200 mmol, 0.300 equiv) and CuTC 
(389 mg, 2.04 mmol, 3.00 equiv) were quickly added in the same time. The reaction was 
stirred for 1 h before being quenched with water (15 mL). The aqueous phase was extracted 
with Et2O (3 × 15 mL), the organic phases were combined, washed with a saturated 
aqueous solution of lithium chloride (2 × 10 mL), dried over magnesium sulfate, filtered and 
concentrated under vacuum. The product was then purified by flash chromatography (80:20 
PE/Et2O) to give product 2.52 with traces of triphenylphosphine as a pale yellow oil (205 
mg, 40% yield over 2 steps). 
 
1H NMR (CDCl3, 500 MHz,) δ 7.49 (t, J = 2.9 Hz, 1H, H14), 5.94 (m, 1H, H9), 5.14 (m, 1H, 
H9), 4.19 (q, J = 7.1 Hz, 2H, H15), 3.91 (dt, J = 7.1, 4.5 Hz, 1H, H5), 3.59 (s, 2H, H2), 2.87 
(qd, J = 7.0, 4.5 Hz, 1H, H4), 2.61 (m, 2H, H13), 2.52–2.46 (m, 2H, H12), 1.75–1.47 (m, 4H, 
H6/ H7), 1.27 (t, J = 7.1 Hz, 3H, H16), 1.09 (d, J = 7.0 Hz, 3H, H17), 0.92 (s, 9H, H20 ), 0.09 (s, 
3H, H18), 0.09 (s, 3H, H18’). 
 
13C NMR (CDCl3, 126 MHz) δ 205.2 (C3 or C11), 200.8 (C3 or C11), 168.5 (C1), 158.1 (C14), 
142.9 (C10), 138.2 (C8), 115.8 (C9), 73.6 (C5), 61.3 (C15), 51.9 (C4), 49.6 (C2), 36.0 (C12), 
32.8 (C6), 31.3 (C7), 30.5 (C13), 26.0 (C20), 18.2 (C19), 14.3 (C16), 12.1 (C17), −4.3 (C18/C18’). 
 
[α]D25 −24.8 (c = 0.50, CHCl3). 
 
IR (thin film): 2924, 2855, 1736, 1705, 1250, 1026 cm−1.  
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HRMS (ESI) for C23H38NaO5Si: 445.2381, found: 445.2363. 
 
Ethyl (4R,5S)-5-[(tert-butyldimethylsilyl)oxy]-4-methyl-3-oxo-2-(3-
oxocyclopentyl)non-8-enoate (2.27).35 
 
C23H40SiO5 
Mol. Wt. = 424.64 g/mol 
 
 
To a solution of 1.126 (0.51 g, 1.5 mmol, 1.1 equiv) and 2-cyclopentenone (0.11 mL, 1.3 
mmol) in ethanol (1 mL) was added potassium carbonate (80 mg, 0.50 mmol, 0.40 equiv). 
The mixture was left to stir overnight and then was diluted with water (5 mL) and Et2O (5 
mL). The two layers were separated and the aqueous layer extracted with Et2O (3 x 10 mL). 
The combined organic layers were dried over magnesium sulfate and concentrated under 
vacuum. The crude material was purified by column chromatography (90:10 PE:EtOAc) to 
furnish the product 2.27 as a colourless oil (0.49 g, 88%) as an unseperable mixture of 4 
diastereomers. 
 
Due to the presence of 4 diastereomers and for purpose of clarity, only the major ones are 
described below: 
 
1H NMR (CDCl3, 400 MHz) δ 5.68–5.56 (m, 1H, H8), 4.89–4.79 (m, 2H, H9), 4.12–4.06 (m, 
2H, H16), 3.75 (d, J = 7.6 Hz, 1H, H2), 3.64–3.56 (m, 1H, H5), 2.90–2.84 (m, 1H, H4), 2.80–
2.64 (m, 2H, H12/H14), 2.43–2.00 (m, 2H, H12/H14), 1.99–1.77 (m, 4H, H7/H15), 1.77–1.61 (m, 
1H, H11), 1.50–1.32 (m, 2H, H6), 1.17–1.10 (m, 3H, H17), 1.07–1.04 (m, 3H, H10), 0.82 (s, 
9H, H20), 0.05 (s, 3H, H18), −0.02 (s, 3H, H18’). 
 
In agreement with literature data.35  
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Ethyl (4R,5S)-2-(2’-bromo-3’-oxocyclopentyl)-5-((tert-
butyldimethylsilyl)oxy)-4-methyl-3-oxonon-8-enoate (2.33). 
 
C23H39BrO5Si 
Mol. Wt. = 503.5 g/mol 
 
 
 
Michael product 2.33 (yellow oil) was obtained from the corresponding ketoester 1.126 and 
bromoketone 2.32 according to the procedure described above for Michael product 2.27. 
Purification by flash column chromatography (90:10 PE/EtOAc). 
Scale: 1.1 mmol 
Yield: 61% as 8 inseparable diastereomers. 
 
Due to the presence of 4 diastereomers and for purpose of clarity, only the major ones are 
described below: 
 
1H NMR (CDCl3, 400 MHz) δ 5.88–5.70 (m, 1H, H8), 5.09–4.85 (m, 2H, H9), 4.33–4.12 (m, 
2H, H16), 4.02–3.93 (m, 1H, H12), 3.92–3.78 (m, 1H, H2), 3.70–3.55 (m, 1H, H5), 2.40−2.20 
(m, 2H, H4/H14) 2.19–1.97 (m, 3H, H14/H7/H11), 1.96–1.68 (m, 1H, H15) 1.67–1.41 (m, 1H, 
H7), 1.37–1.27 (m, 4H, H17/H15), 1.22–1.15 (m, 2H, H6) 1.12 (d, J = 6.9 Hz, 3H, H10), 0.93–
0.89 (m, 9H, H20), 0.14–0.03 (m, 6H, H18/ H18’). 
 
13C NMR (CDCl3, 126 MHz) δ 213.3, 173.6, 172.9, 164.8, 139.0, 138.8, 114.8, 114.1, 113.9, 
110.1, 109.9, 105.3, 104.8, 86.5, 83.2, 83.0, 82.8, 84, 73.7, 73.3, 73.0, 63.2, 61.9, 61.1, 
59.7, 59.4, 53.6, 51.0, 45.6, 43.5, 41.7, 40.9, 37.6, 35.3, 34.9, 34.5, 33.2, 33.1, 29.7, 28.4, 
28.2, 27.5, 27.4, 25.7, 25.6, 25.3, 25.1, 24.6, 23.8, 23.5, 20.8, 18.1 17.5, 17.3, 16.0, 15.8, 
15.0, 14.5, 14.1, 13.6, −2.8, −5.2. 
 
IR (thin film) 2955, 2931, 2856, 1755, 1703, 1631, 1462, 1371, 1241, 1224, 1101, 1026 
cm- 1 
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HRMS (CI) for C23H39O579BrSi: 503.1828, found: 503.1832. 
 
Ethyl (4R,5S)-2-(2-bromo-3-oxocyclopentyl)-5-((tert-
butyldimethylsilyl)oxy)-4-methyl-3-oxonon-8-ynoate (2.35). 
 
C23H37BrO5Si 
Mol. Wt. = 501.53 g/mol 
 
 
 
Michael product 2.35 (yellow oil) was obtained from the corresponding ketoester 2.36 
according to the procedure described above for Michael product 2.27. 
Purification by flash column chromatography (90:10 PE/EtOAc) 
Scale: 2.9 mmol 
Yield: 22% as an inseparable mixture of 8 diastereomers. 
 
Due to the presence of 8 diastereomers and for purpose of clarity, only the major ones are 
described below: 
 
1H NMR (CDCl3, 500 MHz) δ 4.33–4.09 (m, 2H, H16), 4.00–3.75 (m, 2H, H2/H12), 3.74–3.41 
(m, 1H, H5), 2.37–2.05 (m, 4H, H4/H14/H7), 2.01–1.84 (m, 2H, H11/H9), 1.80–1.59 (m, 3H, 
H6/H7), 1.34–1.24 (m, 3H, H17), 1.24–1.16 (m, 2H, H15), 1.14 (m, 3H, H10), 0.98–0.82 (m, 
9H, H20), 0.18– -0.02 (m, 6H, H18/H18’). 
 
13C NMR (CDCl3, 126 MHz) δ 213.4, 213.3, 210.5, 208.9, 208.6, 208.6, 205.9, 205.2, 173.2, 
172.5, 168.2, 167.4, 167.1, 165.4, 164.9, 164.9, 105.8, 105.3, 91.9, 84.9, 84.8, 84.0, 83.9, 
83.8, 83.7, 83.1, 82.9, 73.0, 72.5, 72.4, 70.6, 69.2, 68.8, 68.7, 68.2, 63.6, 62.4, 62.2, 62.0, 
61.9, 61.5, 60.0,  59.7, 53.9, 53.6, 53.4, 52.4, 52.0, 51.5, 51.3, 51.1, 50.9, 43.7, 43.5, 41.5, 
41.0, 40.9, 37.6, 35.0, 34.8, 34.6, 34.4, 32.6, 30.4, 29.8, 28.6, 26.1, 26.0, 25.9, 25.4, 25.3, 
18.3, 18.2, 15.8, 15.0, 14.9, 14.7, 14.5, 14.3, 14.2, 12.9, −4.1, −4.5. 
 
IR (thin film) 2955, 2933, 1728, 1709, 1373, 1249, 1226, 1217, 1097, 1030 cm-1. 
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HRMS (ESI) for C23H37NaO5Si79Br: 523.1486, found: 523.1479. 
 
Ethyl (4R,5S)-2-(2-bromo-3-oxocyclopentyl)-5-((tert-
butyldimethylsilyl)oxy)-4-methyl-3-oxo-9-(trimethylsilyl)non-8-
ynoate (2.43). 
 
C26H45BrO5Si2 
Mol. Wt. = 573.71 g/mol 
 
 
 
To a solution of 2.43 (0.10 g, 0.24 mmol, 1.1 equiv) and bromoketone 2.32 (0.34 g, 0.21 
mmol) in ethanol (2 mL) was added trifluoroethanol (0.15 mL, 0.21 mmol, 1.0 equiv) and 
potassium carbonate (12 mg, 84 μmol, 0.4 equiv). The mixture was left to stir overnight and 
then was diluted with water (10 mL) and Et2O (10 mL). The two layers were separated and 
the aqueous layer extracted with Et2O (3 x 10 mL). The combined organic layers were dried 
over magnesium sulfate, filtered and concentrated under vacuum. The crude material was 
purified by column chromatography (80:20 PE:Et2O) to furnish the product 2.43 as a 
colourless oil (0.10 g, 74%) and as an inseparable mixture of 8 diastereomers. 
 
Due to the presence of 8 diastereomers and for purpose of clarity, only the major ones are 
described below: 
 
1H NMR (CDCl3, 500 MHz) δ 4.29–4.16 (m, 2H, H16), 3.99–3.91 (m, 1H, H12), 3.90–3.85 (m, 
1H, H2), 3.57–3.50 (m, 1H, H5), 2.37–2.24 (m, 3H, H4/H14/H11), 2.23–2.12 (m, 2H, H14/H15), 
1.77–1.62 (m, 2H, H15/ H6), 1.49–1.44 (m, 4H, H6/ H17), 1.28 (m, 2H, H15), 1.14 (d, J = 6.9 
Hz, 3H, H10), 0.88 (d, J = 2.9 Hz, 9H, H20), 0.15–0.13 (m, 9H, HTMS), 0.13–0.11 (m, 6H, H18/ 
H18’). 
 
13C NMR (CDCl3, 126 MHz) δ 213.3, 213.2, 173.4, 172.5, 165.0, 164.9, 107.8, 107.7, 105.94, 
105.2, 84.5, 84.4, 83.1, 82.9, 72.8, 72.6, 56.0, 43.7, 43.6, 37.8, 37.6, 35.0, 34.7, 34.6, 34.4, 
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26.1, 26.1, 26.0, 26.0, 25.5, 25.2, 18.2, 18.2, 15.7, 15.3, 14.7, 14.6, 14.5, 0.3, 0.3, 0.2, 0.23, 
−4.1, −4.1, −4.5, −4.5. 
 
IR 2955, 2928, 2175, 1737, 1710, 1249, 1099, 1060 cm−1. 
 
Ethyl (4R,5S)-5-[(tert-butyldimethylsilyl)oxy]-4-methyl-3,8-dioxo-2-
(3-oxocyclopentyl) nonanoate (1.140). 35 
 
C23H40SiO6 
Mol. Wt. = 440.64 g/mol 
 
 
Palladium(II) chloride (17 mg, 0.097 mmol, 0.10 equiv) and CuCl (96 mg, 0.97 mmol, 1.0 
equiv) was added to a 3:1 mixture of DMF/ water (2.1 mL) and oxygen was bubbled through 
the solution for 1 h. A solution of 2.27 (0.41 g, 0.97 mmol) in DMF (0.8 mL) was added and 
the mixture was stirred overnight under an oxygen atmosphere. The mixture was then 
diluted with water and extracted with Et2O (3 x 10 mL) then filtered on celite. The combined 
organic layers were washed with brine (3 x 10 mL), dried over magnesium sulfate and 
concentrated under vacuum. The crude material was purified by column chromatography 
(80:20 PE/EtOAc) to furnish the product 1.140 as a colourless oil (0.33 g, 78%) as an 
inseparable mixture of 4 diastereomers. 
 
Due to the presence of 4 diastereomers and for purpose of clarity, only the major ones are 
described below: 
 
1H NMR (CDCl3, 400 MHz) δ 4.12–4.01 (m, 2H, H16), 3.71 (d, J = 9.5 Hz, 1H, H2), 3.66–3.60 
(m, 1H, H5), 2.89–2.82 (m, 1H, H4), 2.80–2.64 (m, 2H, H12/H14), 2.43–2.00 (m, 3H, 
H12/H14/H15), 1.99 (s, 3H, H9), 1.88–1.67 (m, 3H, H7/H15), 1.67–1.52 (m, 1H, H11), 1.51–1.31 
(m, 2H, H6), 1.17–1.10 (m, 3H, H17), 1.02–0.91 (m, 3H. H10), 0.79–0.74 (m, 9H, H20), –0.05 
(s, 3H, H18), –0.10 (s, 3H, H18’). 
 
In agreement with literature data.  
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 Ethyl (4R,5S)-2-(2-Bromo-3-oxocyclopentyl)-5-((tert-
butyldimethylsilyl)oxy)-4-methyl-3,8-dioxononanoate (2.31). 
 
C23H39BrO6Si 
Mol. Wt. = 519.25 g/mol 
 
 
 
 
Ketone 2.31 (colourless oil) was obtained from the corresponding Michael product 2.33 
according to the procedure described above for ketone 1.140. 
Purification by flash column chromatography (80:20 PE/EtOAc) 
Scale: 0.6 mmol 
Yield: 78% as a mixture of 8 inseparable diastereomers. 
 
Due to the presence of 8 diastereomers and for purpose of clarity, only the major ones are 
described below: 
 
1H NMR (CDCl3, 400 MHz) δ 4.28–4.05 (m, 2H, H16), 3.96–3.74 (m, 2H, H12/ H2), 3.69–3.45 
(m, 1H, H5), 2.61–2.35 (m, 1H, H4), 2.37–2.14 (m, 2H, H14), 2.14–2.06 (m, 2H, H7), 2.03–
1.92 (m, 3H, H9), 1.92–1.79 (m, 1H, H11), 1.80–1.62 (m, 2H, H6/H15), 1.60–1.45 (m, 2H, 
H7/H15), 1.33–1.23 (m, 3H, H17), 1.21 (d, J = 6.8 Hz, 3H, H10), 0.95–0.81 (m, 9H, H20), 0.12–
−0.04 (m, 6H, H18/H18’). 
 
13C NMR (126 MHz, CDCl3) δ 213.7, 213.2, 209.2, 173.5, 172.8, 165.0, 105.7, 105.1, 83.2, 
83.0, 73.3, 72.6, 72.3, 63.6, 62.1, 59.9, 59.6, 53.8, 51.4, 43.6, 43.4, 41.0, 39.4, 37.7, 37.5, 
37.2, 35.0, 34.6, 34.0, 32.0, 30.4, 30.1, 29.8, 29.5, 28.9, 28.3, 26.1, 25.4, 24.0, 23.7, 22.8, 
20.9, 20.7, 18.2, 17.5, 17.4, 17.3, 16.3, 15.8, 15.0 14.4, 14.1, 8.0, −3.9, −4.8, −4.9, −5.2. 
 
IR (thin film) 2955, 2931, 2856, 2360, 1755, 1742, 1703, 1371, 1251, 1224, 1163 cm-1. 
 
HRMS (ESI) for C23H39NaO6Si 79Br: 541.1591, found: 541.1583. 
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((2-Bromocyclopent-2-en-1-yl)oxy)triethylsilane (2.77). 
 
C11H21BrOSi 
Mol. Wt. = 277.28 g/mol 
 
 
 
A solution of 2-bromocyclopent-2-enone 2.32 (6.74 g, 41.9 mmol) in CH2Cl2 (250 mL) was 
cooled to −78 °C then a 1 M solution of diisobutylaluminium hydride in heptane (84 mL, 84 
mmol, 2.0 equiv) was added dropwise. The reaction was stirred at −78 °C for 1 h then was 
quenched by addition of a saturated aqueous solution of Rochelle salt (200 mL) and allowed 
to warm up to RT. The mixture was stirred for 4 h then the layers were separated. The 
aqueous layer was extracted with CH2Cl2 (3 × 250 mL), the organic layers were combined, 
dried over magnesium sulfate, filtered and concentrated under vacuum to furnish the crude 
allylic alcohol (6.8 g) as a colourless liquid that was used in the next step without further 
purification. 
 
2-Bromocyclopent-2-en-1-ol (6.80 g, 41.7 mmol) was dissolved in dry DMF (100 mL) then 
imidazole (8.52 g, 125 mmol, 3.00 equiv) and DMAP (0.51 g, 4.2 mmol, 0.10 equiv) were 
added. The reaction was cooled to 0 °C then chlorotriethylsilane (10.5 mL, 62.6 mmol, 3.00 
equiv) was added dropwise and the reaction was stirred for 5 min. The mixture was warmed 
to RT and stirred for 1 h. The mixture was then diluted with water (100 mL), the layers were 
separated and the aqueous layer was extracted with Et2O (3 × 100 mL). The combined 
organic extracts were washed with brine (2 × 300 mL), dried over magnesium sulfate, 
filtered and concentrated under vacuum. The crude was purified by flash chromatography 
(99:1 PE/Et2O) to give product 2.77 (8.9 g, 77% over 2 steps) as a yellow oil. 
 
1H NMR (CDCl3, 400 MHz) δ 6.02 (td, J = 2.5, 1.1 Hz, 1H, H2), 4.74–4.69 (m, 1H, H5), 2.51–
2.41 (m, 1H, H4), 2.35–2.26 (m, 1H, H3), 2.27–2.17 (m, 1H, H4), 1.82 (ddt, J = 12.6, 8.6, 4.4 
Hz, 1H, H3), 1.01 (t, J = 8.0 Hz, 9H, H7), 0.68 (t, J = 8.0 Hz, 6H, H6). 
 
13C NMR (CDCl3, 101MHz) δ 133.7 (C2), 125.7 (C1), 79.4 (C5), 33.4 (C3), 30.4 (C4), 7.0 (C7), 
5.0 (C6). 
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IR (thin film) 2955, 2878, 1096, 1003 cm−1. 
 
HRMS (ESI) for C21H2179BrNaOSi: 299.0437, found: 299.0431. 
 
1-(5-((Triethylsilyl)oxy)cyclopent-1-en-1-yl)cyclohexan-1-ol (2.78). 
 
C17H32O2Si 
Mol. Wt. = 296.53 g/mol 
 
 
 
Cerium(III) chloride heptahydrate (7.52 g, 20.2 mmol, 2.20 equiv) was finely grinded then 
stirred under vacuum (P < 1 mbar) and warmed to 120 °C for 2 h, 140 °C for 2 h and 160 °C 
for 3 h. Cerium(III) chloride was cooled to RT under inert atmosphere then THF (25 mL) 
was added and the white suspension was stirred vigorously overnight. 
((2-Bromocyclopent-2-en-1-yl)oxy)triethylsilane 2.77 (5.10 g, 18.3 mmol, 2.00 equiv) was 
dissolved in THF (15 mL), the mixture was cooled to −78 °C and a 2.2 M solution of n-BuLi 
in hexane (8.90 mL, 19.3 mmol, 2.10 equiv) was added. The mixture was stirred for 20 min 
at −78 °C then was added dropwise to the cerium(III) chloride white suspension at −78 °C. 
The red/brown slurry was stirred for 1 h then cyclohexanone (0.95 mL, 9.2 mmol) in THF 
(10 mL) was added dropwise (over 30 min). The mixture was stirred at −78 °C for 4 h then 
quenched with water (50 mL) and allowed to warm up to RT. The layers were separated, 
the aqueous layer was extracted with Et2O (3 × 50 mL), the organic layers were combined, 
dried over magnesium sulfate, filtered and concentrated under vacuum. The crude was 
purified by flash chromatography (95:5 PE/Et2O) to yield product 2.78 (1.96 g, 72%) as a 
colourless oil. 
 
1H NMR (CDCl3, 500 MHz) δ 5.73 (t, J = 3.0 Hz, 1H, H2), 5.10 (td, J = 7.0, 1.7 Hz, 1H, H5), 
4.01 (s, 1H, OH), 2.46–2.35 (m, 1H, H3), 2.30–2.25 (m, 1H, H4), 2.25–2.17 (m, 1H, H3), 
1.80–1.67 (m, 6H, H4/H7/H9), 1.62–1.47 (m, 5H, H8/H9), 0.99 (t, J = 7.9 Hz, 9H, H11), 0.66 
(q, J = 7.9 Hz, 6H, H10). 
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13C NMR (CDCl3, 126 MHz) δ 149.1 (C1), 126.9 (C2), 79.0 (C5), 71.0 (C6), 36.4 (C7), 34.5 
(C4), 29.4 (C3), 26.0 (C8), 22.3 (C9), 6.8 (C11), 5.0 (C10). 
 
IR (thin film) 3503, 2932, 2878, 1065, 1003 cm−1. 
 
HRMS (ESI) for C17H32NaO2Si: 319.2064, found: 319.2062. 
 
2-(1-Hydroxycyclohexyl)cyclopent-2-en-1-one (2.79). 
 
C11H16O2 
Mol. Wt. = 180.25 g/mol 
 
 
 
A solution of 2.78 (1.93 g, 6.51 mmol) in THF (30 mL) in a high-density polyethylene vessel 
was cooled to 0 °C and pyridine (10.5 mL, 130 mmol, 20 equiv) was added. The mixture 
was stirred for 10 min followed by addition of HF.pyridine (5.90 mL, 65.1 mmol, 10 equiv). 
The reaction was stirred at 0 °C for 1 h then was quenched by careful addition of a saturated 
aqueous solution of sodium bicarbonate (30 mL) and allowed to warm up to RT. The layers 
were separated and the aqueous layer was extracted with EtOAc (5 x 30 mL). The organic 
layers were combined, dried over sodium sulfate, filtered and concentrated under vacuum 
to give the crude diol (1.19 g) as a colourless oil. The crude product was used in the next 
step without further purification. (The aqueous layer was diluted and the glassware was 
rinsed with a saturated aqueous solution of calcium(II) chloride to remove any traces of HF). 
 
Crude diol (1.19 g, 6.53 mmol) was dissolved in CH2Cl2 (25 mL) and was added to a flask 
containing both the 4Å molecular sieves and NMO (1.53 g, 13.1 mmol, 2.00 equiv) in CH2Cl2 
(25 mL). After stirring the mixture for 10 min, TPAP (0.23 g, 0.65 mmol, 0.10 equiv) was 
added and the reaction was stirred at RT for 1 h. The reaction was then filtered through a 
short pad of celite and the solvent removed under vacuum. The crude mixture was purified 
by flash chromatography (70:30 PE/Et2O) to give enone 2.79 (0.88 g, 75% over 2 steps) as 
a colourless oil. 
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1H NMR (CDCl3, 500 MHz) δ 7.40 (t, J = 2.8 Hz, 1H, H3), 3.55 (s, 1H, OH), 2.61–2.54 (m, 
2H, H4), 2.46–2.42 (m, 2H, H5), 1.83–1.77 (m, 2H, H7), 1.73 (tt, J = 12.3, 3.5 Hz, 2H, H8), 
1.68–1.64 (m, 1H, H9), 1.60 (td, J = 12.3, 3.7 Hz, 2H, H7), 1.51 (dt, J = 12.9, 3.7 Hz, 2H, 
H8), 1.29–1.19 (m, 1H, H9). 
 
13C NMR (CDCl3, 126 MHz) δ 211.0 (C1), 156.7 (C3), 151.3 (C2), 70.6 (C6), 36.4 (C7), 35.7 
(C5), 26.2 (C4), 25.7 (C9), 21.5 (C8). 
 
IR (thin film) 3487, 2932, 2855, 1674, 1312 cm−1. 
 
HRMS (ESI) for C11H16NaO2: 203.1043, found: 203.1040. 
 
Ethyl 2-(2-cyclohexylidene-3-oxocyclopentyl)-3-oxobutanoate 
(2.82).  
 
C17H24O4 
Mol. Wt. = 292.38 g/mol 
 
 
 
To a mixture of enone 2.79 (50 mg, 0.28 mmol), benzil (58 mg, 0.28 mmol, 1.0 equiv) and 
indium(III) chloride (3.1 mg, 0.014 mmol, 0.050 equiv) in CH2Cl2 (1 mL) was added 
dimethylchlorosilane (34 µL, 0.31 mmol, 1.10 equiv). After 15 min the reaction was 
quenched with a saturated aqueous solution of sodium bicarbonate (1 mL), the layers were 
separated and the aqueous layer was extracted with EtOAc (3 × 5 mL). The combined 
extracts were dried over sodium sulfate, filtered and concentrated under vacuum to furnish 
a mixture of the unstable chloro product 2.81 (55 mg) and benzil (58 mg) as a yellow oil that 
was used in the next step without further purification. 
 
To a solution of 2.81 and benzil (55 and 58 mg) in THF (1 mL) was added 
tetrakis(triphenylphosphine)palladium(0) (32 mg, 0.028 mmol, 0.10 equiv) and the mixture 
was stirred at RT for 30 min. Ethyl acetoacetate (35 µL, 0.28 mmol, 1.0 equiv) in THF (1 
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mL) was cooled to 0 °C then sodium hydride (11 mg, 0.28 mmol, 1.0 equiv) was added to 
the solution. The solution was stirred for 15 min then was added dropwise to the previous 
mixture (2.81/Palladium). The reaction was stirred at RT for 5 min then was quenched with 
water (2 mL). The layers were separated, the aqueous phase was extracted Et2O (3 × 5 
mL). The combined organic layers were dried over magnesium sulfate, filtered and 
concentrated under vacuum. The mixture was purified by flash chromatography (70:30 
PE/Et2O) to yield product 2.82 (31 mg, 40% over 2 steps) as a colourless oil. 
 
1H NMR (CDCl3, 500 MHz) δ 4.19–4.05 (m, 2H, H14), 3.81 (dt, J = 13.2, 7.8 Hz, 1H, H5), 3.54 
(d, J =  7.8 Hz, 1H, H2), 3.07 (dt, J = 13.2, 5.4 Hz, 2H, H11), 2.98–2.81 (m, 2H, H8), 2.74–
2.66 (m, 1H, H11), 2.39–2.23 (m, 3H, H11/H12), 2.22 (s, 3H, H4), 2.18–2.12 (m, 1H, H9), 2.07–
1.94 (m, 1H, H9), 1.91–1.83 (m, 1H, H13), 1.69–1.59 (m, 2H, H12), 1.59–1.50 (m, 1H, H13), 
1.26–1.20 (m, 3H, H15). 
 
13C NMR (CDCl3, 126 MHz) δ 207.6 (C3 or C7), 202.7 (C3 or C7), 169.1 (C1), 157.2 (C10), 
129.8 (C6), 62.1 (C14), 61.7 (C2), 39.5 (C8), 37.4 (C5), 34.0 (C11), 31.1 (C4), 30.8 (C5), 30.4 
(C11), 29.0 (C12), 28.4 (C12), 26.3 (C13), 14.2 (C15). 
 
IR (thin film) 2931, 1705, 1620, 1172 cm−1. 
 
HRMS (ESI) for C17H24NaO4: 315.1567, found: 315.1556. 
 
2-(1-Hydroxyhex-5-en-1-yl)cyclopent-2-en-1-one (2.68).73 
 
C11H16O2 
Mol. Wt. = 180.25 g/mol 
 
 
 
2-Cyclopenten-1-one (0.10 mL, 1.2 mmol) and hex-5-en-1-al 2.67 (0.24 g, 2.4 mmol, 2.0 
equiv) were dissolved in a 3:2 mixture of CHCl3/MeOH (2.5 mL). Dimethylphenylphosphine 
(17 µL, 0.12 mmol, 0.10 equiv) was added dropwise and the reaction was stirred for 2 h at 
RT. The solvents were concentrated under vacuum and the resulting crude product was 
purified by flash chromatography (70:30 PE/Et2O) to furnish product 2.68 (0.21 g, 94%) as 
a colourless oil. 
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1H NMR (CDCl3, 500 MHz) δ 7.44 (td, J = 2.7, 1.1 Hz, 1H, H3), 5.80 (ddt, J = 17.1, 10.1, 6.7 
Hz, 1H, H10), 5.01 (dq, J = 17.1, 1.7 Hz, 1H, H11), 4.96 (ddt, J = 10.1, 1.7, 1.1 Hz, 1H, H11), 
4.48–4.42 (m, 1H, H6), 2.77 (d, J = 5.6 Hz, 1H, OH), 2.64–2.59 (m, 2H, H4), 2.47–2.43 (m, 
2H, H5), 2.12–2.05 (m, 2H, H9), 1.74–1.65 (m, 2H, H7), 1.62–1.56 (m, 1H, H8), 1.49–1.41 
(m, 1H, H8). 
 
13C NMR (CDCl3, 126 MHz) δ 210.2 (C1), 157.9 (C3), 147.9 (C2), 138.7 (C10), 114.9 (C11), 
67.9 (C6), 35.5 (C4), 35.4 (C5), 33.6 (C9), 26.8 (C8), 24.9 (C7). 
 
In agreement with literature data.104 
 
2-(1-Chlorohex-5-en-1-yl)cyclopent-2-en-1-one (2.65). 
 
C11H15ClO 
Mol. Wt. = 198.69 g/mol 
 
 
 
To a solution of 2.68 (100 mg, 0.55 mmol) in CH2Cl2 (3 mL) was added triethylamine 
(115  µL, 0.830 mmol, 1.50 equiv) and methanesulfonyl chloride (65 µL, 0.83 mmol, 
1.5  equiv). The mixture was stirred at RT for 2 h then was quenched by addition of water 
(3 mL) and the layers were separated. The organic layer was washed with brine (2 × 5 mL), 
dried over sodium sulfate, filtered and concentrated under vacuum to give the unstable 
chlorocyclopentenone 2.65 (75 mg) that was used in the next step without further 
purification. 
 
1H NMR (CDCl3, 500 MHz) δ 7.66 (td, J = 2.7, 1.1 Hz, 1H, H3), 5.78 (ddt, J = 17.1, 10.2, 6.6 
Hz, 1H, H10), 5.02 (dq, J = 17.1, 1.7 Hz, 1H, H11), 4.97 (dt, J = 10.2, 1.7 Hz, 1H, H11), 4.68 
(ddt, J = 7.4, 3.0, 1.3 Hz, 1H, H6), 2.67–2.62 (m, 2H, H4), 2.50–2.47 (m, 2H, H5), 2.15–2.02 
(m, 2H, H9), 2.00–1.91 (m, 1H, H7), 1.91–1.83 (m, 1H, H7) 1.65–1.56 (m, 1H, H8), 1.54–1.46 
(m, 1H, H8). 
 
IR (thin film) 3055, 2932, 2862, 1705, 1643 cm−1. 
 
HRMS (CI+) for C11H16ClO: 199.0884, found: 199.0890. 
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Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-2-((E)-2’-(hex-5’-en-
1’-ylidene)-3-oxocyclopentyl)-4,8-dimethyl-3-oxonon-8-enoate 
(2.63). 
 
C30H50O5Si 
Mol. Wt. = 518.81 g/mol 
 
 
To a solution of chlorocyclopentenone 2.65 (254 mg, 1.27 mmol) in THF (5 mL) was added 
tetrakis(triphenylphosphine)palladium(0) (162 mg, 0.140 mmol, 0.11 equiv) and the reaction 
was stirred for 20 min at RT. In parallel, sodium hydride (59.0 mg, 1.47 mmol, 1.05 equiv) 
was added to a solution of ketoester 2.64 (500 mg, 1.40 mmol, 1.10 equiv) in THF (5 mL) 
and the mixture was stirred for 10 min before dropwise addition to the 
palladium/chlorocyclopentenone mixture. The reaction was stirred for 5 min then was 
quenched by addition of a 1 M aqueous solution of hydrochloric acid (10 mL). The layers 
were separated and the aqueous layer was extracted with Et2O (3 × 15 mL), the organic 
phases were combined, dried over magnesium sulfate, filtered and concentrated under 
vacuum. The mixture was purified by flash chromatography (90:10 PE/Et2O) to yield product 
2.63 (458 mg, 69%) as yellow oil and as an inseparable mixture of 4 diastereomers. 
 
Due to the presence of 4 diastereomers and for purpose of clarity, only the major ones are 
described below: 
 
1H NMR (CDCl3, 400 MHz) δ 6.54 (t, J = 6.8 Hz, 1H, H16), 5.84–5.71 (m, 1H, H20), 5.05–
4.94 (m, 2H, H21), 4.72–4.64 (m, 1H, H9), 4.64 (d, J = 1.0 Hz, 1H, H9), 4.18–4.07 (m, 2H, 
H23), 4.02 (d, J = 5.1 Hz, 1H, H2), 3.97–3.90 (m, 1H, H5), 3.73–3.64 (m, 1H, H11), 2.87 (qd, 
J = 7.0, 4.1 Hz, 1H, H4), 2.51–2.38 (m, 1H, H14), 2.33–2.22 (m, 1H, H14), 2.21–2.12 (m, 2H, 
H17), 2.12–2.02 (m, 3H, H15/H19), 2.02–1.93 (m, 3H, H7/H15), 1.70 (s, 3H, H10), 1.64–1.45 (m, 
4H, H6/H18), 1.27–1.19 (m, 3H, H24), 1.09 (d, J = 7.0 Hz, 3H, H22), 0.89 (s, 9H, H27), 0.07 (s, 
3H, H25), 0.04 (s, 3H, H25’). 
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13C NMR (CDCl3, 126 MHz) δ 206.5 (C3 or C13), 206.3 (C3 or C13), 168.3 (C1), 145.5 (C8 or 
C12), 139.0 (C8 or C12), 138.5 (C16), 138.1 (C20), 115.4 (C21), 110.1 (C9), 72.7 (C5), 61.6 (C2), 
60.7 (C23), 52.1 (C4), 38.1 (C11), 35.7 (C14), 34.1 (C19), 33.4 (C6) 33.1 (C7), 28.9 (C17), 28.0 
(C18), 26.1 (C27), 23.1 (C15), 22.7 (C10), 18.3 (C26), 14.2 (C24), 13.1 (C22),  −4.2 (C25), −4.4 
(C25’). 
 
IR (thin film) 2940, 2862, 1736, 1643, 845 cm−1. 
 
HRMS (CI+) for C30H51O5Si: 519.3500, found: 519.3506. 
 
Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-2’-((E)-2-(hex-5’-en-
1’-ylidene)-3-hydroxycyclopentyl)-4,8-dimethyl-3-oxonon-8-enoate 
(2.75). 
 
C30H52O5Si 
Mol. Wt. = 520.83 g/mol 
 
 
Ketone 2.63 (170 mg, 0.330 mmol) and cerium(III) chloride heptahydrate (240 mg, 0.640 
mmol, 2.00 equiv) were dissolved in ethanol (2.5 mL) and cooled to 0 °C. The mixture was 
stirred for 1 h at 0 °C then cooled to −78 °C before addition of sodium borohydride (14 mg, 
0.36 mmol, 1.1 equiv). The reaction was left to stir at −78 °C for 1 h, 0 °C for 1 h and RT for 
2 h. The crude mixture was diluted with a saturated aqueous solution of ammonium chloride 
(2.5 mL), the layers were separated and the aqueous layer was extracted with Et2O (3 × 5 
mL). The combined organic layers were dried over magnesium sulfate, filtered and 
concentrated under vacuum. The crude product was purifed by flash chromatography 
(70:30 PE/Et2O) to give allylic alcohol 2.75 (111 mg, 66%) as a colourless oil and as a 
mixture of 8 diastereomers. 
 
Due to the presence of 8 diastereomers and for purpose of clarity, only the major ones are 
described below: 
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1H NMR (CDCl3, 500 MHz) δ 5.79 (ddt, J = 16.9, 10.1, 6.7 Hz, 1H, H20), 5.71–5.63 (m, 1H, 
H16), 5.00 (dq, J = 16.9, 1.9 Hz, 1H, H21), 4.98–4.93 (m, 1H, H21), 4.68 (s, 1H, H9), 4.64 (s, 
1H, H9), 4.33–4.26 (m, 1H, H13), 4.23 (d, J = 5.4 Hz, 1H, H2), 4.19–4.12 (m, 2H, H23), 3.98–
3.89 (m, 1H, H5), 3.62 (s, 1H, OH), 3.18–3.08 (m, 1H, H11), 2.96–2.88 (m, 1H, H4), 2.13–
1.97 (m, 7H, H7/ H15/H17/ H19), 1.91–1.79 (m, 3H, H14/H15), 1.73 (s, 3H, H10), 1.69–1.59 (m, 
2H, H6), 1.51–1.43 (m, 2H, H18), 1.27–1.19 (m, 3H, H24), 1.09 (d, J = 6.9 Hz, 3H, H22), 0.90 
(s, 9H, H27), 0.09 (s, 3H, H25), 0.08 (s, 3H, H25’). 
 
13C NMR (CDCl3, 126 MHz) δ 206.8 (C3), 170.3 (C1), 145.4 (C8 or C12), 145.0 (C8 or C12), 
138.5 (C20), 129.2 (C16), 115.0 (C21), 110.2 (C9), 77.7 (C13), 73.3 (C5), 61.5 (C24), 60.5 (C2), 
50.8 (C4), 38.6 (C11), 34.4 (C19), 33.5 (C7), 33.4 (C6), 33.2 (C14), 28.7 (C18), 28.6 (C17), 27.0 
(C15), 26.1 (C27), 22.7 (C10), 18.32 (C26), 14.2 (C24), 12.5 (C22), −4.0 (C25), −4.1 (C25’). 
 
IR (thin film) 2932, 2855, 1736, 1643, 833 cm−1. 
 
HRMS (ESI) for C30H52NaO5Si: 543.3476, found: 543.3449. 
 
Ethyl (6R,7S,15E)-7-((tert-butyldimethylsilyl)oxy)-6,10-dimethyl-
1,5-dioxo-2,3,3a,4,5,6,7,8,9,12,13,14-dodecahydro-1H-
cyclopenta[14]annulene-4-carboxylate (2.73). 
 
C28H46O5Si 
Mol. Wt. = 490.76 g/mol 
 
 
To a degassed solution of Hoveyda-Grubbs catalyst (7.0 mg, 11 µmol, 0.10 equiv) in toluene 
(1 mL) was added dropwise (over 3 h) a mixture of product 2.63 (59 mg, 0.11 mmol) in 
toluene (3 mL) at 110 °C. After addition, the solvent was concentrated under vacuum and 
the crude was purified by flash chromatography (95:5 PE/Et2O) to give product 2.73  (15 
mg, 28%) as a brown oil and as a mixture of 8 diastereomers (Ratio E/Z was 73/27). 
 
Mixture of E diastereomers is described below: 
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1H NMR (CDCl3, 500 MHz) δ 6.65 (td, J = 9.0, 2.3 Hz, 1H, H15), 5.38 (t, J = 7.4 Hz, 1H, H11), 
4.23 (ddd, J = 8.6, 4.3, 3.0 Hz, 1H, H7), 4.12 (d, J = 3.9 Hz, 1H, H4), 4.02 (q, J = 7.2 Hz, 2H, 
OCH2CH3), 3.41–3.35 (m, 1H, H3), 2.83 (qd, J = 6.6, 3.0 Hz, 1H, H6), 2.73 (ddd, J = 19.1, 
10.7, 8.0 Hz, 1H, H16), 2.73–2.69 (m, 1H, H16) 2.36 (ddt, J = 13.8, 10.7, 3.2 Hz, 1H, H17), 
2.31–2.23 (m, 2H, H9/ H12), 2.21–2.16 (m, 2H, H14), 2.12 (ddd, J = 14.6, 10.5, 3.9 Hz, 1H, 
H9), 2.06–1.95 (m, 1H, H12), 1.91–1.82 (m, 2H, H8/ H17), 1.74–1.69 (m, 1H, H8), 1.68 (s, 3H, 
H19), 1.66–1.59 (m, 1H, H13), 1.53–1.47 (m, 1H, H13), 1.17 (t, J = 7.2 Hz, 3H, OCH2CH3), 
1.06 (d, J = 6.6 Hz, 3H, H18), 0.84 (s, 9H, H22), 0.07 (s, 3H, H20), −0.01 (s, 3H, H20’).  
 
13C NMR (CDCl3, 126 MHz) δ 207.2 (C5), 205.4 (C1), 167.9 (C(O)OEt), 139.1 (C2), 137.5 
(C15), 136.1 (C10), 125.6 (C11), 70.4 (C7), 61.2 (OCH2CH3), 59.4 (C4), 49.1 (C6), 37.2 (C3), 
36.9 (C16), 35.4 (C9), 31.7 (C8), 28.9 (C13), 28.0 (C14), 26.7 (C12), 25.9 (C22), 19.9 (C17), 18.2 
(C21), 15.5 (C19), 14.2 (OCH2CH3), 8.4 (C18), −3.5 (C20), −4.83 (C20’). 
 
IR (thin film) 2932, 2855, 1736, 1643, 1713, 833 cm−1. 
 
HRMS (ESI) for C28H46NaO5Si: 513.3007, found: 513.2889. 
 
Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-4-methyl-3,8-
dioxononanoate (2.28).  
 
C18H34O5Si 
Mol. Wt. = 358.55 g/mol 
 
 
Method 1: 
 
A solution of 1.140 (0.353 g, 0.800 mmol) and freshly distilled triethylamine (0.16 mL, 1.2 
mmol 1.5 equiv) in CH2Cl2 (2 mL) was cooled to −78 °C and stirred for 5 min. Triethylsilyl 
trifluoromethanesulfonate (0.23 mL, 1.0 mmol, 1.3 equiv) was added dropwise. The mixture 
was stirred at −78 °C for 1 h then at room temperature for 1 h. The reaction was quenched 
with a saturated solution of sodium bicarbonate then extracted with pentane (10 mL). The 
organic layer was dried over Na2SO4, concentrated under vacuum to give silyl enol ether 
1.145 as a colourless oil that was used in the next step without further purification. 
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The crude mixture was then dissolved in a 1:1 mixture of THF/EtOH (5 mL) and potassium 
hydroxide (45 mg, 0.80 mmol, 1.0 equiv) was added. The reaction was stirred at RT for 2 h 
then was quenched by addition of a 1 M aqueous solution of hydrochloric acid (5 mL) and 
extracted with Et2O (3 × 5 mL). The organic layers were combined, dried over magnesium 
sulfate, filtered and concentrated under vacuum. The crude was purified by column 
chromatography (70:30 PE/Et2O) to furnish the product 2.28 as a colourless oil (115 mg, 
40%). 
 
Method 2:55 
 
To a solution of compound 2.64 (1.78 g, 5.04 mmol) in a 5:1 mixture of dioxane/water (70 
mL) were added 2,6-lutidine (1.18 mL, 10.1 mmol, 2.00 equiv), OsO4 (2.5wt% in tert-
butanol, 1.1 mL, 0.10 mmol, 0.020 equiv), and sodium periodate (4.31 g, 20.1 mmol, 4.00 
equiv). The reaction was stirred at RT for 4 h. After the reaction was complete, water (80 
mL) and CH2Cl2 (150 mL) were added. The layers were separated, and the aqueous layer 
was extracted with CH2Cl2 (3 × 70 mL). The combined organic layers were washed with 
brine (250 mL), dried over magnesium sulfate, filtered and concentrated under vacuum. The 
crude product was purified by column chromatography (70:30 PE/Et2O) to afford ketone 
2.38 (1.57 g, 87%) as a colourless oil. 
(The aqueous layer was diluted and the glassware rinsed with a saturated solution of 
sodium sulfite to quench any traces of osmium tetroxide). 
 
1H NMR (CDCl3, 500 MHz) δ 4.17 (q, J = 7.2 Hz, 2H, H11), 3.91 (td, J = 7.2, 4.7 Hz, 1H, H5), 
3.56 (s, 2H, H2), 2.80 (qd, J = 7.0, 4.7 Hz, 1H, H4), 2.55–2.38 (m, 2H, H7), 2.12 (s, 3H, H9), 
1.84–1.72 (m, 1H, H6), 1.62–1.50 (m, 1H, H6), 1.26 (t, J = 7.2 Hz, 3H, H12), 1.09 (d, J = 7.0 
Hz, 3H, H10), 0.89 (s, 9H, H15), 0.07 (s, 3H, H13), 0.06 (s, 3H, H13’). 
 
13C NMR (CDCl3, 126 MHz) δ 208.2 (C3 or C8), 205.2 (C3 or C8), 167.5 (C1), 72.7 (C5), 61.3 
(C11), 51.9 (C4), 49.6 (C2), 39.3 (C7), 30.0 (C9), 27.9 (C6), 26.0 (C15), 18.1 (C14), 14.2 (C12), 
12.3 (C10), −4.3 (C13), −4.5 (C13’). 
 
[α]D25 −44.0 (c = 1.0, CHCl3). 
 
IR (thin film) 2932, 1744, 1713, 1636 cm−1. 
 
HRMS (ESI) for C18H34NaO5Si: 381.2068, found: 381.2051.  
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Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-8-hydroxy-4-methyl-
3-oxo-8-(5’-((triethylsilyl)oxy)cyclopent-1’-en-1’-yl)nonanoate 
(2.76). 
 
C29H56O6Si2 
Mol. Wt. = 556.93 g/mol 
 
 
Alcohol 2.76 (colourless oil) was obtained from the corresponding ketoester 2.28 and bromo 
compound 2.77 according to the procedure described above for alcohol 2.78. 
Purification by flash column chromatography (90:10 PE/EtOAc) 
Scale: 1.39 mmol 
Yield: 62% as an inseparable mixture of 4 diastereomers. 
 
Mixture of diastereomers is described below: 
 
1H NMR (CDCl3, 500 MHz) δ 5.71–5.67 (m, 0.4H, H13a/ H13b), 5.63–5.58 (m, 0.6H, H13c/ 
H13d), 5.12–5.03 (m, 0.6H, H10c/ H10d), 5.03–4.99 (m, 0.4H, H10a/ H10b), 4.23–4.14 (m, 2H, 
H16), 4.00–3.85 (m, 1H, H5), 3.63–3.52 (m, 2H, H2), 2.86–2.80 (m, 0.6H, H4c/ H4d), 2.79–
2.73 (m, 0.4H, H4a/ H4b), 2.46–2.34 (m, 1H, H12), 2.32–2.22 (m, 1H, H11), 2.23–2.12 (m, 1H, 
H12), 1.83–1.69 (m, 2H, H7/H11), 1.68–1.57 (m, 2H, H6/H7), 1.54–1.40 (m, 1H, H6), 1.37–1.24 
(m, 6H, H14/H17), 1.14–1.04 (m, 3H, H15), 1.04–0.94 (m, 9H, H22), 0.95–0.82 (m, 9H, H20), 
0.71–0.63 (m, 6H, H21), 0.12–0.03 (m, 6H, H18/ H18’). 
 
13C NMR (CDCl3, 101 MHz) δ [205.5, 205.4, 205.3, 205.4] (C3), [173.0, 169.9, 167.7, 167.6] 
(C1), [149.3, 149.2, 148.4, 148.2] (C9), [128.1, 128.0, 126.5, 126.4] (C13), [79.6, 79.5, 79.3, 
79.3] (C10), [74.4, 74.4, 74.3, 74.2] (C5), [72.9, 72.7, 72.5, 72.3] (C8), [61.3, 61.3, 61.1, 61.0] 
(C16), [51.9, 51.8, 51.7, 51.6] (C4), [49.5, 49.3, 49.3, 49.0] (C2), [38.3, 38.0, 37.7, 37.7] (C6), 
[34.8, 34.8, 34.7, 34.6] (C11), 29.5 (C7), [29.2, 29.2, 29.2] (C12) 28.6 (C14), [26.1, 26.1, 26.0, 
26.0] (C20), [18.3, 18.2, 18.2] (C19), 14.2 (C17), [11.4, 11.3] (C15), 7.0 (C22), [5.2, 5.2] (C21), 
[−4.0, −4.1, −4.1, −4.1, −4.3, −4.4, −4.5] (C18/ C18’). 
 
IR (thin film) 3495, 2955, 1744, 1713, 1628 cm−1. 
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HRMS (ESI) for C29H56NaO6Si2: 579.3508, found: 579.3485. 
 
Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-8-hydroxy-8-(5’-
hydroxycyclopent-1’-en-1’-yl)-4-methyl-3-oxononanoate (2.83). 
 
C23H42O6Si 
Mol. Wt. = 442.67 g/mol 
 
 
Diol product 2.83 (colourless oil) was obtained from the corresponding alcohol 2.76 
according to the procedure described above for the diol in the procedure for 2.79. 
Purification by flash column chromatography (60:40 PE/EtOAc) 
Scale: 0.69 mmol 
Yield: 90% as an inseparable mixture of 4 diastereomers. 
 
Mixture of diastereomers is described below: 
 
1H NMR (CDCl3, 500 MHz) δ 5.71–5.59 (m, 1H, H13), 5.00–4.90 (m, 1H, H10), 4.18 (q, J = 
7.2 Hz, 2H, H16), 3.95–3.84 (m, 1H, H5), 3.64–3.51 (m, 2H, H2), 2.87–2.78 (m, 1H, H4), 2.52–
2.43 (m, 1H, H12), 2.30–2.22 (m, 1H, H11), 2.22–2.18 (m, 1H, H12), 1.83–1.73 (m, 2H, H6/H11), 
1.65–1.54 (m, 2H, H6/H7), 1.52–1.39 (m, 1H, H7), 1.33 (s, 3H, H14), 1.26 (t, J = 7.2 Hz, 3H, 
H17), 1.08 (d, J = 7.1 Hz, 3H, H15), 0.89 (s, 9H, H19), 0.08 (s, 3H, H18), 0.07 (s, 3H, H18’). 
 
13C NMR (CDCl3, 101 MHz) δ [205.7, 205.6, 205.6] (C3), [167.8, 167.8, 167.7, 167.7] (C1), 
[150.0, 149.9, 149.1, 148.9] (C9), [129.1, 129.0, 127.8, 127.7 ] (C13), [77.9, 77.9, 77.7, 77.7] 
(C10), [74.1, 74.0, 73.9, 73.7] (C8), [73.6, 73.5, 73.4, 73.4] (C5), [61.4, 61.4] (C16), [52.0, 51.8, 
51.8, 51.7] (C4), [49.5, 49.4, 49.4] (C2), [37.8, 37.7, 37.6, 37.5] (C6), [33.9, 33.8, 33.8, 33.7] 
(C11), [29.9, 29.9, 29.8, 29.7] (C12), [29.4, 29.3, 28.8, 28.7] (C14), 28.4 (C7), [26.0, 26.0] (C20), 
[18.3, 18.2, 18.2, 18.2] (C19), 14.3 (C17), [12.5, 12.3, 12.3, 12.2] (C15), [−4.1, −4.1, −4.2, 
−4.4, −4.4, −4.4] (C18/ C18’). 
 
IR (thin film) 3449, 2932, 2855, 1744, 1366, 1227, 1034 cm−1. 
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HRMS (ESI) for C23H42NaO6Si: 465.2643, found: 465.2622. 
 
Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-8-hydroxy-4-methyl-
3-oxo-8-(5’-oxocyclopent-1’-en-1’-yl)nonanoate (2.84). 
 
C23H40O6Si 
Mol. Wt. = 440.65 g/mol 
 
 
To a solution of diol 2.83 (20 mg, 0.045 mmol) in CH2Cl2 (1 mL) was added activated 
manganese(II) oxide (80 mg, 0.90 mmol, 20 equiv) and the reaction was stirred at RT for 
3  h. The mixture was filtered through a short pad of celite to furnish product 2.84 (17 mg, 
89%) as a thick colourless oil and as an inseparable 1:1 mixture of 2 diastereomers. 
 
Mixture of diastereomers is described below: 
 
1H NMR (CDCl3, 500 MHz) δ 7.40 (q, J = 2.7 Hz, 1H, H13), 4.19 (q, J = 7.1 Hz, 2H, H16), 
3.91–3.84 (m, 1H, H5), 3.56 (s, 1H, H2a), 3.55 (s, 1H, H2b), 2.86–2.76 (m, 1H, H4), 2.62–2.55 
(m, 2H, H12), 2.48–2.43 (m, 2H, H11), 1.88–1.76 (m, 1H, H7), 1.75–1.69 (m, 1H, H7), 1.51–
1.45 (m, 1H, H6), 1.44 (s, 3H, H14a), 1.44 (s, 3H, H14b), 1.34–1.30 (m, 1H, H6), 1.27 (t, J = 
7.1 Hz, 3H, H17), 1.06 (d, J = 7.1 Hz, 1.5H, H15a), 1.05 (d, J = 7.1 Hz, 1.5H, H15b), 0.89 (s, 
5H, H20a), 0.88 (s, 4H, H20b) 0.06 (s, 3H, H18), 0.06 (s, 3H, H18’). 
 
13C NMR (CDCl3, 126 MHz) δ 210.5 (C3a or C10a), 210.5 (C3b or C10b), 210.4 (C3b or C10b), 
205.6 (C3b or C10b), 167.6 (C1a), 167.6 (C1b), 157.8 (C13a), 157.8 (C13b) 149.9 (C9a), 149.8 
(C9b), 73.8 (C5a), 73.8 (C5b), 72.2 (C8a), 72.2 (C8b), 61.3 (C16), 51.7 (C4a), 51.7 (C4b) 49.5 
(C2), 37.0 (C6), 35.6 (C11), 30.5 (C14a), 28.9 (C7), 27.0 (C14b), 26.2 (C12), 26.0 (C20), 18.2 
(C19), 14.3 (C17), 12.1 (C15a), 12.1 (C15b), −4.2 (C18),−4.4 (C18’). 
 
IR (thin film) 2931, 1743, 1690, 1265 cm−1. 
 
HRMS (ESI) for C23H40NaO6Si: 463.2486, found: 463.2465. 
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Ethyl (4R,5S)-5-((tert-butyldimethylsilyl)oxy)-8-chloro-4-methyl-3-
oxo-8-(5’-oxocyclopent-1’-en-1’-yl)nonanoate (2.85). 
 
C23H39ClO5Si 
Mol. Wt. = 459.09 g/mol 
 
 
N-Chlorosuccinimide (54 mg, 0.40 mmol, 3.0 equiv) was dissolved in CH2Cl2 (1 mL) at 0 °C 
and dimethyl sulfide (31 µL, 0.43 mmol, 3.2 equiv) was added dropwise. The white 
suspension was stirred at 0 °C for an additional 15 min before dropwise addition of 
compound 2.84 (59 mg, 0.13 mmol) in CH2Cl2 (0.5 mL). The reaction was left to stir at 0 °C 
for 2 h then was quenched by addition of brine (3 mL). The phases were separated and the 
aqueous phase was extracted with Et2O (3 × 5 mL). The organic phases were combined, 
washed with brine (3 × 15 mL), dried over sodium sulfate, filtered and concentrated under 
vacuum. The crude was purified by column chromatography (40:60:1 PE/Et2O/Et3N) to 
afford chloro product 2.85 (54 mg, 89%) as a yellow oil and as an inseparable 1:1 mixture 
of 2 diastereomers. 
 
Mixture of diastereomers is described below: 
 
1H NMR (CDCl3, 500 MHz) δ 7.69 (t, J = 2.5 Hz, 1H, H13), 4.18 (q, J = 7.1 Hz, 1H, H16a), 
4.17 (q, J = 7.1 Hz, 1H, H16b), 3.92–3.85 (m, 1H, H5 ) 3.59–3.52 (m, 2H, H2), 2.82–2.73 (m, 
1H, H4), 2.62–2.54 (m, 2H, H12), 2.53–2.46 (m, 2H, H11), 2.37–2.11 (m, 1H, H7a/ H7b), 2.10–
1.87 (m, 1H, H7a/ H7b), 1.79 (s, 1.5H, H14a),  1.78 (s, 1.5H, H14b), 1.51–1.31 (m, 2H, H6), 
1.29–1.24 (m, 3H, H17), 1.07 (d, J = 7.1 Hz, 1.5H, H15a), 1.03 (d, J = 7.0 Hz, 1.5H, H15b), 
0.89 (s, 9H, H20), 0.08–0.03 (m, 6H, H18/H18’).  
 
13C NMR (CDCl3, 101 MHz) δ 205.7 (C3a or C10a), 205.6 (C3a or C10a), 205.4 (C3b or C10b), 
205.3 (C3b or C10b), 167.6 (C1a), 167.5 (C1b) 161.8 (C13a), 161.6 (C13b), 148.5 (C9a), 148.4 
(C9b), 73.4 (C5a), 73.1 (C5b), 71.2 (C8a), 70.9 (C8b), 61.3 (C16a), 61.3 (C16b), 51.6 (C4a), 51.4 
(C4b), 49.5 (C2a), 49.5 (C2b), 38.0 (C6a), 37.5 (C6b), 36.7 (C11), 30.8 (C14a), 30.5 (C14b), 30.0 
(C7a), 30.0 (C7b) 26.0 (C20a), 26.0 (C20b) 25.7 (C12), 18.2 (C19), 14.3 (C17), 12.2 (C15a), 11.8 
(C15b), −4.2 (C18a), −4.2 (C18b), −4.5 (C18a’), −4.5 (C18b’). 
IR (thin film) 1713, 1705, 910, 734 cm−1. 
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HRMS (ESI) for C23H39NaO5Si35Cl: 481.2147, found: 481.2126. 
 
Ethyl (6R,7S,E)-7-((tert-butyldimethylsilyl)oxy)-6,10-dimethyl-1,5-
dioxo-1,2,3,3a,4,5,6,7,8,9-decahydrocyclopenta[9]annulene-4-
carboxylate (1.138). 
 
C23H38O5Si 
Mol. Wt. = 422.64 g/mol 
 
 
 
Chloro compound 2.85 (9.5 mg, 0.021 mmol) was dissolved in dry DMF (5 mL) and caesium 
carbonate (7.0 mg, 0.021 mmol, 1.0 equiv) was added in one portion to the mixture. The 
reaction was left to stir at RT for 2 h then was diluted with Et2O (5 mL) and water (5 mL). 
The layers were separated and the aqueous layer was extracted with Et2O (3 × 5 mL). The 
organic phases were combined, washed with a saturated aqueous solution of lithium 
chloride (2 × 15 mL), dried over magnesium sulfate, filtered and concentrated under 
vacuum. The crude mixture was purified by column chromatography (80:20 PE/Et2O) to 
afford the nine-membered ring 1.138 (5.6 mg, 64%) as a thick yellow oil and as an 
inseparable mixture of diastereomers. 
 
Mixture of diastereomers is described below: 
 
1H NMR (CDCl3, 500 MHz) δ 4.30–4.12 (m, 2.4H, H7a/H7b/H16), 4.03–3.94 (m, 0.4H, H3a/H3b), 
3.78–3.72 (m, 0.6H, H7c/H7d), 3.73 (d, J = 11.8 Hz, 0.4H, H4a/H4b) 3.65–3.56 (m, 0.6H, 
H3c/H3d), 3.40 (br d, J = 11.3 Hz, 0.6H, H4c/H4d), 3.22–3.12 (m, 0.4H, H6a/H6b) 2.73–2.68 (m, 
0.6H, H6c/H6d), 2.38–2.29 (m, 2H, H11), 2.27 (s, 1.2H, H14a/ H14b), 2.18 (s, 1.8H, H14c/ H14d), 
2.11–1.97 (m, 3H, H8/H12), 1.96–1.86 (m, 1H, H9), 1.78–1.70 (m, 1H, H8), 1.70–1.61 (m, 1H, 
H9), 1.32–1.24 (m, 3H, H13), 1.11 (d, J = 6.8 Hz, 1.8H, H13c/H13d), 1.05 (d, J = 7.1 Hz, 1.2H, 
H13a/H13b), 0.91–0.85 (m, 9H, H20), 0.08–0.03 (m, 6H, H18/H18’). 
13C NMR (CDCl3, 101 MHz) δ [211.4, 211.1, 209.1] (C1 or C5), [206.4, 206.3, 206.1] (C1 or 
C5), [169.4, 168.7, 168.5] (C15), [156.3, 155.0, 152.4] (C10), 132.3 (C2), [77.4, 73.3, 73.0] 
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(C7), [61.9, 61.8] (C16), 61.2 (C4), 52.8 (C6), [43.0, 42.2] (C3), [37.2, 37.2, 37.2] (C11), 34.2 
(C9), [34.0, 33.5] (C12), [26.0, 25.9, 25.9, 25.8] (C20), 25.4 (C8), [19.7, 19.3] (C14), [18.2, 18.1] 
(C19), 15.2 (C13), [14.3, 14.2] (C17), [−4.2, −4.2]  (C18), [−4.5, −4.7] (C18’). 
IR (thin film) 2955, 2932, 2862, 1736, 1720, 1705, 1620, 1250, 1173, 1057, 1018 cm−1 
 
HRMS (ESI) for C23H38NaO5Si: 445.2381, found: 445.2361. 
 
Ethyl (6R,7S,E)-7-((tert-butyldimethylsilyl)oxy)-1-hydroxy-6,10-
dimethyl-5-oxo-1,2,3,3a,4,5,6,7,8,9-
decahydrocyclopenta[9]annulene-4-carboxylate (2.87). 
 
C23H40O5Si 
Mol. Wt. = 424.65 g/mol 
 
 
Cyclononane 1.138 (284 mg, 0.672 mmol) and cerium(III) chloride heptahydrate (661 mg, 
1.77 mmol, 2.60 equiv) were dissolved in methanol (15 mL), cooled to −78 °C and stirred 
for 1 h. Sodium borohydride (27 mg, 0.71 mmol, 1.0 equiv) was then added in small portions. 
The reaction was left to stir at −78 °C for 2 h. The crude mixture was quenched with a 1 M 
aqueous solution of hydrochloric acid (15 mL), the layers were separated and the aqueous 
layer was extracted with Et2O (3 × 15 mL). The combined organic layers were dried over 
magnesium sulfate, filtered and concentrated under vacuum. The crude product was purifed 
by flash chromatography (60:40 PE/Et2O) to give allylic alcohol 2.87 (150 mg, 53%) as a 
thick colourless oil and as an inseparable mixture of 4 diastereomers. 
A mixture of diastereomers are described below: 
1H NMR (CDCl3, 500 MHz) δ 4.76–4.67 (m, 1H, H1), 4.23–4.13 (m, 2.6H, H7a/H7b/H16), 3.71 
–3.65 (m, 0.4H, H7b/H7c) 3.60 (d, J = 11.7 Hz, 1H, H4), 3.42–3.34 (m, 1H, H3), 2.76 (dq, J = 
9.3, 7.1 Hz, 1H, H6), 2.19–2.08 (m, 2H, H12), 2.08–1.98 (m, 2H, H8), 1.92–1.84 (m, 2H, H11), 
1.82 (s, 3H, H14), 1.81–1.72 (m, 2H, H9), 1.28 (t, J = 7.1 Hz, 3H, H17), 1.10 (d, J = 6.8 Hz, 
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1.8H, H13a/H13b), 1.06 (d, J = 7.1 Hz, 1.2H, H13c/H13d), 0.89 (s, 9H, H20), 0.10–0.04 (m, 6H, 
H18/H18’). 
13C NMR (CDCl3, 126 MHz) δ [211.9, 209.5] (C5), [168.9, 168.7] (C15), [139.8, 139.6] (C2 or 
C10), 139.5 (C2 or C10), [73.3, 72.8] (C7), 72.1 (C1), 61.6 (C16), [61.2, 61.1] (C4), 53.2 (C6), 
[43.3, 43.1] (C3), [34.6, 34.2, 34.0, 33.8] (C9), [31.1, 30.5, 30.4] (C11), [29.9, 29.8] (C12), 36.0, 
25.9 (C20), 19.3 (C14), 19.1 (C8), [18.2, 18.2] (C19), 15.2 (C13), 14.3 (C17), −4.1 (C18), −4.4 
(C18’). 
IR (thin film) 3510, 2955, 2932, 2862, 1744, 1706, 1250, 1165, 1080, 1026 cm−1 
 
HRMS (ESI) for C23H40NaO5Si: 447.2537, found: 447.2516. 
 
Ethyl (7S,8R)-7-((tert-butyldimethylsilyl)oxy)-9-hydroxy-4,8-
dimethyl-1,2,4,5,6,7,8,9,10,10a-decahydro-4,9-
epoxycyclopenta[9]annulene-10-carboxylate (2.90).  
 
C23H40O5Si 
Mol. Wt. = 424.65 g/mol 
 
 
 
To a solution of bis(acetonitrile)dichloropalladium(II) (5.5 mg, 0.021 mmol, 0.30 equiv) in 
THF (0.7 mL) was added dropwise a mixture of allylic alcohol 2.87 (27 mg, 0.071 mmol) in 
THF (0.7 mL). The reaction was stirred at RT for 2 h then was filtered through a short pad 
of celite. The crude was then purified by flash chromatography (80:20 PE/Et2O) to afford 
tricycle 2.90 (11 mg, 41%) as a colourless oil and as a separable 1:1 mixture of 2 
diastereomers. 
 
Diastereomer 1: 
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1H NMR (CDCl3, 500 MHz) δ 5.36–5.32 (m, 1H, H2), 4.23–4.16 (m, 2H, H16), 3.82 (ddd, J = 
6.5, 4.7, 1.7 Hz, 1H, H7), 3.29 (d, J = 10.3 Hz, 1H, H10), 3.22–3.13 (m, 1H, H11), 2.36–2.30 
(m, 2H, H1), 2.30–2.23 (m, 1H, H8), 2.06 (ddd, J = 14.4, 9.3, 1.7 Hz, 1H, H6), 1.93–1.83 (m, 
1H, H6), 1.66–1.55 (m, 2H, H5), 1.38 (td, J = 9.5, 2.4 Hz, 1H, H12), 1.34 (s, 3H, H14), 1.28 (t, 
J = 7.1 Hz, 3H, H17), 1.26–1.23 (m, 1H, H12), 1.01 (d, J = 7.1 Hz, 3H, H15), 0.89 (s, 9H, H20), 
0.07 (s, 3H, H18), 0.05 (s, 3H, H18’). 
 
13C NMR (CDCl3, 101 MHz) δ 173.4 (C13), 150.3 (C3), 119.8 (C2), 98.6 (C9), 74.9 (C4), 72.5 
(C7), 60.8 (C16), 54.4 (C10), 48.3 (C8), 42.8 (C11), 36.5 (C5), 32.7 (C1), 31.8 (C6), 29.7 (C12), 
29.0 (C14), 26.1 (C20), 18.3 (C19), 14.4 (C17), 13.2 (C15), −4.7 (C18), −4.8 (C18’). 
 
[α]D25 +16.7 (c = 1.0, CHCl3). 
 
Diastereomer 2: 
 
1H NMR (CDCl3, 500 MHz) δ 5.34–5.32 (m, 1H, H2), 4.23 (dq, J = 10.8, 7.1 Hz, 1H, H16), 
4.19 (dq, J = 10.8, 7.2 Hz, 1H, H16) 3.29 (td, J = 9.8, 2.8 Hz, 1H, H7), 3.20–3.11 (m, 1H, 
H11), 2.54 (d, J = 12.6 Hz, 1H, H10), 2.40–2.32 (m, 1H, H1), 2.32–2.25 (m, 1H, H1), 2.04–
1.92 (m, 3H, H5/H8), 1.92–1.84 (m, 1H, H6), 1.64 (dddd, J = 13.8, 7.8, 3.0, 1.3 Hz, 1H, H6), 
1.52–1.44 (m, 2H, H6/H12), 1.36 (s, 3H, H14), 1.30 (t, J = 7.1 Hz, 3H, H17), 1.27–1.20 (m, 1H, 
H12), 0.96 (d, J = 7.0 Hz, 3H, H15), 0.88 (s, 9H, H20), 0.06 (s, 3H, H18), 0.05 (s, 3H, H18’). 
 
13C NMR (CDCl3, 101 MHz) δ 174.5 (C13), 152.4 (C3), 119.2 (C2), 98.5 (C9), 77.7 (C7), 74.3 
(C4), 61.5 (C16), 54.3 (C8), 50.8 (C10), 44.9 (C11), 40.6 (C5), 32.9 (C6), 31.5 (C1), 29.6 (C12), 
28.4 (C14), 26.0 (C20), 18.2 (C19), 14.7 (C15), 14.3 (C17), −3.8 (C18), −4.3 (C18’). 
 
[α]D25 −8.0 (c = 1.0, CHCl3). 
 
IR (thin film) 2924, 2855, 1728, 1458, 1259, 1065, 1026, 841 cm−1. 
 
HRMS (ESI) for C23H40NaO5Si: 447.2537, found: 447.2518. 
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Ethyl (7S,8R)-7-((tert-butyldimethylsilyl)oxy)-9-hydroxy-4,8-
dimethyldodecahydro-4,9-epoxycyclopenta[9]annulene-10-
carboxylate (2.92). 
 
C23H42O5Si 
Mol. Wt. = 426.67 g/mol 
 
 
 
To a solution of tricycle 2.90 (5 mg, 0.012 mmol) in ethanol (3 mL) under inert atmosphere 
was added palladium on carbon. Inert atmosphere was purged, replaced with hydrogen and 
the reaction was stirred at RT for 2 h. The mixture was filtered through a short pad of celite 
to furnish a separable 4:1 mixture of diastereomers. The crude was then purified by flash 
chromatography (80:20 PE/Et2O) to afford saturated tricycle 2.92 (4 mg, 80%) as a white 
foam and a single diastereomer. 
 
Diastereomer 1: 
 
1H NMR (CDCl3, 500 MHz)  δ 4.22–4.14 (m, 2H, H16), 3.79–3.71 (m, 2H, H7/H10), 3.41 (s, 
1H, OH), 2.55 (tt, J = 12.4, 8.0 Hz, 1H, H11), 2.38–2.31 (m, 1H, H8), 2.32–2.25 (m, 1H, H3), 
2.08–1.98 (m, 2H, H5/H12), 1.91 (t, J = 13.8 Hz, 1H, H6), 1.79–1.67 (m, 2H, H2/H12), 1.51 
(dd, J = 13.8, 6.5 Hz, 1H, H6), 1.46–1.37 (m, 4H, H2/H14), 1.35–1.28 (m, 1H, H1), 1.28–1.24 
(m, 3H, H17) 1.24–1.21 (m, 1H, H5), 1.15–1.05 (m, 1H, H1), 1.02 (d, J = 7.2 Hz, 3H, H15), 
0.91 (s, 9H, H20), 0.08 (s, 3H, H18), 0.05 (s, 3H, H18’). 
 
13C NMR (CDCl3, 126 MHz) δ 174.4 (C13), 97.3 (C9), 74.2 (C4), 73.8 (C7), 60.8 (C16), 50.9 
(C10), 47.5 (C8), 35.1 (C11), 34.4 (C5), 30.5 (C14), 29.9 (C1), 29.5 (C2), 28.9 (C12), 26.1 (C20), 
25.8 (C6), 21.3 (C3), 18.2 (C19), 14.4 (C17), 12.9 (C15), −4.7 (C18), −5.1 (C18’). 
 
[α]D25 −6.0 (c = 1.0, CHCl3). 
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Tricycle 2.92’ was obtained from the corresponding tricycle 2.90’ according to the procedure 
described above for diastereomer 2.92. 
Scale: 0.012 mmol 
Yield: 98% as a 4:1 mixture of 2 diastereomers and some impurities. 
 
Diastereomer 2: 
 
1H NMR (CDCl3, 500 MHz)  δ 4.24–4.16 (m, 2H, H16), 3.36 (ddd, J = 10.8, 9.3, 3.2 Hz, 1H, 
H7), 2.57 (d, J = 12.8 Hz, 1H, H10), 2.49–2.39 (m, 1H, H11), 2.33 (td, J = 10.7, 7.7 Hz, 1H, 
H3), 1.99–1.88 (m, 3H, H6/H8/H12), 1.88–1.82 (m, 1H, H1), 1.77–1.65 (m, 2H, H2/H6), 1.51 
(dd, J = 7.7, 3.5 Hz, 1H, H5), 1.43 (s, 3H, H14), 1.30 (t, J = 7.1 Hz, 3H, H16), 1.28–1.19 (m, 
4H, H1/H2/ H5/H12), 0.92 (d, J = 7.0 Hz, 3H, H15), 0.89 (s, 9H, H20), 0.08 (s, 3H, H18), 0.06 (s, 
3H, H18’). 
 
13C NMR (CDCl3, 126 MHz) δ 175.9 (C13), 97.2 (C9), 77.3 (C4), 74.3 (C7), 61.3 (C16), 54.3 
(C8), 48.2 (C10), 47.5 (C11), 37.5 (C3), 33.5 (C5), 32.7 (C12), 32.5 (C6), 30.6 (C14), 29.7 (C1),  
28.1 (C2), 25.9 (C20), 18.1 (C19), 14.4 (C17), 14.2 (C15), −3.8 (C18), −4.5 (C18’). 
 
[α]D25 +18.0 (c = 1.0, CHCl3). 
 
IR (thin film) 2924, 2855, 1728, 1458, 1250, 1049, 1026, 841, 772 cm−1. 
 
HRMS (ESI) for C23H42NaO5Si: 449.2694, found: 449.2676. 
 
cis-3,5-Diacetoxy-1-cyclopentene (2.103).105 
 
C9H12O4 
Mol. Wt. = 184.19 g/mol 
 
 
In a 1 L photochemistry apparatus, a solution of freshly distilled cyclopentadiene (6.4 mL, 
75 mmol), rose Bengal (151 mg, 0.154 mmol, 0.002 equiv) and thiourea (5.7 g, 75 mmol, 
1.0 equiv) in methanol (1 L) was cooled to 0 °C and irradiated with a UV mercury lamp, 
while oxygen was bubbled through the solution. After 3 h, irradiation and bubbling were 
stopped and the reaction was stirred in the dark overnight. The solvent was then evaporated 
and the crude product 2.102 (3.63 g) was used in the next step without further purification. 
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Acetic anhydride (13.7 mL, 145 mmol, 4.00 equiv) was slowly added to a stirred solution of 
2.102 (3.63 g, 36.0 mmol), pyridine (30.0 mL, 370 mmol, 10.0 equiv) and DMAP (440 mg, 
3.60 mmol, 0.100 equiv) in CH2Cl2 (250 mL) at 0 °C. The mixture was stirred at 0 °C for 30 
min and then warmed to room temperature and stirred for an additional 3 h, after which the 
reaction was quenched by slow addition of a saturated aqueous solution of sodium 
bicarbonate (50 mL). The layers were separated and the organic layer was washed with a 
saturated aqueous solution of sodium bicarbonate (2 × 150 mL), a saturated aqueous 
solution of copper sulfate (3 × 150 mL), brine (150 mL) and water (150 mL). The organic 
layer was dried over magnesium sulfate, filtered and concentrated under vacuum. The 
crude product was then purified by column chromatography (90:10 PE/EtOAc) to furnish 
the product 2.103 (3.74 g, 27% yield over 2 steps) as a colourless oil. 
 
1H NMR (CDCl3, 400 MHz) δ 6.12 (d, J = 0.8 Hz, 2H, H1), 5.59 (m, 2H, H2), 2.91 (dt, J = 
15.0, 7.5 Hz, 1H, H3), 2.09 (s, 6H, H5), 1.77 (dt, J = 15.0, 3.9 Hz, 1H, H3). 
 
13C NMR (CDCl3, 101 MHz) δ 170.6 (C4), 134.6 (C1), 76.6 (C2), 37.2 (C3), 21.1 (C5). 
 
In agreement with literature data.35 
 
(R)-4-Oxocyclopent-2-en-1-yl acetate (2.101).106 
 
C7H8O3 
Mol. Wt. = 140.14 g/mol  
 
 
Diacetate 2.103 (3.76 g, 20.4 mmol) was added to a slowly stirred (180 rpm) solution of 
electric eel acetylcholinesterase (3.5 mg, 2000 units) and sodium azide (15 mg) in an 
aqueous phosphate buffer (150 mL) at RT. The buffer was prepared by dissolving 
anhydrous sodium hydrogen phosphate (16.4 g) in water (200 mL), adjusting the pH to 6.85 
by careful addition of a 2 M aqueous solution of hydrochloric acid. The reaction was stirred 
at RT overnight; after which it was extracted with EtOAc (6 x 50 mL). The combined organic 
extracts were dried over magnesium sulfate and concentrated under vacuum to give the 
product 2.104 (2.44 g) as a white solid that was used in the next step without further 
purification. 
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To a solution of 2.104 (2.4 g, 17 mmol) in CH2Cl2 (75 mL) was added BAIB (6.57 g, 20.4 
mmol, 1.20 equiv) and TEMPO (266 mg, 1.70 mmol, 0.100 equiv). The mixture was then 
stirred at RT for 3 h. The reaction was then diluted by water (75 mL) and the two layers 
separated. The aqueous layer was extracted by CH2Cl2 (3 × 60 mL). The combined organic 
layers were dried over magnesium sulfate, filtered and concentrated under vacuum. The 
crude mixture was purified by column chromatography (80:20 PE/EtOAc) to yield 2.101 as 
a colourless oil (1.93 g, 81% yield over 2 steps). 
 
1H NMR (CDCl3, 400 MHz) δ 7.59 (dd, J = 5.7, 2.4 Hz, 1H, H3), 6.36 (dd, J = 5.7, 1.2 Hz, 
1H, H2), 5.87 (dtd, J = 6.3, 2.4, 1.2 Hz, 1H, H4), 2.85 (dd, J = 18.7, 6.3 Hz, 1H, H5), 2.35 
(dd, J = 18.7, 2.4 Hz, 1H, H5), 2.11 (s, 3H, H7). 
 
13C NMR (CDCl3, 101 MHz) δ 205.0 (C1), 170.5 (C6), 159.1 (C3), 137.1 (C2), 72.0 (C4), 41.1 
(C5), 21.0 (C7). 
 
In agreement with literature data.35 
 
(S)-4-Isopropylcyclopent-2-en-1-one (2.100).82  
 
 
C8H12O 
Mol. Wt. = 124.18 g/mol 
 
 
 
A solution of isopropylmagnesium bromide was prepared from freshly distilled isopropyl 
bromide (4.0 mL, 42 mmol) and magnesium (2.05 g, 84.0 mmol, 2.00 equiv) in THF (42 
mL). A 0.65 M solution of the Grignard reagent in THF (8.0 mL, 5.0 mmol, 1.4 equiv) was 
diluted with additional THF (30 mL) and then cooled to −78 °C. HMPA (1.74 mL, 9.99 mmol, 
2.80 equiv) and recrystallized copper(I) bromide dimethyl sulfide complex (73 mg, 0.36 
mmol, 0.10 equiv) were added consecutively. A solution of (R)-4-acetoxy-2-cyclopenten-1-
one 2.101 (500 mg, 3.57 mmol) and TMSCl (1.26 mL, 9.99 mmol, 2.80 equiv) in THF (30 
mL) was added dropwise (over 20 min). The mixture was stirred at −78 °C for 1 h and then 
at −40 °C for 1 h. The reaction was quenched with a saturated aqueous solution of 
ammonium chloride (60 mL). The solution was allowed to warm to RT, filtered through a 
short pad of celite, diluted with water (30 mL), and extracted with Et2O (3 x 100 mL). The 
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combined organic extracts were dried over sodium sulfate, filtered, and concentrated under 
vacuum (28 °C, 180 mbar) to furnish intermediate 2.105 that was used in the next step 
without further purification. 
 
To a solution of this material in CH2Cl2 (30 mL) was added CSA (500 mg) and water (0.5 
mL). The mixture was heated at reflux overnight, allowed to cool to RT, diluted with 
additional CH2Cl2 (30 mL), washed with water (2 x 60 mL) and brine (60 mL). The organic 
layer was dried, filtered, and again carefully concentrated under vacuum (28 °C, 180 mbar). 
The product was purified by column chromatography (80:20 PE/EtOAc) to furnish 2.100 
(363 mg, 82%) as a colourless oil.  
 
1H NMR (CDCl3, 500 MHz) δ 7.66 (dd, J = 5.7, 2.4, Hz, 1H, H3), 6.18 (dd, J = 5.7, 2.4 Hz, 
1H, H2), 2.83–2.76 (m, 1H, H4), 2.42 (dd, J = 18.8, 6.4, 1H, H5), 2.09 (dd, J = 18.8, 2.4 Hz, 
1H, H5), 1.78 (m, 1H, H6), 0.82 (d, J = 6.7 Hz, 3H, H7 ), 0.77 (d, J = 6.7 Hz, 3H, H7). 
 
13C NMR (CDCl3, 126 MHz) δ 210.2 (C1), 167.5 (C3), 134.5 (C2), 48.2 (C4), 38.6 (C5), 31.7 
(C6), 20.2 (C7), 19.9 (C7). 
 
[α]D25 +181 (c = 0.61, CHCl3), literature [α]D25 +174 (c = 0.61, CHCl3). 
 
In agreement with literature data.82 
 
(S)-2-Bromo-4-isopropylcyclopent-2-en-1-one (2.106). 
 
C8H11BrO 
Mol. Wt. = 203.08 g/mol 
 
 
 
A solution of (S)-4-isopropylcyclopent-2-en-1-one  2.100 (28 mg, 0.23 mmol) in CH2Cl2 (1 
mL) was cooled to 0 °C and a mixture of bromine (14 µL, 0.27 mmol, 1.2 equiv) and CH2Cl2 
(1  mL) was slowly added. The reaction was warmed to RT and stirred for 1 h 30. 
Triethylamine (54 µL, 0.39 mmol, 1.7 equiv) was then added and the mixture stirred for an 
additional 1  h  30. The reaction was quenched by addition of a 1 M aqueous solution of 
hydrochloric acid (2 mL) and the aqueous phase was extracted with Et2O (3 × 2 mL). The 
organic phases were combined, washed with brine (2 × 2 mL), dried over magnesium 
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sulfate, filtered and concentrated under vacuum. The product was then purified by flash 
chromatography (80:20 PE/Et2O) to furnish compound 2.106 as a brown oil (35 mg, 72%). 
 
1H NMR (CDCl3, 500 MHz) δ 7.74 (d, J = 2.8 Hz, 1H, H3), 2.76 (tdd, J = 6.7, 2.8, 2.1 Hz, 
1H, H4), 2.58 (dd, J = 19.0, 6.7 Hz, 1H, H5), 2.23 (dd, J = 19.0, 2.1 Hz, 1H, H5), 1.79 (oct, J 
= 6.7 Hz, 1H, H6), 0.97 (d, J = 6.7 Hz, 3H, H7), 0.94 (d, J = 6.7 Hz, 3H, H7). 
 
13C NMR (CDCl3, 126 MHz) δ 201.5 (C1), 164.7 (C3), 126.0 (C2), 47.2 (C4), 37.1 (C5), 31.8 
(C6), 19.9 (C7), 19.8 (C7). 
 
[α]D25 +71.4 (c = 0.3, CHCl3). 
 
IR (thin film) 2955, 2870, 1713, 926 cm−1. 
 
HRMS (ESI) for C8H11NaO79Br: 224.9885, found: 224.9879. 
 
(((4S)-2-Bromo-4-isopropylcyclopent-2-en-1-yl)oxy)triethylsilane 
(2.99). 
 
C14H27BrOSi 
Mol. Wt. = 319.36 g/mol 
 
 
 
A solution of 2.106 (368 mg, 1.81 mmol) in CH2Cl2 (20 mL) was cooled to −78 °C then a 1 
M solution of diisobutylaluminium hydride in heptane (3.62 mL, 3.62 mmol, 2.00 equiv) was 
added dropwise. The reaction was stirred at −78 °C for 1 h then was quenched by addition 
of a saturated aqueous solution of Rochelle salt (20 mL) and allowed to warm up to RT. The 
mixture was stirred for 4 h then the layers were separated. The aqueous layer was extracted 
with CH2Cl2 (3 × 25 mL), the organic layers were combined, dried over magnesium sulfate, 
filtered and concentrated under vacuum to furnish the allylic alcohol (301 mg, dr = 7:3) as 
a colourless liquid that was used in the next step without further purification. 
 
193 
 
The crude allylic alcohol  (301 mg, 1.47 mmol) was dissolved in dry DMF (10 mL) then 
imidazole (370 mg, 5.41 mmol, 3.70 equiv) and DMAP (22 mg, 0.18 mmol, 0.12 equiv) were 
added. The reaction was cooled to 0 °C then chlorotriethylsilane (0.60 mL, 3.6 mmol, 2.4 
equiv) was added dropwise and the reaction was stirred for 5 min. The mixture was warmed 
to RT over 1 h. The mixture was then diluted with water (10 mL), the layers were separated 
and the aqueous layer was extracted with Et2O (3 × 10 mL). The combined organic extracts 
were washed with brine (2 × 30 mL), dried over magnesium sulfate, filtered and 
concentrated under vacuum. The crude was purified by flash chromatography (99.5:0.5 
PE/Et2O) to give product 2.99 (464 mg, 81% over 2 steps) as a yellow oil and as a mixture 
of 2 diastereomers (dr = 7:3). 
 
Major diastereomer is described below. 
 
1H NMR (CDCl3, 500 MHz) δ 5.99 (dd, J = 2.2, 1.3 Hz, 1H, H3), 4.65 (ddt, J = 7.6, 5.9, 1.5 
Hz, 1H, H1), 2.39 (dt, J = 12.9, 7.6 Hz, 1H, H5), 2.24 (app qt, J = 7.6, 1.9 Hz, 1H, H4), 1.56 
(oct, J = 6.8 Hz, 1H, H6), 1.49–1.42 (m, 1H, H5), 1.00 (t, J = 7.9 Hz, 9H, H8), 0.91 (d, J = 6.8 
Hz, 3H, H7), 0.87 (d, J = 6.8 Hz, 3H, H7), 0.66 (q, J = 7.9 Hz, 6H, H9). 
 
13C NMR (CDCl3, 126 MHz) δ 135.6 (C3), 126.4 (C2), 78.4 (C1), 50.1 (C4), 38.1 (C5), 32.6 
(C6), 20.3 (C7), 20.1 (C7), 6.8 (C9), 4.9 (C8). 
 
IR (thin film) 2955, 2878, 1010, 833 cm−1. 
 
HRMS (ESI) for C14H27NaOSi79Br: 341.0907, found: 341.0898. 
 
 
Dimethyl(2-methyleneheptyl)silane (3.5).86 
 
C10H22Si 
Mol. Wt. = 170.37 g/mol 
 
 
 
Cerium(III) chloride heptahydrate (13.0 g, 35.0 mmol, 3.50 equiv) was finely grinded then 
stirred under vacuum (P < 1 mbar) and warmed to 120 °C for 2 h, 140 °C for 2 h and 160 °C 
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for 3 h. Cerium(III) chloride was cooled to RT under inert atmosphere then THF (100 mL) 
was added and the white suspension was stirred vigorously overnight. 
To a stirred solution of magnesium (1.70 g, 70.0 mmol, 7.00 equiv) and 1,2-dibromoethane 
(3 drops) in THF (100 mL) at 65 °C was added slowly a solution of 
chloromethyldimethylsilane (4.27 mL, 35.0 mmol, 3.50 equiv). The solution was then stirred 
for 30 min at 65 °C and for 2 h at RT. 
The Grignard solution was then added dropwise (over 1 h) at −78 °C to the cerium/THF 
suspension. The reaction was stirred for 1 h, and then ethyl caproate (1.53 mL, 10.0 mmol) 
in dry THF (50 mL) was added at −78 °C. The reaction was stirred at −78 °C for 2 h, the 
flask was then allowed to warm up to RT, and the mixture was stirred for 15 h. A saturated 
aqueous solution of ammonium chloride (250 mL) was added. The mixture was extracted 
with Et2O (3 × 250 mL). The combined ether extracts were washed with brine (2 × 500 mL), 
then dried over magnesium sulfate, filtered and concentrated under vacuum to give a yellow 
oil. The crude intermediate was stirred for 72 h with silica gel in CH2Cl2. The mixture was 
then filtered and carefully concentrated under vacuum (28 °C, 180 mbar) to deliver silane 
3.5 (1.42 g, 86%), with traces of CH2Cl2, as a clear oil. 
 
1H NMR (CDCl3, 500 MHz) δ 4.61 (dt, J = 2.5, 1.4 Hz, 1H, H8), 4.56–4.54 (m, 1H, H8), 3.90 
(non, J = 3.6 Hz, 1H, H10), 1.98 (t, J = 7.4 Hz, 2H, H3), 1.59 (dd, J = 3.6, 1.0 Hz, 2H, H1), 
1.47–1.39 (m, 2H, H4), 1.35–1.23 (m, 4H, H5/H6), 0.89 (t, J = 7.1 Hz, 3H, H7), 0.09 (d, J = 
3.6 Hz, 6H, H9). 
 
13C NMR (CDCl3, 126 MHz) δ 147.7 (C2), 107.3 (C8), 38.0 (C3), 31.8  (C5 or C6), 27.6 (C4), 
24.5 (C1), 22.7 (C5 or C6), 14.2 (C7), −4.12 (C9). 
 
In agreement with literature data.86 
 
 (R)-(4-(Benzyloxy)-2-methyleneheptyl)dimethylsilane (3.6’).86 
 
C17H28OSi 
Mol. Wt. = 276.49 g/mol 
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Silane 3.6’ was obtained from the corresponding ester 3.3’ and chloromethyldimethylsilane 
according to the procedure described above for silane 3.5. 
Scale: 3.22 mmol. 
Yield: 83%. 
 
1H NMR (CDCl3, 400 MHz) δ 7.37–7.23 (m, 5H, HAr), 4.72–4.67 (m, 1H, H8), 4.68–4.64 (m, 
1H, H8), 4.57 (d, J = 11.5 Hz, 1H, H11), 4.50 (d, J = 11.5 Hz, 1H, H11), 3.93 (non, J = 3.6 Hz, 
1H, H10), 3.59–3.51 (m, 1H, H4), 2.37 (ddd, J = 14.0, 6.2, 1.4 Hz, 1H, H3), 2.16 (ddd, J = 
14.0, 6.5, 1.1 Hz, 1H, H3), 1.62 (ddd, J = 3.6, 1.4, 1.1 Hz, 2H, H1), 1.54–1.45 (m, 4H, H5/H6), 
0.90 (t, J = 7.1 Hz, 3H, H7), 0.11 (d, J = 3.6 Hz, 3H, H9), 0.10 (d, J = 3.6 Hz, 3H, H9). 
 
13C NMR (CDCl3, 126 MHz)δ 144.5 (C2), 139.1 (CAr), 128.4 (CAr), 127.9 (CAr), 127.5 (CAr), 
110.4 (C8), 77.7 (C4), 71.1 (C11), 42.8 (C3), 36.6 (C5), 24.8 (C1), 18.8 (C6), 14.4 (C7),−4.2 
(C9). 
 
[α]D25 +14.7 (c = 1.0, CHCl3), literature [α]D25  +15.2 (c = 1.0, CHCl3). 
 
In agreement with literature data.86 
 
 (4-(Benzyloxy)-2-methyleneheptyl)dimethylsilane (3.6).86 
 
C17H28OSi 
Mol. Wt. = 276.49 g/mol 
 
 
Silane 3.6 was obtained from the corresponding ester 3.3 and chloromethyldimethylsilane 
according to the procedure described above for silane 3.5. 
Scale: 5.59 mmol. 
Yield: 52%. 
 
In agreement with literature data.86 
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Dimethyl(2-methyleneheptyl)((1-phenylhex-5-en-3-yl)oxy)silane 
(3.33).<sup>87</sup><sup>87</sup><sup>87</sup> 
 
C22H36OSi 
Mol. Wt. = 344.61 g/mol 
 
 
 
To a stirred solution of alcohol 3.31 (400 mg, 2.33 mmol), silane 3.5 (327 mg, 2.56 mmol, 
1.10 equiv) and Xantphos copper(I) chloride (79 mg, 0.12 mmol, 0.050 equiv) in toluene 
(100 mL) at 85 °C was added dropwise (over 4 h) a 2.2 M solution of lithium tert-butoxide 
in THF (750 µL, 1.63 mmol, 0.700 equiv) diluted in toluene (20 mL). The solution was stirred 
for another 30 min at 85 °C. The reaction was cooled to RT, and then was quenched by 
addition of a saturated aqueous solution of ammonium chloride (80 mL). The mixture was 
extracted with Et2O (3 × 80 mL) and the combined organic layers were washed with brine 
(150 mL), dried over magnesium sulfate, filtered and concentrated under vacuum. The 
crude was purified by flash chromatography (99.9:0.01 PE/Et2O) to give the oxysilane 3.33 
(530 mg, 74%) as a clear oil. 
 
1H NMR (CDCl3, 400 MHz) δ 7.35–7.27 (m, 2H, HAr), 7.21–7.14 (m, 3H, HAr), 5.81 (ddt, J = 
17.0, 10.4, 7.3 Hz, 1H, H5), 5.10–5.02 (m, 2H, H6), 4.62 (dt, J = 2.6, 1.0 Hz, 1H, H14), 4.60–
4.54 (m, 1H, H14), 3.76 (p, J = 6.0 Hz, 1H, H3), 2.72 (ddd, J = 13.7, 10.3, 6.0 Hz, 1H, H1), 
2.57 (ddd, J = 13.7, 10.5, 6.0 Hz, 1H, H1), 2.26 (ddt, J = 7.3, 6.0, 1.3 Hz, 2H, H4), 2.00 (t, J 
= 7.7 Hz, 2H, H9), 1.79–1.70 (m, 2H, H2), 1.63 (dd, J = 5.5, 1.0 Hz, 2H, H7), 1.49–1.39 (m, 
2H, H10) 1.36–1.22 (m, 4H, H11/H12), 0.89 (t, J = 7.0 Hz, 3H, H13), 0.14 (s, 6H, H15). 
 
13C NMR (CDCl3, 126 MHz) δ 147.9 (C8), 143.4 (CAr), 136.0 (C5), 129.4 (CAr), 129.3 (CAr), 
126.7 (CAr), 118.0 (C6), 108.6 (C14), 72.9 (C3), 43.0 (C4), 39.6 (C2), 39.3 (C9), 32.9 (C1), 32.7 
(C11 or C12), 28.5 (C10), 28.2 (C7), 23.6 (C11 or C12), 15.1 (C13), 0.00 (C15), −0.13 (C15). 
 
IR (thin film) 2924, 2862, 1250, 1088, 1065 cm−1. 
 
HRMS (ESI) for C22H36NaOSi: 367.2428, found: 367.2410. 
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4-(Benzyloxy)-2-methyleneheptyl)dimethyl((1-phenylhex-5-en-3-
yl)oxy)silane (3.34). 
 
C29H42O2Si 
Mol. Wt. = 450.74 g/mol 
 
 
 
Oxysilane 3.34 (colourless oil) was obtained from the corresponding silane 3.6 and alcohol 
3.31 according to the procedure described above for oxysilane 3.33. 
Purification by flash chromatography (99.5:0.05 PE/Et2O). 
Scale: 1.18 mmol. 
Yield: 84%. 
 
1H NMR (CDCl3, 500 MHz) δ 7.38–7.22 (m, 7H, HAr), 7.22–7.14 (m, 3H, HAr), 5.86–5.74 (m, 
1H, H5), 5.08–5.02 (m, 2H, H6), 4.72 (s, 1H, H14), 4.68 (s, 1H, H14), 4.58 (d, J = 11.4 Hz, 1H, 
H15), 4.49 (d, J = 11.4 Hz, 1H, H15), 3.80–3.71 (m, 1H, H3), 3.56 (app quint, J = 6.1 Hz, 1H, 
H10), 2.75–2.67 (m, 1H, H1), 2.62–2.52 (m, 1H, H1), 2.39 (t, J = 6.1 Hz, 1H, H9), 2.30–2.23 
(m, 2H, H4), 2.18 (ddd, J = 6.1, 3.6, 1.0 Hz, 1H, H9), 1.82–1.71 (m, 2H, H2), 1.67–1.65 (m, 
2H, H7), 1.55–1.46 (m, 3H, H11/H12), 1.41–1.31 (m, 1H, H12), 0.92–0.87 (m, 3H, H13), 0.15 
(s, 6H, H16). 
 
13C NMR (CDCl3, 126 MHz) δ 143.7 (C8), 142.5 (CAr), 139.2 (CAr), 135.1 (C5), 128.5 (CAr), 
128.5 (CAr), 128.4 (CAr), 127.9 (CAr), 127.5 (CAr), 125.9 (CAr), 117.2 (C6), 110.8 (C14), 77.8 
(C10), 72.1 (C3), 71.1 (C15), 43.3 (C9), 42.1 (C4), 38.7 (C2), 36.6 (C11), 32.1 (C1), 27.6 (C7), 
18.9 (C12), 14.4 (C13), −0.9 (C16), −1.00 (C16). 
 
IR (thin film) 3071, 3024, 2955, 2932, 1250, 1065, 833 cm−1. 
 
HRMS (ESI) for C29H42NaO2Si: 473.2846, found: 473.2829. 
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Dimethyl(2-methyleneheptyl)((2-methylhex-5-en-3-yl)oxy)silane 
(3.35). 
 
C17H34OSi 
Mol. Wt. = 282.54 g/mol 
 
 
 
Oxysilane 3.35 (colourless oil) was obtained from the corresponding silane 3.5 and alcohol 
3.32 according to the procedure described above for oxysilane 3.33. 
Purification by flash chromatography (99.9:0.01 PE/Et2O). 
Scale: 2.50 mmol. 
Yield: 65%. 
 
1H NMR (CDCl3, 500 MHz) δ 5.81 (ddt, J = 17.3, 10.2, 7.2 Hz, 1H, H5), 5.07–5.00 (m, 2H, 
H6), 4.60 (dt, J = 2.5, 1.4 Hz, 1H, H14), 4.55 (dt, J = 2.5, 1.0 Hz, 1H, H14), 3.47 (dt, J = 6.5, 
5.1 Hz, 1H, H3), 2.21–2.16 (m, 2H, H4), 1.99 (t, J = 7.7 Hz, 2H, H9), 1.72–1.64 (m, 1H, H2), 
1.62 (app s, 2H, H7), 1.47–1.39 (m, 2H, H10), 1.35–1.25 (m, 4H, H11/H12), 0.87 (d, J = 4.2 
Hz, 3H, H1), 0.89 (t, J = 7.1 Hz, 3H, H13), 0.86 (d, J = 4.2 Hz, 3H, H1), 0.12 (s, 3H, H15), 0.11 
(s, 3H, H15). 
 
13C NMR (CDCl3, 126 MHz) δ 147.8 (C8), 136.0 (C5), 116.6 (C6), 107.5 (C14), 77.4 (C3), 39.0 
(C4), 38.4 (C9), 32.9 (C2), 31.8 (C11 or C12), 27.6 (C10), 27.5 (C7), 22.8 (C11 or C12), 18.9 (C1), 
17.6 (C1), 14.2 (C13), −0.85 (C15), −1.01 (C15). 
 
IR (thin film) 2963, 2932, 1636, 1466, 1366, 1250, 1050 cm−1. 
 
HRMS (ESI) for C17H34NaOSi: 305.2271, found: 305.2260. 
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2,2-Dimethyl-4-pentyl-7-phenethyl-2,3,6,7-tetrahydro-1,2-
oxasilepine (3.36). 
 
C20H32OSi 
Mol. Wt. = 316.56 g/mol 
 
 
 
Oxysilane 3.33 (460 mg, 1.33 mmol) was dissolved in dry degassed CH2Cl2 (60 mL). Grubbs 
2nd generation catalyst (37 mg, 0.037 mmol, 0.025 equiv) was added in one portion and the 
solution was heated at reflux for 2 h. The solvent was removed under vacuum and the 
product purified by column chromatography (99.5:0.05 PE/Et2O) furnishing the seven-
membered ring 3.36 (308 mg, 73%) as a clear oil. 
 
1H NMR (CDCl3, 500 MHz) δ 7.30–7.24 (m, 2H, HAr), 7.21–7.14 (m, 3H, HAr), 5.32 (t, J = 7.3 
Hz, 1H, H5), 3.84–3.76 (m, 1H, H7), 2.74 (ddd, J = 14.5, 9.7, 5.2 Hz, 1H, H9), 2.67–2.55 (m, 
1H, H9), 2.27 (dt, J = 15.0, 7.3 Hz, 1H, H6), 2.19 (ddd, J = 15.0, 7.3, 2.3 Hz, 1H, H6), 1.96 
(t, J = 7.6 Hz, 2H, H10), 1.87–1.78 (m, 1H, H8), 1.73–1.67 (m, 2H, H3/H8), 1.64–1.59 (m, 1H, 
H3), 1.40–1.35 (m, 2H, H11), 1.34–1.22 (m, 4H, H12/H13), 0.89 (t, J = 7.2 Hz, 3H, H14), 0.15 
(s, 3H, H15), 0.10 (s, 3H, H15). 
 
13C NMR (CDCl3, 126 MHz) δ 142.5 (C4), 141.4 (CAr), 128.4 (CAr), 128.2 (CAr), 125.6 (CAr), 
118.7 (C5), 72.6 (C7), 40.7 (C8), 39.7 (C10), 36.3 (C6), 32.1 (C9), 27.0 (C11), 22.5 (C3), 22.2 
(C12), 18.4 (C13), 13.9 (C14), −1.6 (C15), −2.0 (C15). 
 
IR (thin film) 2924, 2862, 1450, 1250, 1096 cm−1. 
 
HRMS (ESI) for C20H32NaOSi: 339.2115, found: 339.2099. 
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4-(2-(Benzyloxy)pentyl)-2,2-dimethyl-7-phenethyl-2,3,6,7-
tetrahydro-1,2-oxasilepine (3.37). 
 
C27H38O2Si 
Mol. Wt. = 422.68 g/mol 
 
 
 
Seven-membered ring 3.37 (yellow oil) was obtained from the corresponding oxysilane 3.34 
according to the procedure described above for seven-membered ring 3.36. 
Purification by flash chromatography (99.5:0.05 PE/Et2O). 
Scale: 0.27 mmol. 
Yield: 95%. 
 
1H NMR (CDCl3, 500 MHz) δ 7.37–7.32 (m, 4H, HAr), 7.31–7.26 (m, 3H, HAr), 7.22–7.18 (m, 
3H, HAr), 5.44 (t, J =  7.0 Hz, 1H, H5), 4.55 (d, J = 11.6 Hz, 1H, H15), 4.51 (d, J = 11.6, 1H, 
H15), 3.87–3.78 (m, 1H, H7), 3.56–3.48 (m, 1H, H11), 2.76 (ddd, J = 14.5, 9.7, 5.2 Hz, 1H, 
H9), 2.68–2.60 (m, 1H, H9), 2.40–2.26 (m, 2H, H6/H10), 2.26–2.19 (m, 1H, H6), 2.16–2.09 
(m, 1H, H10), 1.90–1.80 (m, 1H, H8), 1.75–1.64 (m, 2H, H3/H8), 1.55–1.47 (m, 3H, H12/H13), 
1.47–1.41 (m, 1H, H3), 1.40–1.32 (m, 1H, H13), 0.95–0.88 (m, 3H, H14), 0.17 (s, 3H, H16), 
0.16 (s, 3H, H16). 
 
13C NMR (CDCl3, 126 MHz) δ 142.6 (C4), 139.1 (CAr), 138.4 (CAr), 128.7 (CAr), 128.6 (CAr), 
128.4 (CAr), 127.9 (CAr), 127.5 (CAr), 125.7 (CAr), 122.2 (C5), 77.1 (C11), 72.8 (C7), 71.1 (C15), 
46.0 (C10), 40.0 (C8), 36.8 (C6), 36.6 (C12), 32.4 (C9), 23.0 (C3), 18.9 (C13), 14.4 (C14), −1.7 
(C16), −1.8 (C16). 
 
IR (thin film) 3026, 2955, 2930, 2870, 1250, 1096, 1063 cm−1. 
 
HRMS (ESI) for C27H38NaO2Si: 445.2533, found: 445.2512. 
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7-Isopropyl-2,2-dimethyl-4-pentyl-2,3,6,7-tetrahydro-1,2-
oxasilepine 3.38. 
 
C15H30OSi 
Mol. Wt. = 254.49 g/mol 
 
 
 
Seven-membered ring 3.38 (colourless oil) was obtained from the corresponding oxysilane 
3.35 according to the procedure described above for seven-membered ring 3.36. 
Purification by flash chromatography (99.9:0.01 PE/Et2O). 
Scale: 1.26 mmol. 
Yield: 82%. 
 
1H NMR (CDCl3, 500 MHz) δ 5.33 (td, J = 7.6, 1.3 Hz, 1H, H5), 3.48 (ddd, J = 8.4, 6.3, 2.1 
Hz, 1H, H7), 2.28–2.12 (m, 2H, H6), 1.96 (t, J = 7.5 Hz, 2H, H10), 1.66 (s, 2H, H3), 1.65–1.59 
(m, 1H, H8), 1.43–1.34 (m, 2H, H11), 1.34–1.21 (m, 4H, H12/H13), 0.91–0.84 (m, 9H, H9/H14), 
0.10 (s, 3H, H15), 0.08 (s, 3H, H15). 
 
13C NMR (CDCl3, 126 MHz) δ 141.2 (C4), 119.4 (C5), 78.8 (C7), 41.1 (C10), 34.6 (C8), 33.6 
(C6), 31.8 (C12 or C13), 27.3 (C11), 22.8 (C12 or C13), 22.6 (C3), 18.9 (C9), 18.5 (C9), 14.2 (C14), 
0.1 (C15), −1.8 (C15). 
 
IR (thin film) 2955, 2924, 2862, 1466, 1250, 1042, 833 cm−1. 
 
HRMS (CI+) for C15H31OSi: 255.2139, found: 255.2144. 
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(Z)-2-Pentyl-7-phenylhept-2-ene-1,5-diol (3.43).  
 
C18H28O2 
Mol. Wt. = 276.42 g/mol 
 
 
 
To a solution of seven-membered ring 3.36 (30 mg, 0.095 mmol) in a 1:1 mixture of 
THF/methanol (4 mL) was added potassium fluoride (28 mg, 0.47 mmol, 5.0 equiv), 
potassium bicarbonate (22 mg, 0.22 mmol, 2.3 equiv) and a 30% wt aqueous solution of 
hydrogen peroxide (0.50 mL, 3.79 mmol, 40.0 equiv). The reaction was warmed to 40 °C 
and stirred for 4 h. Water (5 mL) was added and the aqueous phase was extracted with 
EtOAc (3 × 5 mL). The organic layers were combined, dried over sodium sulfate, filtered 
and concentrated under vacuum. The crude was purified by flash chromatography (50:50 
PE/Et2O) to furnish diol 3.43 (18.5 mg, 70%) as a thick colourless oil. 
 
1H NMR (CDCl3, 500 MHz) δ 7.33–7.27 (m, 2H, HAr), 7.23–7.17 (m, 3H, HAr), 5.35 (t, J = 8.1 
Hz, 1H, H3), 4.15 (d, J = 11.5 Hz, 1H, H1), 3.97 (d, J = 11.5 Hz, 1H, H1), 3.64 (tdd, J = 7.6, 
5.1, 3.8 Hz, 1H, H5), 2.85–2.72 (m, 1H, H7), 2.74 (brs, 1H, OH), 2.74–2.64 (m, 1H, H7), 
2.34–2.23 (m, 2H, H4), 2.17–2.09 (m, 2H, H8), 1.85–1.77 (m, 2H, H6), 1.48–1.38 (m, 2H, 
H9), 1.36–1.23 (m, 4H, H10/H11), 0.89 (t, J = 7.1 Hz, 3H, H12). 
 
13C NMR (CDCl3, 126 MHz) δ 143.1 (C2), 142.0 (CAr), 128.6 (CAr), 128.5 (CAr), 126.0 (CAr), 
124.1 (C3), 70.1 (C5), 59.9 (C1), 38.9 (C6), 36.6 (C8), 35.6 (C4), 32.3 (C7), 31.7 (C10 or C11), 
28.1 (C9), 22.7 (C10 or C11), 14.2 (C12). 
 
IR (thin film) 3318, 2924, 2855, 1450, 1003 cm−1. 
 
HRMS (ESI) for C18H28NaO2: 299.1982, found: 299.1969. 
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(Z)-2-(2-(Benzyloxy)pentyl)-7-phenylhept-2-ene-1,5-diol (3.44). 
 
C25H34O3 
Mol. Wt. = 382.54 g/mol 
 
 
 
Diol 3.44 (colourless oil) was obtained from the corresponding seven-membered ring 3.37 
according to the procedure described above for diol 3.43. 
Purification by flash chromatography (40:60 PE/Et2O). 
Scale: 0.25 mmol. 
Yield: 90%. 
 
1H NMR (CDCl3, 500 MHz)  δ 7.36–7.31 (m, 4H, HAr), 7.31–7.26 (m, 3H, HAr), 7.23–7.17 (m, 
3H, HAr), 5.43 (t, J = 8.0 Hz, 1H, H3), 4.60–4.48 (m, 2H, H13), 4.18–3.92 (m, 2H, H1), 3.69–
3.62 (m, 1H, H5), 3.62–3.54 (m, 3H, H5/H9), 2.85–2.75 (m, 1H, H7), 2.73–2.63 (m, 1H, H7), 
2.48–2.39 (m, 1H, H4), 2.39–2.21 (m, 3H, H4/H8), 1.84–1.73 (m, 2H, H6), 1.66–1.56 (m, 1H, 
H10), 1.54–1.45 (m, 1H, H10), 1.43–1.33 (m, 2H, H11), 0.91 (t, J = 7.3 Hz, 3H, H12). 
 
13C NMR (CDCl3, 126 MHz) δ 142.2 (C2), 139.6 (CAr), 139.3 (CAr), 138.2 (CAr), 128.5 (CAr), 
128.1 (CAr), 127.9 (CAr), 127.8 (CAr), 127.2 (C3), 125.9 (CAr), 79.2 (C9), 71.3 (C13), 70.2 (C5), 
60.6 (C1), 41.3 (C4), 39.1 (C6), 36.1 (C10), 35.8 (C8), 32.3 (C7), 18.8 (C11), 14.4 (C12). 
 
IR (thin film) 3356, 3324, 2924, 2862, 1450, 1057, 1003, 741 cm−1. 
 
HRMS (ESI) for C25H34NaO3: 405.2400, found: 405.2386. 
 
  
204 
 
(Z)-6-Methyl-2-pentylhept-2-ene-1,5-diol (3.45). 
 
C13H26O2 
Mol. Wt. = 214.35 g/mol 
 
 
 
Diol 3.45 (colourless oil) was obtained from the corresponding seven-membered ring 3.38 
according to the procedure described above for diol 3.43. 
Purification by flash chromatography (50:50 PE/Et2O). 
Scale: 0.95 mmol. 
Yield: 76%. 
 
1H NMR (CDCl3, 500 MHz) δ 5.36 (t, J = 8.2 Hz, 1H, H3), 4.18 (d, J = 11.5 Hz, 1H, H1), 3.92 
(d, J = 11.5 Hz, 1H, H1), 3.34 (ddd, J = 8.2, 6.5, 2.9 Hz, 1H, H5), 2.28 (dt, J = 14.1, 8.7 Hz, 
1H, H4), 2.23–2.15 (m, 1H, H4), 2.12 (app q, J = 6.9 Hz, 2H, H8), 1.76–1.63 (oct, J = 6.5 Hz, 
1H, H6), 1.47–1.39 (m, 2H, H9), 1.35–1.23 (m, 4H, H10 /H11), 0.95 (d, J = 6.5 Hz, 3H, H7), 
0.93 (d, J = 6.5 Hz, 3H, H7), 0.88 (t, J = 7.1 Hz, 3H, H12). 
 
13C NMR (CDCl3, 126 MHz) δ 143.0 (C2), 124.9 (C3), 75.7 (C5), 60.0 (C1), 36.7 (C8), 33.7 
(C6), 32.4 (C4), 31.8 (C10 or C11), 28.1 (C9), 22.7 (C10 or C11), 18.8 (C7), 17.9 (C7), 14.2 (C12). 
 
IR (thin film) 3310, 2955, 2924, 2870, 1465, 1003 cm−1. 
 
HRMS (ESI) for C13H26NaO2: 237.1825, found: 237.1818. 
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(E)-6-Methyl-1-phenylundec-5-en-3-ol (3.46). 
 
C18H28O 
Mol. Wt. = 260.42 g/mol 
 
 
 
Diol 3.43 (50 mg, 0.18) was dissoled in acetonitrile (3 mL) then triphenylphosphine (57 mg, 
0.22 mmol, 1.2 equiv), 2,6-lutidine (21 µL, 0.18 mmol, 1.0 equiv) and carbon tetrabromide 
(72 mg, 0.22 mmol, 1.2 equiv) were added. The reaction was stirred at RT for 1 h then was 
quenched with water (3 mL), the phases were separated and the aqueous phase was 
extracted with Et2O (3 × 5 mL). The organic layers were combined, dried over sodium 
sulfate, filtered and concentrated under vacuum. The crude product was used in the next 
step without further purification. 
The above crude was dissolved in THF (3 mL), cooled to 0 °C and a 1 M solution of lithium 
triethylborohydride (0.9 mL, 0.9 mmol, 5 equiv) in THF was added dropwise (over 10 min). 
The reaction was stirred at 0 °C for 1 h then the reaction was quenched with a 1 M aqueous 
solution of hydrochloric acid (5 mL). The phases were separated and the aqueous phase 
was extracted with Et2O (3 × 5 mL), the combined organic phases were dried over 
magnesium sulfate, filtered and concentrated under vacuum. The crude was purified by 
flash chromatography (70:30 PE/Et2O) to afford product 3.46 (33 mg, 71% over 2 steps) as 
a clear oil. 
 
1H NMR (CDCl3, 500 MHz) δ 7.31–7.27 (m, 2H, HAr), 7.24–7.16 (m, 3H, HAr), 5.19–5.14 (m, 
1H, H5), 3.64 (dt, J = 12.6, 6.8 Hz, 1H, H3), 2.82 (ddd, J = 13.7, 9.1, 6.3 Hz, 1H, H1), 2.69 
(ddd, J = 13.7, 9.2, 7.2 Hz, 1H, H1), 2.22 (t, J = 6.8 Hz, 2H, H4), 2.01 (t, J = 7.6 Hz, 2H, H7), 
1.83–1.77 (m, 2H, H2), 1.63 (d, J = 1.4 Hz, 3H, H12) 1.40 (quint, J = 7.6 Hz, 2H, H8), 1.35–
1.28 (m, 2H, H10), 1.28–1.21 (m, 2H, H9), 0.89 (t, J = 7.2 Hz, 3H, H11). 
 
13C NMR (CDCl3, 126 MHz) δ 142.4 (CAr), 139.7 (C6), 128.6 (CAr), 128.5 (CAr), 125.9 (CAr), 
119.6 (C5), 71.1 (C3), 40.0 (C7), 38.6 (C2), 36.4 (C4), 32.3 (C1), 31.7 (C9), 27.8 (C8), 22.7 
(C10), 16.4 (C12), 14.2 (C11). 
 
IR (thin film) 3372, 2924, 2855, 1604, 1450, 1049 cm−1. 
 
HRMS (ESI) for C18H28NaO: 283.2032, found: 283.2020. 
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 (E)-8-(Benzyloxy)-6-methyl-1-phenylundec-5-en-3-ol (3.47). 
 
C25H34O2 
Mol. Wt. = 366.55 g/mol 
 
 
 
Product 3.47 (colourless oil) was obtained from the corresponding diol 3.44 according to 
the procedure described above for product 3.46. 
Purification by flash chromatography (70:30 PE/Et2O). 
Scale: 0.11 mmol. 
Yield: 65% over 2 steps. 
 
1H NMR (CDCl3, 500 MHz)  δ 7.32 (t, J = 4.1 Hz, 4H, HAr), 7.30–7.27 (m, 3H, HAr), 7.22–
7.17 (m, 3H, HAr), 5.24 (app q, J = 7.6 Hz, 1H, H5), 4.51 (d, J = 3.4 Hz, 1H, H13), 4.50 (d, J 
= 3.4 Hz, 1H, H13), 3.67–3.58 (m, 1H, H3), 3.55–3.46 (m, 1H, H8), 2.84–2.75 (m, 1H, H1), 
2.71–2.63 (m, 1H, H1), 2.35 (dd, J = 13.8, 6.6 Hz, 1H, H7), 2.24–2.14 (m, 3H, H4/H7), 1.81–
1.74 (m, 2H, H2), 1.65 (s, 3H, H12), 1.53–1.41 (m, 3H, H9/H10), 1.39–1.27 (m, 1H, H10), 0.92–
0.83 (m, 3H, H11). 
 
13C NMR (CDCl3, 101 MHz) δ 142.2 (C6), 138.9 (CAr), 136.1 (CAr), 128.4 (CAr), 128.4 (CAr), 
128.3 (CAr), 127.7 (CAr), 127.4 (CAr), 125.8 (CAr), 122.5 (C5), 77.2 (C8), 70.9 (C3), 70.8 (C13), 
44.7 (C7), 38.4 (C2), 36.3 (C4), 36.2 (C9), 32.2 (C1), 18.6 (C10), 16.9 (C12), 14.2 (C11). 
 
IR (thin film) 3352, 2924, 2862, 1451, 1350, 1057, 732 cm−1. 
 
HRMS (ESI) for C25H34NaO2: 389.2451, found: 389.2432. 
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 (E)-2,6-dimethylundec-5-en-3-ol (3.48). 
 
C13H26O 
Mol. Wt. = 198.35 g/mol 
 
 
 
Product 3.48 (colourless oil) was obtained from the corresponding diol 3.45 according to 
the procedure described above for product 3.46. 
Purification by flash chromatography (70:30 PE/Et2O). 
Scale: 0.65 mmol. 
Yield: 76% over 2 steps. 
 
1H NMR (CDCl3, 500 MHz) δ 5.19–5.14 (m, 1H, H5), 3.34 (dt, J = 9.4, 5.1 Hz, 1H, H3), 2.19–
2.10 (m, 2H, H4), 2.00 (t, J = 7.4 Hz, 2H, H7), 1.73–1.65 (m, 1H, H2), 1.62 (s, 3H, H12), 1.43–
1.36 (m, 2H, H8), 1.34–1.26 (m, 2H, H10), 1.26–1.19 (m, 2H, H9), 0.94 (d, J = 6.9 Hz, 3H, 
H1), 0.92 (d, J = 6.9 Hz, 3H, H1), 0.88 (t, J = 7.2 Hz, 3H, H11). 
 
13C NMR (CDCl3, 126 MHz) δ 139.4 (C6), 120.3 (C5), 76.5 (C3), 40.0 (C7), 33.2 (C2), 33.1 
(C4), 31.7 (C9), 27.8 (C8), 22.7 (C10), 19.0 (C1), 17.7 (C1), 16.3 (C12), 14.2 (C11). 
 
IR (thin film) 3364, 2954, 2924, 2862, 1458, 1381, 1034, 995 cm−1. 
 
HRMS (ESI) for C13H26NaO: 221.1876, found: 221.1867. 
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